Intel (INTC) 10-K 14 Feb 14 2013 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
In Billions, except Share data in Millions, unless otherwise specified	Dec. 28, 2013	Feb. 07, 2014	Jun. 28, 2013
Document and Entity Information [Abstract]	'	'	'
Entity Registrant Name	'Intel Corporation	'	'
Entity Central Index Key	'0000050863	'	'
Company Fiscal Year End Date	'--12-28	'	'
Entity Filer Category	'Large Accelerated Filer	'	'
Document Type	'10-K	'	'
Document Period End Date	28-Dec-13	'	'
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'
Amendment Flag	'false	'	'
Entity Common Stock Shares Outstanding	'	4,972	'
Entity Well-known Seasoned Issuer	'Yes	'	'
Entity Voluntary Filers	'No	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Public Float	'	'	$120.60

Consolidated_Statements_of_Inc

Consolidated Statements of Income (USD $)	12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Dec. 28, 2013	Dec. 29, 2012	Dec. 31, 2011
Net revenue	$52,708	$53,341	$53,999
Cost of sales	21,187	20,190	20,242
Gross margin	31,521	33,151	33,757
Research and development	10,611	10,148	8,350
Marketing, general and administrative	8,088	8,057	7,670
Restructuring and asset impairment charges	240	0	0
Operating expenses	19,230	18,513	16,280
Operating income	12,291	14,638	17,477
Gains (losses) on equity investments, net	471	141	112
Interest and other, net	-151	94	192
Income before taxes	12,611	14,873	17,781
Provision for taxes	2,991	3,868	4,839
Net income	9,620	11,005	12,942
Basic earnings per common share (in dollars per share)	$1.94	$2.20	$2.46
Diluted earnings per common share (in dollars per share)	$1.89	$2.13	$2.39
Weighted average common shares outstanding:	'	'	'
Basic (shares)	4,970	4,996	5,256
Diluted (shares)	5,097	5,160	5,411
Operating Expense [Member]	'	'	'
Amortization of acquisition-related intangibles	$291	$308	$260

Consolidated_Statements_of_Com

Consolidated Statements of Comprehensive Income (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 28, 2013	Dec. 29, 2012	Dec. 31, 2011
Consolidated Statements Of Comprehensive Income [Abstract]	'	'	'
Net income	$9,620	$11,005	$12,942
Other comprehensive income, net of tax:	'	'	'
Change in net unrealized holding gains (losses) on available-for-sale investments	1,181	470	-170
Change in net deferred tax asset valuation allowance	-26	-11	-99
Change in net unrealized holding gains (losses) on derivatives	-89	85	-119
Change in net prior service costs	18	0	4
Change in actuarial valuation	520	-172	-588
Change in net foreign currency translation adjustment	38	10	-142
Other comprehensive income (loss)	1,642	382	-1,114
Total comprehensive income	$11,262	$11,387	$11,828

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 28, 2013	Dec. 29, 2012
In Millions, unless otherwise specified
Current assets:	'	'
Cash and cash equivalents	$5,674	$8,478
Short-term investments	5,972	3,999
Trading assets	8,441	5,685
Accounts receivable, net of allowance for doubtful accounts of $38 ($38 in 2012)	3,582	3,833
Inventories	4,172	4,734
Deferred tax assets	2,594	2,117
Other current assets	1,649	2,512
Total current assets	32,084	31,358
Property, plant and equipment, net	31,428	27,983
Marketable equity securities	6,221	4,424
Other long-term investments	1,473	493
Goodwill	10,513	9,710
Identified intangible assets, net	5,150	6,235
Other long-term assets	5,489	4,148
Total assets	92,358	84,351
Current liabilities:	'	'
Short-term debt	281	312
Accounts payable	2,969	3,023
Accrued compensation and benefits	3,123	2,972
Accrued advertising	1,021	1,015
Deferred income	2,096	1,932
Other accrued liabilities	4,078	3,644
Total current liabilities	13,568	12,898
Long-term debt	13,165	13,136
Long-term deferred tax liabilities	4,397	3,412
Other long-term liabilities	2,972	3,702
Stockholders' equity:	'	'
Preferred stock, $0.001 par value, 50 shares authorized; none issued	0	0
Common stock, $0.001 par value, 10,000 shares authorized; 4,967 issued and outstanding (4,944 issued and outstanding in 2012) and capital in excess of par value	21,536	19,464
Accumulated other comprehensive income (loss)	1,243	-399
Retained earnings	35,477	32,138
Total stockholders' equity	58,256	51,203
Total liabilities and stockholders' equity	$92,358	$84,351

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Dec. 28, 2013	Dec. 29, 2012
In Millions, except Per Share data, unless otherwise specified
Current assets:	'	'
Accounts receivable allowance for doubtful accounts	$38	$38
Stockholders' equity:	'	'
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares authorized	50	50
Preferred stock, shares issued	0	0
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares authorized	10,000	10,000
Common stock, shares issued	4,967	4,944
Common stock, shares outstanding	4,967	4,944

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 28, 2013	Dec. 29, 2012	Dec. 31, 2011
Cash and cash equivalents, beginning of year	$8,478	$5,065	$5,498
Cash flows provided by (used for) operating activities:	'	'	'
Net income	9,620	11,005	12,942
Adjustments to reconcile net income to net cash provided by operating activities:	'	'	'
Depreciation	6,790	6,357	5,141
Share-based compensation	1,118	1,102	1,053
Restructuring and asset impairment charges	240	0	0
Excess tax benefit from share-based payment arrangements	-49	-142	-37
Amortization of intangibles	1,242	1,165	923
(Gains) losses on equity investments, net	-425	-141	-112
(Gains) losses on divestitures	0	0	-164
Deferred taxes	-900	-242	790
Changes in assets and liabilities:	'	'	'
Accounts receivable	271	-176	-678
Inventories	563	-626	-243
Accounts payable	267	67	596
Accrued compensation and benefits	155	192	-95
Income taxes payable and receivable	1,019	229	660
Other assets and liabilities	865	94	187
Total adjustments	11,156	7,879	8,021
Net cash provided by operating activities	20,776	18,884	20,963
Cash flows provided by (used for) investing activities:	'	'	'
Additions to property, plant and equipment	-10,711	-11,027	-10,764
Acquisitions, net of cash acquired	-925	-638	-8,721
Purchases of available-for-sale investments	-12,493	-8,694	-11,230
Sales of available-for-sale investments	934	2,282	9,076
Maturities of available-for-sale investments	8,336	5,369	11,029
Purchases of trading assets	-16,718	-16,892	-11,314
Maturities and sales of trading assets	13,677	15,786	11,771
Collection of loans receivable	132	149	134
Origination of loans receivable	-200	-216	-206
Investments in non-marketable equity investments	-440	-475	-693
Return of equity method investments	45	137	263
Proceeds from divestitures	0	0	50
Other investing	326	369	370
Net cash used for investing activities	-18,073	-14,060	-10,301
Cash flows provided by (used for) financing activities:	'	'	'
Increase (decrease) in short-term debt, net	-31	65	209
Proceeds from government grants	129	63	124
Excess tax benefit from share-based payment arrangements	49	142	37
Issuance of long-term debt, net of issuance costs	0	6,124	4,962
Repayment of debt	0	-125	0
Proceeds from sales of shares through employee equity incentive plans	1,588	2,111	2,045
Repurchase of common stock	-2,440	-5,110	-14,340
Payment of dividends to stockholders	-4,479	-4,350	-4,127
Other financing	-314	-328	-10
Net cash used for financing activities	-5,498	-1,408	-11,100
Effect of exchange rate fluctuations on cash and cash equivalents	-9	-3	5
Net increase (decrease) in cash and cash equivalents	-2,804	3,413	-433
Cash and cash equivalents, end of year	5,674	8,478	5,065
Cash paid during the year for:	'	'	'
Interest, net of capitalized interest	204	71	0
Income taxes, net of refunds	2,874	3,930	3,338
Licensed Technology and Patents [Member]	'	'	'
Adjustments to reconcile net income to net cash provided by operating activities:	'	'	'
Amortization of intangibles	272	214	181
Cash flows provided by (used for) investing activities:	'	'	'
Purchases of licensed technology and patents	-36	-815	-66
IM Flash Technologies, LLC and IM Flash Singapore, LLP [Member] | Micron Technology, Inc. [Member]	'	'	'
Cash flows provided by (used for) investing activities:	'	'	'
Proceeds from the sale of IM Flash Singapore, LLP assets and certain IM Flash Technologies, LLC assets	$0	$605	$0

Consolidated_Statements_of_Sto

Consolidated Statements of Stockholders' Equity (USD $)	Total	Common Stock and Capital in Excess of Par Value [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Retained Earnings [Member]
In Millions, unless otherwise specified
Beginning Balance at Dec. 25, 2010	$49,430	$16,178	$333	$32,919
Beginning Balance, shares at Dec. 25, 2010	'	5,511	'	'
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'	'	'	'
Proceeds from sales of shares through employee equity incentive plans, net excess tax benefit/tax deficiency, and other, shares	'	142	'	'
Repurchase of Common Stock, Shares	'	-653	'	'
Components of comprehensive income, net of tax:	'	'	'	'
Net income	12,942	'	'	12,942
Other comprehensive income (loss)	-1,114	'	-1,114	'
Total comprehensive income	11,828	'	'	'
Proceeds from sales of shares through employee equity incentive plans, net excess tax benefit/tax deficiency, and other	2,019	2,019	'	'
Assumption of equity awards in connection with acquisitions	48	48	'	'
Share-based compensation	1,053	1,053	'	'
Repurchase of Common Stock, Value	-14,340	-2,262	'	-12,078
Cash dividends declared	-4,127	'	'	-4,127
Ending Balance at Dec. 31, 2011	45,911	17,036	-781	29,656
Ending Balance, shares at Dec. 31, 2011	'	5,000	'	'
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'	'	'	'
Proceeds from sales of shares through employee equity incentive plans, net excess tax benefit/tax deficiency, and other, shares	'	148	'	'
Repurchase of Common Stock, Shares	'	-204	'	'
Components of comprehensive income, net of tax:	'	'	'	'
Net income	11,005	'	'	11,005
Other comprehensive income (loss)	382	'	382	'
Total comprehensive income	11,387	'	'	'
Proceeds from sales of shares through employee equity incentive plans, net excess tax benefit/tax deficiency, and other	2,257	2,257	'	'
Share-based compensation	1,108	1,108	'	'
Repurchase of Common Stock, Value	-5,110	-937	'	-4,173
Cash dividends declared	-4,350	'	'	-4,350
Ending Balance at Dec. 29, 2012	51,203	19,464	-399	32,138
Ending Balance, shares at Dec. 29, 2012	4,944	4,944	'	'
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'	'	'	'
Proceeds from sales of shares through employee equity incentive plans, net excess tax benefit/tax deficiency, and other, shares	'	130	'	'
Repurchase of Common Stock, Shares	'	-107	'	'
Components of comprehensive income, net of tax:	'	'	'	'
Net income	9,620	'	'	9,620
Other comprehensive income (loss)	1,642	'	1,642	'
Total comprehensive income	11,262	'	'	'
Proceeds from sales of shares through employee equity incentive plans, net excess tax benefit/tax deficiency, and other	1,593	1,593	'	'
Share-based compensation	1,117	1,117	'	'
Repurchase of Common Stock, Value	-2,440	-638	'	-1,802
Cash dividends declared	-4,479	'	'	-4,479
Ending Balance at Dec. 28, 2013	$58,256	$21,536	$1,243	$35,477
Ending Balance, shares at Dec. 28, 2013	4,967	4,967	'	'

Consolidated_Statements_of_Sto1

Consolidated Statements of Stockholders' Equity (Parenthetical) (Retained Earnings [Member], USD $)	12 Months Ended
	Dec. 28, 2013	Dec. 29, 2012	Dec. 31, 2011
Retained Earnings [Member]	'	'	'
Cash dividends declared per common share (in dollars per share)	$0.90	$0.87	$0.78

Basis_of_Presentation

Basis of Presentation	12 Months Ended
	Dec. 28, 2013
Basis of Presentation [Abstract]	'
Basis of Presentation [Text Block]	'
	Note 1: Basis of Presentation
	We have a 52- or 53-week fiscal year that ends on the last Saturday in December. Fiscal years 2013 and 2012 were 52-week years. Fiscal year 2011 was a 53-week year. The next 53-week year will end on December 31, 2016. Our consolidated financial statements include the accounts of Intel Corporation and our subsidiaries. We have eliminated intercompany accounts and transactions. We use the equity method to account for equity investments in instances in which we own common stock or similar interests and have the ability to exercise significant influence, but not control, over the investee.
	In the first quarter of 2011, we completed the acquisition of McAfee, Inc. (McAfee). For further information, see “Note 8: Acquisitions.” Certain of the operations acquired from McAfee have a functional currency other than the U.S. dollar. As a result, we have recorded translation adjustments through accumulated other comprehensive income (loss) beginning in 2011.

Accounting_Policies

Accounting Policies	12 Months Ended
	Dec. 28, 2013
Accounting Policies [Abstract]	'
Accounting Policies [Text Block]	'
	Note 2: Accounting Policies
	Use of Estimates
	The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires us to make estimates and judgments that affect the amounts reported in our consolidated financial statements and the accompanying notes. The accounting estimates that require our most significant, difficult, and subjective judgments include:
	•	the valuation of non-marketable equity investments and the determination of other-than-temporary impairments;
	•	the assessment of recoverability of long-lived assets (property, plant and equipment; goodwill; and identified intangibles);
	•	the recognition and measurement of current and deferred income taxes (including the measurement of uncertain tax positions);
	•	the valuation of inventory; and
	•	the recognition and measurement of loss contingencies.
	The actual results that we experience may differ materially from our estimates.
	Fair Value
	Fair value is the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining fair value, we consider the principal or most advantageous market in which we would transact, and we consider assumptions that market participants would use when pricing the asset or liability. Our financial assets are measured and recorded at fair value, except for equity method investments, cost method investments, cost method loans receivable, and reverse repurchase agreements with original maturities greater than approximately three months. Most of our liabilities are not measured and recorded at fair value.
	Fair Value Hierarchy
	The three levels of inputs that may be used to measure fair value are as follows:
	Level 1. Quoted prices in active markets for identical assets or liabilities.
	Level 2. Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in less active markets, or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated with observable market data for substantially the full term of the assets or liabilities. Level 2 inputs also include non-binding market consensus prices that can be corroborated with observable market data, as well as quoted prices that were adjusted for security-specific restrictions.
	Level 3. Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of assets or liabilities. Level 3 inputs also include non-binding market consensus prices or non-binding broker quotes that we were unable to corroborate with observable market data.
	For further discussion of fair value, see “Note 4: Fair Value” and “Note 17: Retirement Benefit Plans.”
	Cash Equivalents
	We consider all highly liquid debt investments with original maturities from the date of purchase of approximately three months or less as cash equivalents. Cash equivalents can include investments such as asset-backed securities, bank deposits, commercial paper, corporate bonds, government bonds, money market fund deposits, municipal bonds, and reverse repurchase agreements classified as cash equivalents. See "Note 4: Fair Value" for the instruments held as cash equivalents.
	Trading Assets
	Marketable debt instruments are generally designated as trading assets when a market risk is economically hedged at inception with a related derivative instrument, or when the marketable debt instrument itself is used to economically hedge foreign exchange rate risk from remeasurement. Investments designated as trading assets are reported at fair value. The gains or losses of these investments arising from changes in fair value due to interest rate and currency market fluctuations and credit market volatility, largely offset by losses or gains on the related derivative instruments and balance sheet remeasurement, are recorded in interest and other, net. We also designate certain floating-rate securitized financial instruments, primarily asset-backed securities, as trading assets.
	Available-for-Sale Investments
	We consider all liquid available-for-sale debt instruments with original maturities from the date of purchase of approximately three months or less to be cash and cash equivalents. Available-for-sale debt instruments with original maturities at the date of purchase greater than approximately three months and remaining maturities of less than one year are classified as short-term investments. Available-for-sale debt instruments with remaining maturities beyond one year are classified as other long-term investments.
	Investments that we designate as available-for-sale are reported at fair value, with unrealized gains and losses, net of tax, recorded in accumulated other comprehensive income (loss), except as noted in the “Other-Than-Temporary Impairment” section that follows. We determine the cost of the investment sold based on an average cost basis at the individual security level. Our available-for-sale investments include:
	•	Marketable debt instruments when the interest rate and foreign currency risks are not hedged at the inception of the investment or when our criteria for designation as trading assets are not met. We generally hold these debt instruments to generate a return commensurate with the U.S.-dollar three-month LIBOR. We record the interest income and realized gains and losses on the sale of these instruments in interest and other, net.
	•	Marketable equity securities when there is no plan to sell or hedge the investment at the time of original classification. We acquire these equity investments to promote business and strategic objectives. To the extent that these investments continue to have strategic value, we typically do not attempt to reduce or eliminate the equity market risks through hedging activities. We record the realized gains or losses on the sale or exchange of marketable equity securities in gains (losses) on equity investments, net.
	Non-Marketable and Other Equity Investments
	Our non-marketable equity and other equity investments are included in other long-term assets. We account for non-marketable equity and other equity investments for which we do not have control over the investee as:
	•	Equity method investments when we have the ability to exercise significant influence, but not control, over the investee. Equity method investments include marketable and non-marketable investments. Our proportionate share of the income or loss is recognized on a one-quarter lag and is recorded in gains (losses) on equity investments, net.
	•	Non-marketable cost method investments when the equity method does not apply. We record the realized gains or losses on the sale of non-marketable cost method investments in gains (losses) on equity investments, net.
	Other-Than-Temporary Impairment
	Our available-for-sale investments and non-marketable and other equity investments are subject to a periodic impairment review. Investments are considered impaired when the fair value is below the investment’s adjusted cost basis. Impairments affect earnings as follows:
	•	Marketable debt instruments when the fair value is below amortized cost and we intend to sell the instrument, or when it is more likely than not that we will be required to sell the instrument before recovery of its amortized cost basis, or when we do not expect to recover the entire amortized cost basis of the instrument (that is, a credit loss exists). When we do not expect to recover the entire amortized cost basis of the instrument, we separate other-than-temporary impairments into amounts representing credit losses, which are recognized in interest and other, net, and amounts related to all other factors, which are recognized in other comprehensive income (loss).
	•	Marketable equity securities based on the specific facts and circumstances present at the time of assessment, which include the consideration of general market conditions, the duration and extent to which the fair value is below cost, and our ability and intent to hold the investment for a sufficient period of time to allow for recovery of value in the foreseeable future. We also consider specific adverse conditions related to the financial health of, and the business outlook for, the investee, which may include industry and sector performance, changes in technology, operational and financing cash flow factors, and changes in the investee’s credit rating. We record other-than-temporary impairment charges on marketable equity securities and marketable equity method investments in gains (losses) on equity investments, net.
	•	Non-marketable equity investments based on our assessment of the severity and duration of the impairment, and qualitative and quantitative analysis, including:
	•	the investee’s revenue and earnings trends relative to pre-defined milestones and overall business prospects;
	•	the technological feasibility of the investee’s products and technologies;
	•	the general market conditions in the investee’s industry or geographic area, including adverse regulatory or economic changes;
	•	factors related to the investee’s ability to remain in business, such as the investee’s liquidity and debt ratios, and the rate at which the investee is using its cash; and
	•	the investee’s receipt of additional funding at a lower valuation.
	We record other-than-temporary impairment charges for non-marketable cost method investments and equity method investments in gains (losses) on equity investments, net.
	Derivative Financial Instruments
	Our primary objective for holding derivative financial instruments is to manage currency exchange rate and interest rate risk, and, to a lesser extent, equity market risk, commodity price risk, and credit risk. Our derivative financial instruments are recorded at fair value and are included in other current assets, other long-term assets, other accrued liabilities, or other long-term liabilities.
	Our accounting policies for derivative financial instruments are based on whether they meet the criteria for designation as a cash flow hedge. A designated hedge with exposure to variability in the functional currency equivalent of the future foreign currency cash flows of a forecasted transaction is one example of a cash flow hedge. The criteria for designating a derivative as a cash flow hedge include the assessment of the instrument’s effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction, and the assessment of the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the after-tax gain or loss from the effective portion of the hedge as a component of accumulated other comprehensive income (loss) and reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings, and in the same line item on the consolidated statements of income as the impact of the hedged transaction. Derivatives that we designate as cash flow hedges are classified in the consolidated statements of cash flows in the same section as the underlying item, primarily within cash flows from operating activities.
	We recognize gains and losses from changes in fair value of derivatives that are not designated as hedges for accounting purposes in the line item on the consolidated statements of income most closely associated with the related exposures, primarily in interest and other, net and gains (losses) on equity investments, net. As part of our strategic investment program, we also acquire equity derivative instruments, such as equity conversion rights associated with debt instruments, that we do not designate as hedging instruments. We recognize the gains or losses from changes in fair value of these equity derivative instruments in gains (losses) on equity investments, net. Gains and losses from derivatives not designated as hedges are classified in the consolidated statements of cash flows within cash flows from operating activities.
	Measurement of Effectiveness
	•	Effectiveness for forwards is generally measured by comparing the cumulative change in the fair value of the hedge contract with the cumulative change in the fair value of the forecasted cash flows of the hedged item. For currency forward contracts used in cash flow hedging strategies related to capital purchases, forward points are excluded, and effectiveness is measured using spot rates to value both the hedge contract and the hedged item. For currency forward contracts used in cash flow hedging strategies related to operating expenditures, forward points are included and effectiveness is measured using forward rates to value both the hedge contract and the hedged item.
	•	Effectiveness for options is generally measured by comparing the cumulative change in the intrinsic value of the hedge contract with the cumulative change in the intrinsic value of an option instrument representing the hedged risks in the hedged item. Time value is excluded and effectiveness is measured using spot rates to value both the hedge contract and the hedged item.
	•	Effectiveness for interest rate swaps and commodity swaps is generally measured by comparing the cumulative change in fair value of the swap with the cumulative change in the fair value of the hedged item.
	If a cash flow hedge is discontinued because it is probable that the original hedged transaction will not occur as previously anticipated, the cumulative unrealized gain or loss on the related derivative is reclassified from accumulated other comprehensive income (loss) into earnings. Subsequent gains or losses on the related derivative instrument are recognized in interest and other, net in each period until the instrument matures, is terminated, is re-designated as a qualified cash flow hedge, or is sold. Ineffective portions of cash flow hedges, as well as amounts excluded from the assessment of effectiveness, are recognized in earnings in interest and other, net. For further discussion of our derivative instruments and risk management programs, see “Note 6: Derivative Financial Instruments.”
	Securities Lending
	We may enter into securities lending agreements with financial institutions, generally to facilitate hedging and certain investment transactions. Selected securities may be loaned, secured by collateral in the form of cash or securities. The loaned securities continue to be carried as investment assets on our consolidated balance sheets. For lending agreements collateralized by cash and cash equivalents, collateral is recorded as an asset with a corresponding liability. For lending agreements collateralized by other securities, we do not record the collateral as an asset or a liability, unless the collateral is repledged.
	Loans Receivable
	We make loans to third parties that are classified within other current assets or other long-term assets. We may elect the fair value option for loans when the interest rate or foreign currency exchange rate risk is economically hedged at inception with a related derivative instrument. We record the gains or losses on these loans arising from changes in fair value due to interest rate, currency, and counterparty credit changes, largely offset by losses or gains on the related derivative instruments, in interest and other, net. Loans that are denominated in U.S. dollars and have a floating-rate coupon are carried at amortized cost. We measure interest income for all loans receivable using the interest method, which is based on the effective yield of the loans rather than the stated coupon rate. For further discussion of our loans receivable, see “Note 4: Fair Value.”
	Inventories
	We compute inventory cost on a first-in, first-out basis. Costs incurred to manufacture our products are included in the valuation of inventory beginning in the quarter in which a product meets the technical criteria to qualify for sale to customers. Prior to qualification for sale, costs that do not meet the criteria for research and development (R&D) are included in cost of sales in the period incurred. Inventories at the end of each period were as follows:
	(In Millions)		Dec 28,			Dec 29,
			2013			2012
	Raw materials		$	458		$	478
	Work in process		1,998			2,219
	Finished goods		1,716			2,037
	Total inventories		$	4,172		$	4,734
	Property, Plant and Equipment
Property, plant and equipment, net at the end of each period were as follows:
(In Millions)		Dec 28,			Dec 29,
		2013			2012
Land and buildings		$	21,098		$	18,807
Machinery and equipment		40,540			39,033
Construction in progress		11,778			8,206
Total property, plant and equipment, gross		73,416			66,046
Less: accumulated depreciation		(41,988		)	(38,063		)
Total property, plant and equipment, net		$	31,428		$	27,983
We compute depreciation for financial reporting purposes using the straight-line method. Substantially all of our depreciable property, plant and equipment assets are depreciated over the following estimated useful lives: machinery and equipment, 2 to 4 years; buildings, 10 to 25 years.
We capitalize a majority of interest on borrowings related to eligible capital expenditures. Capitalized interest is added to the cost of qualified assets and amortized over the estimated useful lives of the assets. We record capital-related government grants earned as a reduction to property, plant and equipment.
Goodwill
We record goodwill when the purchase price of an acquisition exceeds the fair value of the net tangible and identified intangible assets as of the date of acquisition, assigning the goodwill to our applicable reporting units based on the relative expected fair value provided by the acquisition. We perform a quarterly review of goodwill for indicators of impairment. During the fourth quarter of each year, we perform an impairment assessment for each reporting unit, and we perform impairment tests using a fair value approach when necessary. The reporting unit’s carrying value used in an impairment test represents the assignment of various assets and liabilities, excluding certain corporate assets and liabilities, such as cash, investments, and debt. For further discussion of goodwill, see “Note 10: Goodwill.”
Identified Intangible Assets
Licensed technology and patents are generally amortized on a straight-line basis over the periods of benefit. We amortize all acquisition-related intangible assets that are subject to amortization over their estimated useful life based on economic benefit. Acquisition-related in-process R&D assets represent the fair value of incomplete R&D projects that had not reached technological feasibility as of the date of acquisition; initially, these are classified as “other intangible assets” that are not subject to amortization. Assets related to projects that have been completed are transferred from “other intangible assets” to “acquisition-related developed technology;” these are subject to amortization, while assets related to projects that have been abandoned are impaired and expensed to R&D. In the quarter following the period in which identified intangible assets become fully amortized, we remove the fully amortized balances from the gross asset and accumulated amortization amounts.
The estimated useful life ranges for substantially all identified intangible assets that are subject to amortization as of December 28, 2013, were as follows:
(In Years)		Estimated
		Useful Life
Acquisition-related developed technology		4	–	9
Acquisition-related customer relationships		5	–	8
Acquisition-related trade names		4	–	8
Licensed technology and patents		5	–	17
We perform a quarterly review of finite-lived identified intangible assets to determine whether facts and circumstances indicate that the useful life is shorter than we had originally estimated or that the carrying amount of assets may not be recoverable. If such facts and circumstances exist, we assess recoverability by comparing the projected undiscounted net cash flows associated with the related asset or group of assets over their remaining lives against their respective carrying amounts. Impairments, if any, are based on the excess of the carrying amount over the fair value of those assets. If an asset’s useful life is shorter than originally estimated, we accelerate the rate of amortization and amortize the remaining carrying value over the new shorter useful life. We perform an annual impairment assessment in the fourth quarter of each year for indefinite-lived intangible assets, or more frequently if indicators of potential impairment exist, to determine whether it is more likely than not that the carrying value of the assets may not be recoverable. If necessary, a quantitative impairment test is performed to compare the fair value of the indefinite-lived intangible asset with its carrying value. Impairments, if any, are based on the excess of the carrying amount over the fair value of those assets.
For further discussion of identified intangible assets, see “Note 11: Identified Intangible Assets.”
Product Warranty
The vast majority of our products are sold with a limited warranty on product quality and a limited indemnification for customers against intellectual property (IP) rights infringement claims related to our products. The accrual and the related expense for known product warranty issues were not significant during the periods presented. Due to product testing, the short time typically between product shipment and the detection and correction of product failures, and the historical rate of payments on indemnification claims, the accrual and related expense for estimated incurred but unidentified issues were not significant during the periods presented.
Revenue Recognition
We recognize net product revenue when the earnings process is complete, as evidenced by an agreement with the customer, delivery has occurred, and acceptance, if applicable, as well as fixed pricing and probable collectibility. We record pricing allowances, including discounts based on contractual arrangements with customers, when we recognize revenue as a reduction to both accounts receivable and net revenue. Because of frequent sales price reductions and rapid technology obsolescence in the industry, we defer product revenue and related costs of sales from component sales made to distributors under agreements allowing price protection or right of return until the distributors sell the merchandise. The right of return granted generally consists of a stock rotation program in which distributors are able to exchange certain products based on the number of qualified purchases made by the distributor. Under the price protection program, we give distributors credits for the difference between the original price paid and the current price that we offer. We include shipping charges billed to customers in net revenue, and include the related shipping costs in cost of sales.
Revenue from license agreements with our McAfee business generally includes service and support agreements for which the related revenue is deferred and recognized ratably over the performance period. Revenue derived from online subscription products is deferred and recognized ratably over the performance period. Professional services revenue is recognized as services are performed or, if required, upon customer acceptance. For arrangements with multiple elements, including software licenses, maintenance, and/or services, revenue is allocated across the separately identified deliverables and may be recognized or deferred. When vendor-specific objective evidence (VSOE) does not exist for undelivered elements such as maintenance and support, the entire arrangement fee is recognized ratably over the performance period. Direct costs, such as costs related to revenue-sharing and royalty arrangements associated with license arrangements, as well as component costs associated with product revenue and sales commissions, are deferred and amortized over the same period that the related revenue is recognized.
We record deferred revenue offset by the related cost of sales on our consolidated balance sheets as deferred income.
Advertising
Cooperative advertising programs reimburse customers for marketing activities for certain of our products, subject to defined criteria. We accrue cooperative advertising obligations and record the costs at the same time that the related revenue is recognized. We record cooperative advertising costs as marketing, general and administrative (MG&A) expenses to the extent that an advertising benefit separate from the revenue transaction can be identified and the fair value of that advertising benefit received is determinable. We record any excess in cash paid over the fair value of the advertising benefit received as a reduction in revenue. Advertising costs, including direct marketing costs, recorded within MG&A expenses were $1.9 billion in 2013 ($2.0 billion in 2012 and $2.1 billion in 2011).
Employee Equity Incentive Plans
We have employee equity incentive plans, which are described more fully in “Note 19: Employee Equity Incentive Plans.” We use the straight-line attribution method to recognize share-based compensation over the service period of the award. Upon exercise, cancellation, forfeiture, or expiration of stock options, or upon vesting or forfeiture of restricted stock units (RSUs), we eliminate deferred tax assets for options and restricted stock units with multiple vesting dates for each vesting period on a first-in, first-out basis as if each vesting period were a separate award.
Income Taxes
We compute the provision for income taxes using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating losses and tax credit carryforwards. We measure deferred tax assets and liabilities using the currently enacted tax rates that apply to taxable income in effect for the years in which those tax assets are expected to be realized or settled. We record a valuation allowance to reduce deferred tax assets to the amount that it is believed more likely than not to be realized.
We recognize tax benefits from uncertain tax positions only if that tax position is more likely than not to be sustained on examination by the taxing authorities, based on the technical merits of the position. We then measure the tax benefits recognized in the financial statements from such positions based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. We recognize interest and penalties related to unrecognized tax benefits within the provision for taxes on the consolidated statements of income. For more information about income taxes, see “Note 24: Income Taxes.”

Accounting_Changes

Accounting Changes	12 Months Ended
	Dec. 28, 2013
Accounting Changes [Abstract]	'
Accounting Changes [Text Block]	'
	Note 3: Accounting Changes
	2012
	In the first quarter of 2012, we adopted amended standards that increase the prominence of items reported in other comprehensive income. These amended standards eliminate the option to present components of other comprehensive income as part of the statement of changes in stockholders’ equity, and they require that all changes in stockholders’ equity—except investments by, and distributions to, owners—be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. Our adoption of these amended standards impacted the presentation of other comprehensive income, as we have elected to present two separate but consecutive statements, but it did not have an impact on our financial position or results of operations.
	In the fourth quarter of 2012, we adopted amended standards to simplify how we test indefinite-lived intangible assets for impairment; these amended standards improve consistency in impairment testing requirements among long-lived asset categories. The amended standards allow for an assessment of qualitative factors such that we can determine whether the fair value of an indefinite-lived intangible asset is more likely than not to be less than its carrying value. For assets in which this assessment concludes that the fair value is more likely than not to be more than its carrying value, these amended standards eliminate the requirement to perform quantitative impairment testing as outlined in the previously issued standards. Our adoption of these amended standards did not have an impact on our consolidated financial statements.
	2011
	In the first quarter of 2011, we adopted new standards for revenue recognition with multiple deliverables. These new standards change the determination of whether the individual deliverables included in a multiple-element arrangement may be treated as separate units for accounting purposes. Additionally, these new standards modify the method by which revenue is allocated to the separately identified deliverables. The adoption of these new standards did not have a significant impact on our consolidated financial statements.
	In the first quarter of 2011, we adopted new standards that remove certain tangible products and associated software from the scope of the software revenue recognition guidance. The adoption of these new standards did not have a significant impact on our consolidated financial statements.
	In the fourth quarter of 2011, we adopted amended standards that simplify how entities test goodwill for impairment. These amended standards allow for an assessment of qualitative factors such that we can determine whether the fair value of a reporting unit in which goodwill resides is more likely than not to be less than its carrying value. For reporting units in which this assessment concludes that the fair value is more likely than not to be more than its carrying value, these amended standards eliminate the requirement to perform goodwill impairment testing. Our adoption of these amended standards did not have an impact on our consolidated financial statements.

Fair_Value

Fair Value	12 Months Ended
	Dec. 28, 2013
Fair Value [Abstract]	'
Fair Value [Text Block]	'
	Note 4: Fair Value
	Assets/Liabilities Measured and Recorded at Fair Value on a Recurring Basis
	Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following types of instruments at the end of each period were as follows:
		28-Dec-13								29-Dec-12
		Fair Value Measured and						Total		Fair Value Measured and						Total
		Recorded at Reporting Date Using								Recorded at Reporting Date Using
	(In Millions)	Level 1		Level 2		Level 3				Level 1		Level 2		Level 3
	Assets
	Cash equivalents:
	Bank deposits	$	—	$	1,017	$	—	$	1,017	$	—	$	822	$	—	$	822
	Commercial paper	—		2,341		—		2,341		—		2,711		—		2,711
	Corporate bonds	—		21		—		21		—		—		—		—
	Government bonds	—		—		—		—		400		66		—		466
	Money market fund deposits	1,041		—		—		1,041		1,086		—		—		1,086
	Reverse repurchase agreements	—		400		—		400		—		2,800		—		2,800
	Short-term investments:
	Bank deposits	—		1,782		—		1,782		—		540		—		540
	Commercial paper	—		2,123		—		2,123		—		1,474		—		1,474
	Corporate bonds	383		1,121		19		1,523		75		292		21		388
	Government bonds	268		276		—		544		1,307		290		—		1,597
	Trading assets:
	Asset-backed securities	—		684		4		688		—		—		68		68
	Bank deposits	—		92		—		92		—		247		—		247
	Commercial paper	—		240		—		240		—		336		—		336
	Corporate bonds	2,625		773		—		3,398		482		1,109		—		1,591
	Government bonds	2,267		1,618		—		3,885		1,743		1,479		—		3,222
	Money market fund deposits	82		—		—		82		18		—		—		18
	Municipal bonds	—		56		—		56		—		203		—		203
	Other current assets:
	Derivative assets	48		309		—		357		12		208		1		221
	Loans receivable	—		103		—		103		—		203		—		203
	Marketable equity securities	6,221		—		—		6,221		4,424		—		—		4,424
	Other long-term investments:
	Asset-backed securities	—		—		9		9		—		—		11		11
	Bank deposits	—		157		—		157		—		56		—		56
	Corporate bonds	282		518		27		827		10		218		26		254
	Government bonds	295		185		—		480		59		113		—		172
	Other long-term assets:
	Derivative assets	—		7		29		36		—		20		18		38
	Loans receivable	—		702		—		702		—		577		—		577
	Total assets measured and recorded at fair value	$	13,512	$	14,525	$	88	$	28,125	$	9,616	$	13,764	$	145	$	23,525
	Liabilities
	Other accrued liabilities:
	Derivative liabilities	$	—	$	372	$	—	$	372	$	1	$	291	$	—	$	292
	Other long-term liabilities:
	Derivative liabilities	—		50		—		50		—		20		—		20
	Total liabilities measured and recorded at fair value	$	—	$	422	$	—	$	422	$	1	$	311	$	—	$	312
	Government bonds include bonds issued or deemed to be guaranteed by government entities. Government bonds include instruments such as non-U.S. government bonds, U.S. agency securities, and U.S. Treasury securities.
	Investments in Debt Securities
	Debt securities reflected in the preceding table include investments such as asset-backed securities, bank deposits, commercial paper, corporate bonds, government bonds, money market fund deposits, municipal bonds, and reverse repurchase agreements classified as cash equivalents. When we use observable market prices for identical securities that are traded in less active markets, we classify our debt investments as Level 2. When observable market prices for identical securities are not available, we price our debt investments using non-binding market consensus prices that are corroborated with observable market data; quoted market prices for similar instruments; or pricing models, such as a discounted cash flow model, with all significant inputs derived from or corroborated with observable market data. Non-binding market consensus prices are based on the proprietary valuation models of pricing providers or brokers. These valuation models incorporate a number of inputs, including non-binding and binding broker quotes; observable market prices for identical or similar securities; and the internal assumptions of pricing providers or brokers that use observable market inputs and unobservable market inputs that we consider to be not significant. We corroborate non-binding market consensus prices with observable market data using statistical models when observable market data exists. The discounted cash flow model uses observable market inputs, such as LIBOR-based yield curves, currency spot and forward rates, and credit ratings.
	Debt securities classified as Level 3, are classified as such because the fair values are generally derived from discounted cash flow models, performed either by us or our pricing providers, using inputs that we are unable to corroborate with observable market data. We monitor and review the inputs and results of these valuation models to ensure the fair value measurements are reasonable and consistent with market experience in similar asset classes.
	Fair Value Option for Loans Receivable
	We elected the fair value option for loans receivable when the interest rate or currency exchange rate risk was hedged at inception with a related derivative instrument. As of December 28, 2013, the fair value of our loans receivable for which we elected the fair value option did not significantly differ from the contractual principal balance based on the contractual currency. Loans receivable are classified within other current assets and other long-term assets. Fair value is determined using a discounted cash flow model, with all significant inputs derived from or corroborated with observable market data. Gains and losses from changes in fair value on the loans receivable and related derivative instruments, as well as interest income, are recorded in interest and other, net. During all periods presented, changes in the fair value of our loans receivable were largely offset by changes in the related derivative instruments, resulting in an insignificant net impact on our consolidated statements of income. Gains and losses attributable to changes in credit risk are determined using observable credit default spreads for the issuer or comparable companies; these gains and losses were insignificant during all periods presented. We did not elect the fair value option for loans receivable when the interest rate or foreign exchange rate risk was not hedged at inception with a related derivative instrument. Loans receivable not measured and recorded at fair value are included in the "Financial Instruments Not Recorded at Fair Value on a Recurring Basis" section that follows.
	Assets Measured and Recorded at Fair Value on a Non-Recurring Basis
	Our non-marketable equity investments, marketable equity method investments, and non-financial assets, such as intangible assets and property, plant and equipment, are recorded at fair value only if an impairment charge is recognized.
	A portion of our non-marketable equity investments has been measured and recorded at fair value due to events or circumstances that significantly impacted the fair value of those investments, resulting in other-than-temporary impairment charges. We classified these investments as Level 3, as we used unobservable inputs to the valuation methodologies that were significant to the fair value measurements, and the valuations required management judgment due to the absence of quoted market prices. Impairment charges recognized on non-marketable equity investments held as of December 28, 2013, were $106 million during 2013 ($68 million during 2012 on non-marketable equity investments held as of December 29, 2012 and $62 million during 2011 on non-marketable equity investments held as of December 31, 2011). The fair value of the non-marketable equity investments impaired during 2013 was $47 million at the time of impairment ($73 million and $69 million for non-marketable equity investments impaired during 2012 and 2011, respectively).
	Financial Instruments Not Recorded at Fair Value on a Recurring Basis
	On a quarterly basis, we measure the fair value of our non-marketable cost method investments, indebtedness carried at amortized cost, cost method loans receivable, grants receivable, and reverse repurchase agreements with original maturities greater than approximately three months; however, the assets are recorded at fair value only when an impairment charge is recognized. The carrying amounts and fair values of certain financial instruments not recorded at fair value on a recurring basis at the end of each period were as follows:
		December 28, 2013
		Carrying		Fair Value Measured Using						Fair Value
	(In Millions)	Amount		Level 1		Level 2		Level 3
	Non-marketable cost method investments	$	1,270	$	—	$	—	$	2,105	$	2,105
	Loans receivable	$	267	$	—	$	250	$	17	$	267
Reverse repurchase agreements	$	400	$	—	$	400	$	—	$	400
Grants receivable	$	416	$	—	$	481	$	—	$	481
Long-term debt	$	13,165	$	10,937	$	2,601	$	—	$	13,538
Short-term debt	$	24	$	—	$	24	$	—	$	24
NVIDIA Corporation cross-license agreement liability	$	587	$	—	$	597	$	—	$	597
	December 29, 2012
	Carrying		Fair Value Measured Using						Fair Value
(In Millions)	Amount		Level 1		Level 2		Level 3
Non-marketable cost method investments	$	1,202	$	—	$	—	$	1,766	$	1,766
Loans receivable	$	199	$	—	$	150	$	48	$	198
Reverse repurchase agreements	$	50	$	—	$	50	$	—	$	50
Grants receivable	$	198	$	—	$	205	$	—	$	205
Long-term debt	$	13,136	$	11,442	$	2,926	$	—	$	14,368
Short-term debt	$	48	$	—	$	48	$	—	$	48
NVIDIA Corporation cross-license agreement liability	$	875	$	—	$	890	$	—	$	890
As of December 28, 2013, and December 29, 2012, the unrealized loss position of our non-marketable cost method investments was insignificant.
Our non-marketable cost method investments are valued using the market and income approaches. The market approach includes the use of financial metrics and ratios of comparable public companies. The selection of comparable companies requires management judgment and is based on a number of factors, including comparable companies’ sizes, growth rates, industries, and development stages. The income approach includes the use of a discounted cash flow model, which requires significant estimates regarding the investees’ revenue, costs, and discount rates based on the risk profile of comparable companies. Estimates of revenue and costs are developed using available market, historical, and forecast data. The valuation of these non-marketable cost method investments also takes into account variables such as conditions reflected in the capital markets, recent financing activities by the investees, the investees’ capital structure, the terms of the investees’ issued interests, and the lack of marketability of the investments.
The carrying amount and fair value of loans receivable exclude loans measured and recorded at a fair value of $805 million as of December 28, 2013 ($780 million as of December 29, 2012). The carrying amount and fair value of short-term debt exclude drafts payable.
The fair value of our loans receivable and reverse repurchase agreements, including those held at fair value, is determined using a discounted cash flow model, with all significant inputs derived from or corroborated with observable market data, such as LIBOR-based yield curves, currency spot and forward rates, and credit ratings. The credit quality of these assets remains high, with credit ratings of A+/A1 or better for a substantial majority of our loans receivable and reverse repurchase agreements as of December 28, 2013.
The fair value of our grants receivable is determined using a discounted cash flow model, which discounts future cash flows using an appropriate yield curve. As of December 28, 2013, and December 29, 2012, the carrying amount of our grants receivable was classified within other current assets and other long-term assets, as applicable.
Our long-term debt recognized at amortized cost is comprised of our senior notes and our convertible debentures. The fair value of our senior notes is determined using active market prices, and it is therefore classified as Level 1. The fair value of our convertible long-term debt is determined using discounted cash flow models with observable market inputs, and it takes into consideration variables such as interest rate changes, comparable securities, subordination discount, and credit-rating changes, and it is therefore classified as Level 2.
The NVIDIA Corporation (NVIDIA) cross-license agreement liability in the preceding table was incurred as a result of entering into a long-term patent cross-license agreement with NVIDIA in January 2011. We agreed to make payments to NVIDIA over six years. As of December 28, 2013, and December 29, 2012, the carrying amount of the liability arising from the agreement was classified within other accrued liabilities and other long-term liabilities, as applicable. The fair value is determined using a discounted cash flow model, which discounts future cash flows using our incremental borrowing rates.

Cash_and_Investments

Cash and Investments	12 Months Ended
	Dec. 28, 2013
Cash and Investments [Abstract]	'
Cash And Investments [Text Block]	'
	Note 5: Cash and Investments
	Cash and investments at the end of each period were as follows:
	(In Millions)	Dec 28,		Dec 29,
		2013		2012
	Available-for-sale investments	$	18,086	$	14,001
	Cash	854		593
	Equity method investments	1,038		992
	Loans receivable	1,072		979
	Non-marketable cost method investments	1,270		1,202
	Reverse repurchase agreements	800		2,850
	Trading assets	8,441		5,685
	Total cash and investments	$	31,561	$	26,302
	In the third quarter of 2013, we sold our shares in Clearwire Corporation, which had been accounted for as available-for-sale marketable equity securities, and our interest in Clearwire Communications, LLC (Clearwire LLC), which had been accounted for as an equity method investment. In total, we received proceeds of $470 million on these transactions and recognized a gain of $439 million, which is included in gains (losses) on equity investments, net on the consolidated statements of income. Proceeds received and gains recognized for each investment are included in the "Available-for-Sale Investments" and "Equity Method Investments" sections that follow.
	Available-for-Sale Investments
	Available-for-sale investments at the end of each period were as follows:
		December 28, 2013											December 29, 2012
	(In Millions)	Adjusted		Gross			Gross				Fair		Adjusted		Gross		Gross			Fair
		Cost		Unrealized			Unrealized				Value		Cost		Unrealized		Unrealized			Value
				Gains			Losses								Gains		Losses
	Asset-backed securities	$	11	$	—		$	(2	)		$	9	$	14	$	—	$	(3	)	$	11
	Bank deposits	2,951		6			(1		)		2,956		1,417		1		—			1,418
	Commercial paper	4,464		—			—				4,464		4,184		1		—			4,185
	Corporate bonds	2,359		15			(3		)		2,371		635		8		(1		)	642
	Government bonds	1,024		—			—				1,024		2,235		—		—			2,235
	Marketable equity securities	3,340		2,881			—				6,221		3,356		1,069		(1		)	4,424
	Money market fund deposits	1,042		—			(1		)		1,041		1,086		—		—			1,086
	Total available-for-sale investments	$	15,191	$	2,902		$	(7	)		$	18,086	$	12,927	$	1,079	$	(5	)	$	14,001
	In the preceding table, government bonds include bonds issued or deemed to be guaranteed by government entities. Government bonds include instruments such as non-U.S. government bonds, U.S. agency securities, and U.S. Treasury securities. Bank deposits were primarily held by institutions outside the U.S. as of December 28, 2013, and December 29, 2012.
	During the third quarter of 2012, we purchased ASML Holding N.V. equity securities totaling $3.2 billion. This equity interest has been accounted for as an available-for-sale investment and is included as marketable equity securities in the preceding table.
	For information on the unrealized holding gains (losses) on available-for-sale investments reclassified out of accumulated other comprehensive income into the consolidated statements of income, see "Note 25: Other Comprehensive Income (Loss)."
	We sold available-for-sale investments for proceeds of $934 million in 2013 ($2.3 billion in 2012 and $9.1 billion in 2011). Proceeds received in 2013 included $142 million from the sale of our shares in Clearwire Corporation, which are included in sales of available-for-sale investments within investing activities on the consolidated statements of cash flows. Substantially all of the proceeds in 2011 were from debt investments primarily used to fund our acquisition of McAfee. The gross realized gains on sales of available-for-sale investments were $146 million in 2013 ($166 million in 2012 and $268 million in 2011). In 2013, we recognized a gain of $111 million on the sale of our shares in Clearwire Corporation, previously included as marketable equity securities in the preceding table. We determine the cost of an investment sold on an average cost basis at the individual security level. Impairment charges recognized on available-for-sale investments were $14 million in 2013 ($36 million in 2012 and $73 million in 2011).
	The amortized cost and fair value of available-for-sale debt investments, by contractual maturity, as of December 28, 2013, were as follows:
	(In Millions)	Cost		Fair Value
	Due in 1 year or less	$	9,170	$	9,188
	Due in 1–2 years	979		978
	Due in 2–5 years	421		421
	Instruments not due at a single maturity date	1,281		1,278
	Total	$	11,851	$	11,865
	Instruments not due at a single maturity date in the preceding table include all asset-backed securities, most callable government bonds, and all money market fund deposits.
	Equity Method Investments
	Equity method investments, classified within other long-term assets, at the end of each period were as follows:
		December 28, 2013				December 29, 2012
	(Dollars In Millions)	Carrying		Ownership		Carrying				Ownership
		Value		Percentage		Value				Percentage
	IM Flash Technologies, LLC	$	646	49	%	$	642			49	%
	Intel-GE Care Innovations, LLC	117		50	%	146				50	%
	Clearwire Communications, LLC	—		—	%	—				6	%
	Other equity method investments	275				204
	Total	$	1,038			$	992
	IM Flash Technologies, LLC and IM Flash Singapore, LLP
	Micron Technology, Inc. (Micron) and Intel formed IM Flash Technologies, LLC (IMFT) in 2006 and IM Flash Singapore, LLP (IMFS) in 2007 to manufacture NAND flash memory products for Micron and Intel. During the second quarter of 2012, we entered into agreements with Micron that modified our joint venture relationship including an agreement to sell our ownership interest in IMFS. We received $605 million in the second quarter of 2012 from the sale of assets of IMFS and certain assets of IMFT to Micron.
	As part of the agreements to modify our joint venture relationship, we also entered into an amended operating agreement for IMFT. This amended operating agreement extends the term of IMFT to 2024, unless earlier terminated under certain terms and conditions, and provides that IMFT may manufacture certain emerging memory technologies in addition to NAND flash memory. These agreements include a supply agreement for Micron to supply us with NAND flash memory products. We provided approximately $365 million to Micron in the second quarter of 2012, primarily for subsequent product purchases under the supply agreement with Micron. The agreements also extend and expand our NAND joint development program with Micron to include emerging memory technologies. Additionally, the amended agreement provides for certain rights that, beginning in 2015, will enable us to sell to Micron, or enable Micron to purchase from us, our interest in IMFT. If Intel exercises this right, Micron would set the closing date of the transaction within two years following such election and could elect to receive financing from Intel for one to two years.
	IMFT is a variable interest entity. All costs of the IMFT joint venture will be passed on to Micron and Intel pursuant to our purchase agreements. Intel's portion of IMFT costs, primarily related to product purchases and production-related services, was approximately $380 million in 2013 (approximately $705 million in 2012 and approximately $985 million in 2011 for IMFT and IMFS). Subsequent to the sale of our ownership interest in IMFS in the second quarter of 2012, we no longer incur costs related to IMFS. The amount due to IMFT for product purchases and services provided was approximately $75 million as of December 28, 2013 (approximately $90 million as of December 29, 2012). IMFT returned $45 million to Intel in 2013, which is reflected as a return of equity method investment within investing activities on the consolidated statements of cash flows ($137 million in 2012 and $263 million in 2011).
	IMFT depends on Micron and Intel for any additional cash needs. Our known maximum exposure to loss approximated the carrying value of our investment balance in IMFT, which was $646 million as of December 28, 2013. Except for the amount due to IMFT for product purchases and services, we did not have any additional liabilities recognized on our consolidated balance sheets in connection with our interests in this joint venture as of December 28, 2013. In addition, our potential future losses could be higher than the carrying amount of our investment, as Intel and Micron are liable for other future operating costs or obligations of IMFT. Future cash calls could also increase our investment balance and the related exposure to loss. In addition, because we are currently committed to purchasing 49% of IMFT’s production output and production-related services, we may be required to purchase products at a cost in excess of realizable value.
	We have determined that we do not have the characteristics of a consolidating investor in the variable interest entity and, therefore, we account for our interest in IMFT (and accounted for our prior interest in IMFS) using the equity method of accounting.
	Intel-GE Care Innovations, LLC
	In the first quarter of 2011, Intel and General Electric Company (GE) formed Intel-GE Care Innovations, LLC (Care Innovations), an equally owned joint venture in the healthcare industry, that focuses on independent living and delivery of health-related services by means of telecommunications. The company was formed by combining assets of GE Healthcare’s Home Health division and Intel’s Digital Health Group. As a result of forming Care Innovations, we recognized a gain of $164 million in the first quarter of 2011, which is included in interest and other, net on the consolidated statements of income.
	Care Innovations is a variable interest entity and depends on Intel and GE for any additional cash needs. Our known maximum exposure to loss approximated the carrying value of our investment balance in Care Innovations, which was $117 million as of December 28, 2013.
	Intel and GE equally share the power to direct all of Care Innovations' activities that most significantly impact its economic performance. We have determined that we do not have the characteristics of a consolidating investor in the variable interest entity and, therefore, we account for our interest in Care Innovations using the equity method of accounting.
	Clearwire Communications, LLC
	In 2008, we invested in Clearwire LLC. We recognized our proportionate share of losses to the extent that our investment had a positive carrying value. We recognized equity method losses of $145 million in 2011. In the third quarter of 2013, we sold our interest in Clearwire LLC for proceeds of $328 million, which is included in other investing within investing activities on the consolidated statements of cash flows. We recognized a gain on the sale of our interest in Clearwire LLC of $328 million.
	Non-marketable cost method investments
	The carrying value of our non-marketable cost method investments was $1.3 billion as of December 28, 2013 ($1.2 billion as of December 29, 2012). In 2013, we recognized impairment charges of $103 million on non-marketable cost method investments, which is included within gains (losses) on equity investments, net on the consolidated statements of income ($104 million in 2012 and $56 million in 2011).
Trading Assets
As of December 28, 2013, and December 29, 2012, all of our trading assets were marketable debt instruments. Net losses related to trading assets still held at the reporting date were $70 million in 2013 (net gains of $16 million in 2012 and net losses of $71 million in 2011). Net gains on the related derivatives were $86 million in 2013 (net gains of $11 million in 2012 and $58 million in 2011).

Derivative_Financial_Instrumen

Derivative Financial Instruments	12 Months Ended
	Dec. 28, 2013
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Derivative Financial Instruments [Text Block]	'
	Note 6: Derivative Financial Instruments
	Our primary objective for holding derivative financial instruments is to manage currency exchange rate risk and interest rate risk, and, to a lesser extent, equity market risk and commodity price risk. We also enter into master netting arrangements with counterparties when possible to mitigate credit risk in derivative transactions. A master netting arrangement may allow counterparties to net settle amounts owed to each other as a result of multiple, separate derivative transactions. For presentation on our consolidated balance sheets, we do not offset fair value amounts recognized for derivative instruments under master netting arrangements.
	Currency Exchange Rate Risk
	We are exposed to currency exchange rate risk and generally hedge our exposures with currency forward contracts, currency interest rate swaps, or currency options. Substantially all of our revenue is transacted in U.S. dollars. However, a significant amount of our operating expenditures and capital purchases is incurred in or exposed to other currencies, primarily the euro, the Japanese yen, and the Israeli shekel. We have established balance sheet and forecasted transaction currency risk management programs to protect against fluctuations in fair value and the volatility of the functional currency equivalent of future cash flows caused by changes in exchange rates. Our non-U.S.-dollar-denominated investments in debt instruments and loans receivable are generally hedged with offsetting currency forward contracts or currency interest rate swaps. We may also hedge foreign currency risk arising from funding foreign currency denominated forecasted investments. These programs reduce, but do not eliminate, the impact of currency exchange movements.
	Our currency risk management programs include:
	•	Currency derivatives with cash flow hedge accounting designation that utilize currency forward contracts and currency options to hedge exposures to the variability in the U.S.-dollar equivalent of anticipated non-U.S.-dollar-denominated cash flows. These instruments generally mature within 12 months. For these derivatives, we report the after-tax gain or loss from the effective portion of the hedge as a component of accumulated other comprehensive income (loss), and we reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings, and in the same line item on the consolidated statements of income as the impact of the hedged transaction.
	•	Currency derivatives without hedge accounting designation that utilize currency forward contracts or currency interest rate swaps to economically hedge the functional currency equivalent cash flows of recognized monetary assets and liabilities, non-U.S.-dollar-denominated debt instruments classified as trading assets, and hedges of non-U.S.-dollar-denominated loans receivable recognized at fair value. The majority of these instruments mature within 12 months. Changes in the functional currency equivalent cash flows of the underlying assets and liabilities are approximately offset by the changes in fair value of the related derivatives. We record net gains or losses in the line item on the consolidated statements of income most closely associated with the related exposures, primarily in interest and other, net, except for equity-related gains or losses, which we primarily record in gains (losses) on equity investments, net.
	Interest Rate Risk
	Our primary objective for holding investments in debt instruments is to preserve principal while maximizing yields. We generally swap the returns on our investments in fixed-rate debt instruments with remaining maturities longer than six months into U.S. dollar three-month LIBOR-based returns, unless management specifically approves otherwise. These swaps are settled at various interest payment times involving cash payments at each interest and principal payment date, with the majority of the contracts having quarterly payments.
	Our interest rate risk management programs include:
	•	Interest rate derivatives with cash flow hedge accounting designation that utilize interest rate swap agreements to modify the interest characteristics of debt instruments. For these derivatives, we report the after-tax gain or loss from the effective portion of the hedge as a component of accumulated other comprehensive income (loss), and we reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings, and in the same line item on the consolidated statements of income as the impact of the hedged transaction.
	•	Interest rate derivatives without hedge accounting designation that utilize interest rate swaps and currency interest rate swaps in economic hedging transactions, including hedges of non-U.S.-dollar-denominated debt instruments classified as trading assets and hedges of non-U.S.-dollar-denominated loans receivable recognized at fair value. Floating interest rates on the swaps are reset on a quarterly basis. Changes in fair value of the debt instruments classified as trading assets and loans receivable recognized at fair value are generally offset by changes in fair value of the related derivatives, both of which are recorded in interest and other, net.
	Equity Market Risk
	Our investments include marketable equity securities and equity derivative instruments. We typically do not attempt to reduce or eliminate our equity market exposure through hedging activities at the inception of the investment. Before we enter into hedge arrangements, we evaluate legal, market, and economic factors, as well as the expected timing of disposal to determine whether hedging is appropriate. Our equity market risk management program may include equity derivatives with or without hedge accounting designation that utilize warrants, equity options, or other equity derivatives. We recognize changes in the fair value of such derivatives in gains (losses) on equity investments, net. We also utilize total return swaps to offset changes in liabilities related to the equity market risks of certain deferred compensation arrangements. Gains and losses from changes in fair value of these total return swaps are generally offset by the losses and gains on the related liabilities, both of which are recorded in cost of sales and operating expenses.
	Deferred compensation liabilities were $1.1 billion as of December 28, 2013 ($859 million as of December 29, 2012), and are included in other accrued liabilities.
	In 2010, we sold our ownership interest in Numonyx B.V. to Micron for consideration consisting of shares of Micron. We also entered into equity option transactions that economically hedged a portion of the ownership interest in Micron that we acquired. In the second quarter of 2011, we sold our remaining ownership interest in Micron and the related equity options matured.
	Commodity Price Risk
	We operate facilities that consume commodities and have established forecasted transaction risk management programs to protect against fluctuations in fair value and the volatility of future cash flows caused by changes in commodity prices, such as those for natural gas. These programs reduce, but do not always eliminate, the impact of commodity price movements.
	Our commodity price risk management program includes commodity derivatives with cash flow hedge accounting designation that utilize commodity swap contracts to hedge future cash flow exposures to the variability in commodity prices. These instruments generally mature within 12 months. For these derivatives, we report the after-tax gain (loss) from the effective portion of the hedge as a component of accumulated other comprehensive income (loss) and reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings, and in the same line item on the consolidated statements of income as the impact of the hedged transaction.
	Volume of Derivative Activity
	Total gross notional amounts for outstanding derivatives (recorded at fair value) at the end of each period were as follows:
	(In Millions)		Dec 28,				Dec 29,				Dec 31,
			2013				2012				2011
	Currency forwards		$	13,404			$	13,117			$	11,203
	Currency interest rate swaps		4,377				2,711				1,650
	Embedded debt derivatives		3,600				3,600				3,600
	Interest rate swaps		1,377				1,101				1,837
	Total return swaps		914				807				761
	Other		67				127				182
	Total		$	23,739			$	21,463			$	19,233
	The gross notional amounts for currency forwards and currency interest rate swaps (presented by currency) at the end of each period were as follows:
	(In Millions)		Dec 28,				Dec 29,				Dec 31,
			2013				2012				2011
	British pound sterling		$	549			$	308			$	459
	Chinese yuan		1,116				647				688
	Euro		6,874				5,994				3,904
	Israeli shekel		2,244				2,256				2,168
	Japanese yen		4,116				4,389				3,477
	Malaysian ringgit		506				442				805
	Swiss franc		1,189				657				209
	Other		1,187				1,135				1,143
	Total		$	17,781			$	15,828			$	12,853
	Fair Value of Derivative Instruments in the Consolidated Balance Sheets
	The fair value of our derivative instruments at the end of each period were as follows:
			December 28, 2013														December 29, 2012
	(In Millions)		Other				Other				Other				Other		Other		Other		Other		Other
			Current				Long-Term				Accrued				Long-Term		Current		Long-Term		Accrued		Long-Term
			Assets				Assets				Liabilities				Liabilities		Assets		Assets		Liabilities		Liabilities
	Derivatives designated as hedging instruments:
	Currency forwards		$	114			$	1			$	118			$	2	$	91	$	2	$	127	$	—
	Total derivatives designated as hedging instruments		$	114			$	1			$	118			$	2	$	91	$	2	$	127	$	—
	Derivatives not designated as hedging instruments:
	Currency forwards		$	66			$	—			$	63			$	—	$	85	$	—	$	58	$	—
	Currency interest rate swaps		124				6				163				29		33		18		72		14
	Embedded debt derivatives		—				—				—				19		—		—		—		6
	Interest rate swaps		5				—				28				—		—		—		34		—
	Total return swaps		48				—				—				—		11		—		—		—
	Other		—				29				—				—		1		18		1		—
	Total derivatives not designated as hedging instruments		$	243			$	35			$	254			$	48	$	130	$	36	$	165	$	20
	Total derivatives		$	357			$	36			$	372			$	50	$	221	$	38	$	292	$	20
	Derivatives in Cash Flow Hedging Relationships
	The before-tax gains (losses), attributed to the effective portion of cash flow hedges, recognized in other comprehensive income (loss) for each period were as follows:
			Gains (Losses)
Recognized in OCI on
Derivatives (Effective Portion)
(In Millions)		2013				2012				2011
Currency forwards		$	(167	)		$	4			$	20
Other		1				9				—
Total		$	(166	)		$	13			$	20
Gains and losses on derivative instruments in cash flow hedging relationships related to hedge ineffectiveness and amounts excluded from effectiveness testing were insignificant during all periods presented in the preceding tables. Additionally, for all periods presented, there was an insignificant impact on results of operations from discontinued cash flow hedges, which arises when forecasted transactions are probable of not occurring.
Derivatives Not Designated as Hedging Instruments
The effects of derivative instruments not designated as hedging instruments on the consolidated statements of income for each period were as follows:
(In Millions)		Location of Gains (Losses)		2013				2012				2011
		Recognized in Income on Derivatives
Currency forwards		Interest and other, net		$	44			$	3			$	58
Currency interest rate swaps		Interest and other, net		29				(71		)		(17		)
Equity options		Gains (losses) on equity investments, net		1				(1		)		(67		)
Interest rate swaps		Interest and other, net		—				31				(26		)
Total return swaps		Various		140				77				(13		)
Other		Gains (losses) on equity investments, net		5				(7		)		4
Other		Interest and other, net		—				3				—
Total				$	219			$	35			$	(61	)

Concentrations_of_Credit_Risk

Concentrations of Credit Risk	12 Months Ended
	Dec. 28, 2013
Risks and Uncertainties [Abstract]	'
Concentrations of Credit Risk [Text Block]	'
	Note 7: Concentrations of Credit Risk
	Financial instruments that potentially subject us to concentrations of credit risk consist principally of investments in debt instruments, derivative financial instruments, loans receivable, and trade receivables. When possible, we enter into master netting arrangements with counterparties to mitigate credit risk in derivative transactions. A master netting arrangement may allow counterparties to net settle amounts owed to each other as a result of multiple, separate derivative transactions. For presentation on our consolidated balance sheets, we do not offset fair value amounts recognized for derivative instruments under master netting arrangements.
	We generally place investments with high-credit-quality counterparties and, by policy, we limit the amount of credit exposure to any one counterparty based on our analysis of that counterparty’s relative credit standing. Most of our investments in debt instruments are in A/A2 or better rated issuances, and the majority of the issuances are rated AA-/Aa3 or better. Our investment policy requires substantially all investments with original maturities at the time of investment of up to six months to be rated at least A-2/P-2 by Standard & Poor’s/Moody’s, and specifies a higher minimum rating for investments with longer maturities. For instance, investments with maturities of greater than three years generally require a minimum rating of AA-/Aa3 at the time of investment. Government regulations imposed on investment alternatives of our non-U.S. subsidiaries, or the absence of A rated counterparties in certain countries, result in some minor exceptions. Credit-rating criteria for derivative instruments are similar to those for other investments. Due to master netting arrangements, the amounts subject to credit risk related to derivative instruments are generally limited to the amounts, if any, by which the counterparty’s obligations exceed our obligations with that counterparty. As of December 28, 2013, our total credit exposure to any single counterparty, excluding Japan government bonds, did not exceed $750 million. We obtain and secure available collateral from counterparties against obligations, including securities lending transactions, when we deem it appropriate.
	A substantial majority of our trade receivables are derived from sales to original equipment manufacturers and original design manufacturers. We also have accounts receivable derived from sales to industrial and retail distributors. Our three largest customers accounted for 44% of net revenue for 2013 (43% for 2012 and 2011). Additionally, these three largest customers accounted for 34% of our accounts receivable as of December 28, 2013 (33% as of December 29, 2012). We believe that the receivable balances from these largest customers do not represent a significant credit risk based on cash flow forecasts, balance sheet analysis, and past collection experience.
	We have adopted credit policies and standards intended to accommodate industry growth and inherent risk. We believe that credit risks are moderated by the financial stability of our major customers. We assess credit risk through quantitative and qualitative analysis, and from this analysis, we establish credit limits and determine whether we will seek to use one or more credit support devices, such as obtaining a parent guarantee or standby letter of credit, or obtaining credit insurance.

Acquisitions

Acquisitions	12 Months Ended
	Dec. 28, 2013
Acquisitions [Abstract]	'
Acquisitions [Text Block]	'
	Note 8: Acquisitions
	2013 Acquisitions
	During 2013, we completed 12 acquisitions qualifying as business combinations in exchange for aggregate net cash consideration of $925 million. Most of the consideration was allocated to goodwill and acquisition-related developed technology intangible assets. Included in these acquisitions is our acquisition of Stonesoft Oyj (Stonesoft) to expand our network security solutions, specifically addressing next generation firewall products. We acquired Stonesoft in the third quarter of 2013 for net cash consideration of $381 million, substantially all of which was allocated to goodwill and acquisition-related developed technology intangible assets. Stonesoft's operating results are included in our software and services operating segments. For information on the assignment of goodwill to our operating segments for our acquisitions, see “Note 10: Goodwill,” and for information on the classification of intangible assets, see “Note 11: Identified Intangible Assets.” The completed acquisitions in 2013, both individually and in the aggregate, were not significant to our consolidated results of operations.
	2012 Acquisitions
	During 2012, we completed 15 acquisitions qualifying as business combinations in exchange for aggregate net cash consideration of $638 million. Substantially all of the consideration was allocated to goodwill and acquisition-related developed technology intangible assets. The completed acquisitions in 2012, both individually and in the aggregate, were not significant to our consolidated results of operations.
	2011 Acquisitions
	McAfee, Inc.
	On February 28, 2011, we completed the acquisition of McAfee by acquiring all issued and outstanding common shares in exchange for cash. The acquired company continues to operate as McAfee and offers products for endpoint security, network and content security, risk and compliance, and consumer and mobile security. In addition to managing the existing McAfee business, the objective of the acquisition was to accelerate and enhance Intel’s combination of hardware and software security solutions, thereby improving the overall security of our platforms.
	Total consideration to acquire McAfee was $6.7 billion (net of $943 million of cash and cash equivalents acquired) and comprised the following:
	(In Millions)
	Cash	$	6,652
	Share-based awards assumed	48
	Total	$	6,700
	The fair value of the assets acquired and liabilities assumed by major class in the acquisition of McAfee was recognized as follows:
	(In Millions)
	Marketable debt securities	$	329
	Goodwill	4,299
	Identified intangible assets	3,552
	Deferred tax assets	738
	Other assets	417
	Deferred income	(1,049		)
	Deferred tax liabilities	(1,191		)
	Other liabilities	(395		)
	Total	$	6,700
	The goodwill of $4.3 billion arising from the acquisition is primarily attributed to synergies to enable a single company to combine security and hardware for the protection of online devices, as well as the assembled workforce of McAfee. Substantially all of the goodwill recognized is not deductible for tax purposes. For information on the assignment of goodwill to our operating segments for the acquisition, see “Note 10: Goodwill.”
	The identified intangible assets assumed in the acquisition of McAfee were recognized as follows based upon their fair value as of February 28, 2011:
			Fair Value		Estimated
			(In Millions)		Useful Life
					(In Years)
	Developed technology		$	1,221	4
	Customer relationships		1,418		2	–	7
	Total identified intangible assets subject to amortization		$	2,639
	In-process research and development		92
	Trade names		821
	Total identified intangible assets		$	3,552
	Acquired developed technology represents the fair value of McAfee products that have reached technological feasibility and were part of McAfee’s product offerings at the date of acquisition. Customer relationships represent the fair value of the underlying relationships and agreements with McAfee’s customers. In-process R&D represents the fair value of incomplete McAfee R&D projects that had not reached technological feasibility as of the date of acquisition. Incremental costs incurred for those projects are expensed as incurred in R&D. Since the acquisition was completed, most of the projects have been completed and the associated costs are being amortized. Trade names are indefinite-lived intangible assets and represent the fair value of brand and name recognition associated with the marketing of McAfee’s products and services.
	Other 2011 Acquisitions
	During 2011, in addition to the McAfee acquisition, we completed 13 acquisitions qualifying as business combinations in exchange for total consideration of $2.1 billion, substantially all cash consideration. Total net cash consideration to acquire the Wireless Solutions (WLS) business of Infineon Technologies AG, which operated as Intel Mobile Communications (IMC), was $1.4 billion. The WLS business offers mobile phone components such as baseband processors, radio frequency transceivers, and power management integrated circuits. In addition to managing the existing WLS business, the objective of the acquisition was to provide solutions that enable wireless connectivity for a broad range of computing applications. In 2013, we completed a reorganization of IMC into our Multi-Comm and existing Phone Group operating segments, see "Note 27: Operating Segments and Geographic Information."
	The fair value of the assets acquired and liabilities assumed by major class in the acquisitions completed during 2011, excluding McAfee, was allocated as follows:
	(In Millions)
	Fair value of net tangible assets acquired	$	206
	Goodwill	517
	Identified intangible assets	1,409
	Total	$	2,132
	For information on the assignment of goodwill to our operating segments for the acquisitions, see “Note 10: Goodwill.”
	The identified intangible assets assumed in the acquisitions completed during 2011, excluding McAfee, were recognized as follows:
			Fair Value		Estimated
			(In Millions)		Useful Life
					(In Years)
	Developed technology		$	1,102	3	–	9
	Customer relationships		144		5	–	8
	Other intangible assets		44		2	–	7
	Total identified intangible assets subject to amortization		$	1,290
	In-process research and development		119
	Total identified intangible assets		$	1,409
	Acquired developed technology represents the fair value of the acquirees’ products that have reached technological feasibility and are a part of the acquirees’ product lines at the time acquired. Customer relationships represent the fair value of the underlying relationships and agreements with the acquirees’ customers. In-process R&D represents the fair value of incomplete R&D projects that had not reached technological feasibility as of the date of acquisition. Since the acquisitions were completed, most of the projects have been completed and the associated costs are being amortized.
	Actual and Pro Forma Results of Acquirees
	Net revenue and net income attributable to acquisitions completed during 2011 have been included in our consolidated statements of income from their respective acquisition dates. The acquisitions completed during 2011 were not individually significant to our consolidated results of operations; however, they were significant in the aggregate. During 2011, the results of the businesses acquired in 2011 contributed approximately $3.6 billion to our net revenue and reduced our net income by approximately $275 million; substantially all of these impacts were attributable to McAfee and the former IMC and include the impacts of the amortization of acquired identified intangible assets.
	McAfee is a non-reportable operating segment and is aggregated with similar non-reportable operating segments within the software and services operating segments category for segment reporting purposes. IMC has been reorganized into our Multi-Comm and existing Phone Group operating segments which are non-reportable operating segments and are aggregated with similar non-reportable operating segments within the other Intel architecture (Other IA) operating segments category for segment reporting purposes. For further information, see “Note 27: Operating Segments and Geographic Information.”
	The unaudited pro forma financial results for 2011 combine the historical results of Intel for 2011 along with the historical results of the businesses acquired during 2011. The results include the effects of pro forma adjustments as if businesses acquired in 2011 were acquired on December 27, 2009.
	The unaudited pro forma financial results presented below do not include any anticipated synergies or other expected benefits of the acquisitions. This is presented for informational purposes only and is not indicative of future operations or results that would have been achieved had the acquisitions been completed as of December 27, 2009.
	(In Millions, Except Per Share Amounts—Unaudited)		2011
	Net revenue		$	54,738
Net income		$	13,028
Diluted earnings per share		$	2.41

Divestitures

Divestitures	12 Months Ended
	Dec. 28, 2013
Divestitures [Abstract]	'
Divestitures [Text Block]	'
	Note 9: Divestitures
	In the first quarter of 2011, we completed the divestiture of our Digital Health Group by entering into an agreement with GE to form an equally owned joint venture to create a new healthcare company focused on independent living and delivery of health-related services via telecommunications. The new company, Care Innovations, was formed by combining assets of GE Healthcare’s Home Health division and Intel’s Digital Health Group. During the first quarter of 2011, as a result of the formation of Care Innovations, we recognized a gain of $164 million, within interest and other, net. For further information, see “Note 5: Cash and Investments.”

Goodwill

Goodwill	12 Months Ended
	Dec. 28, 2013
Goodwill [Abstract]	'
Goodwill [Text Block]	'
	Note 10: Goodwill
	Goodwill activity for each period was as follows:
	(In Millions)	PC Client Group		Data Center Group			Other Intel			Software and Services Operating Segments		Total
							Architecture
							Operating
							Segments
	31-Dec-11	$	2,918	$	1,553		$	844		$	3,939	$	9,254
	Additions due to acquisitions	44		286			78			44		452
	Impairments	—		—			(6		)	—		(6		)
	Effect of exchange rate fluctuations	—		—			—			10		10
	29-Dec-12	$	2,962	$	1,839		$	916		$	3,993	$	9,710
	Additions due to acquisitions	62		14			171			504		751
	Transfers	34		(22		)	(12		)	—		—
	Effect of exchange rate fluctuations	—		—			—			52		52
	28-Dec-13	$	3,058	$	1,831		$	1,075		$	4,549	$	10,513
	In 2013, we completed a reorganization of IMC into our Multi-Comm and existing Phone Group operating segments. Goodwill related to the former IMC was allocated between Multi-Comm and the Phone Group within the Other IA operating segments. Also in 2013, we completed a reorganization that transferred a portion of our wired connectivity business formerly included within the Data Center Group (DCG) to the PC Client Group (PCCG). Due to this reorganization, goodwill was transferred from DCG to PCCG.
	In 2012, we reorganized and allocated goodwill from the Netbook and Tablet Group into three operating segments: Netbook Group, Tablet Group, and Service Provider Group. These three new operating segments are still included in the Other IA operating segments. Additionally, the former Ultra-Mobility Group is now the Phone Group.
	For further information on these reorganizations, see “Note 27: Operating Segments and Geographic Information.”
	During the fourth quarters of 2013, 2012, and 2011, we completed our annual impairment assessments and we concluded that goodwill was not impaired in any of these years. The accumulated impairment losses as of December 28, 2013, were $719 million: $346 million associated with PCCG, $275 million associated with DCG, and $98 million associated with Other IA operating segments.

Identified_Intangible_Assets

Identified Intangible Assets	12 Months Ended
	Dec. 28, 2013
Intangible Assets, Net (Excluding Goodwill) [Abstract]	'
Identified Intangible Assets [Text Block]	'
	Note 11: Identified Intangible Assets
	Identified intangible assets at the end of December 28, 2013, were as follows:
	(In Millions)	Gross		Accumulated			Net
		Assets		Amortization
	Acquisition-related developed technology	$	2,922	$	(1,691	)	$	1,231
	Acquisition-related customer relationships	1,760		(828		)	932
	Acquisition-related trade names	65		(44		)	21
	Licensed technology and patents	3,093		(974		)	2,119
	Identified intangible assets subject to amortization	7,840		(3,537		)	4,303
	Acquisition-related trade names	818		—			818
	Other intangible assets	29		—			29
	Identified intangible assets not subject to amortization	847		—			847
	Total identified intangible assets	$	8,687	$	(3,537	)	$	5,150
	As a result of our acquisitions in 2013, we recorded acquisition-related developed technology of $114 million with a weighted average useful life of five years and acquisition-related customer relationships of $60 million with a weighted average useful life of seven years. During 2013, we purchased licensed technology and patents of $36 million with a weighted average useful life of 10 years.
	Identified intangible assets at the end of December 29, 2012 were as follows:
	(In Millions)	Gross		Accumulated			Net
		Assets		Amortization
	Acquisition-related developed technology	$	2,778	$	(1,116	)	$	1,662
	Acquisition-related customer relationships	1,712		(551		)	1,161
	Acquisition-related trade names	68		(33		)	35
	Licensed technology and patents	2,986		(699		)	2,287
	Other intangible assets	238		(86		)	152
	Identified intangible assets subject to amortization	7,782		(2,485		)	5,297
	Acquisition-related trade names	809		—			809
	Other intangible assets	129		—			129
	Identified intangible assets not subject to amortization	938		—			938
	Total identified intangible assets	$	8,720	$	(2,485	)	$	6,235
	As a result of our acquisitions in 2012, we recorded acquisition-related developed technology of $168 million with a weighted average useful life of 10 years. During 2012, we purchased licensed technology and patents of $815 million with a weighted average useful life of nine years, including wireless patents purchased from InterDigital, Inc. for $375 million to be amortized over approximately 10 years. Additionally, we recorded other intangible assets subject to amortization of $238 million associated with customer relationships, which was fully amortized in 2013.
	In January 2011, we entered into a long-term patent cross-license agreement with NVIDIA. Under the agreement, we received a license to all of NVIDIA’s patents with a capture period that runs through March 2017 while NVIDIA products are licensed to our patents, subject to exclusions for x86 products, certain chipsets, and certain flash memory technology products. The agreement also included settlement of the existing litigation between the companies, as well as broad mutual general releases. We agreed to make payments totaling $1.5 billion to NVIDIA over six years ($300 million in each of January 2011, 2012, and 2013; and $200 million in each of January 2014, 2015, and 2016), which resulted in a liability totaling approximately $1.4 billion, on a discounted basis. In the fourth quarter of 2010, we recognized an expense of $100 million related to the litigation settlement. In the first quarter of 2011, we recognized the remaining amount of $1.3 billion as licensed technology, which will be amortized into cost of sales over its estimated useful life of 17 years. The initial recognition of the intangible asset and associated liability for future payments to NVIDIA was treated as a non-cash transaction and, therefore, had no impact on our consolidated statements of cash flows. Future payments are treated as cash used for financing activities. As of December 28, 2013, the remaining liability of $587 million is classified within other accrued liabilities and other long-term liabilities, based on the expected timing of the underlying payments.
	We recorded amortization expense on the consolidated statements of income as follows: amortization of acquisition-related developed technology and licensed technology and patents is included in cost of sales, amortization of acquisition-related customer relationships and trade names is included in amortization of acquisition-related intangibles, and amortization of other intangible assets is recorded as a reduction of revenue.
	Amortization expenses for each period were as follows:
	(In Millions)	2013		2012			2011
	Acquisition-related developed technology	$	576	$	557		$	482
	Acquisition-related customer relationships	279		296			250
	Acquisition-related trade names	12		12			10
	Licensed technology and patents	272		214			181
	Other intangible assets	103		86			—
	Total amortization expenses	$	1,242	$	1,165		$	923
	Based on identified intangible assets that are subject to amortization as of December 28, 2013, we expect future amortization expense for each period to be as follows:
	(In Millions)	2014		2015			2016		2017		2018
	Acquisition-related developed technology	$	579	$	303		$	211	$	63	$	41
	Acquisition-related customer relationships	268		251			233		142		29
	Acquisition-related trade names	10		9			3		—		—
	Licensed technology and patents	270		252			238		199		158
	Total future amortization expenses	$	1,127	$	815		$	685	$	404	$	228

Other_LongTerm_Assets

Other Long-Term Assets	12 Months Ended
	Dec. 28, 2013
Other Assets, Noncurrent Disclosure [Abstract]	'
Other Long-Term Assets [Text Block]	'
	Note 12: Other Long-Term Assets
	Other long-term assets at the end of each period were as follows:
	(In Millions)	Dec 28,		Dec 29,
		2013		2012
	Equity method investments	$	1,038	$	992
	Non-marketable cost method investments	1,270		1,202
	Non-current deferred tax assets	434		358
	Loans receivable	952		644
	Other	1,795		952
	Total other long-term assets	$	5,489	$	4,148

Restructuring_and_Asset_Impair

Restructuring and Asset Impairment Charges	12 Months Ended
	Dec. 28, 2013
Restructuring and Asset Impairment Charges [Abstract]	'
Restructuring And Asset Impairment Charges [Text Block]	'
	Note 13: Restructuring and Asset Impairment Charges
	In response to the current business environment, during 2013, management approved several restructuring actions including targeted workforce reductions as well as exit of certain businesses and facilities. These actions include the wind down of our 200 millimeter (mm) wafer fabrication facility in Massachusetts, which we expect to cease production by the end of 2014. These targeted reductions will enable the company to better align our resources in areas providing the greatest benefit in the changing market.
	Restructuring and asset impairment charges for each period were as follows:
	(In Millions)	2013			2012			2011
	Employee severance and benefit arrangements	$	201		$	—		$	—
	Asset impairments	39			—			—
	Total restructuring and asset impairment charges	$	240		$	—		$	—
	The restructuring and asset impairment activity for 2013 was as follows:
	(In Millions)	Employee Severance and Benefits			Asset Impairments			Total
	Accrued restructuring balance as of December 29, 2012	$	—		$	—		$	—
	Additional accruals	195			39			234
	Adjustments	6			—			6
	Cash payments	(18		)	—			(18		)
	Non-cash settlements	—			(39		)	(39		)
	Accrued restructuring balance as of December 28, 2013	$	183		$	—		$	183
	We recorded the additional accruals and adjustments as restructuring and asset impairment charges in the consolidated statements of income within the “all other” operating segment. The charges incurred during 2013 included $201 million related to employee severance and benefit arrangements, which impacted approximately 3,900 employees. The accrued restructuring balance as of December 28, 2013, relates to employee severance and benefits which are expected to be paid within the next 12 months and was recorded as a current liability within accrued compensation and benefits in the consolidated balance sheets.
	We may incur additional charges in the future for employee severance and benefit arrangements, as well as facility-related or other exit activities, as we continue to align our resources to meet the needs of the business.

Deferred_Income

Deferred Income	12 Months Ended
	Dec. 28, 2013
Deferred Income [Abstract]	'
Deferred Income [Text Block]	'
	Note 14: Deferred Income
	Deferred income at the end of each period was as follows:
	(In Millions)	Dec 28,		Dec 29,
		2013		2012
	Deferred income on shipments of components to distributors	$	852	$	694
	Deferred income from software and services operating segments	1,244		1,238
	Current deferred income	$	2,096	$	1,932
	Non-current deferred income from software and services operating segments	506		473
	Total deferred income	$	2,602	$	2,405
	We classify non-current deferred income from the software and services operating segments in other long-term liabilities.

Chipset_Design_Issue

Chipset Design Issue	12 Months Ended
	Dec. 28, 2013
Chipset Design Issue [Abstract]	'
Chipset Design Issue [Text Block]	'
	Note 15: Chipset Design Issue
	In January 2011, as part of our ongoing quality assurance procedures, we identified a design issue with the Intel® 6 Series Express Chipset family. The issue affected chipsets sold in the fourth quarter of 2010 and January 2011. We subsequently implemented a silicon fix and began shipping the updated version of the affected chipset in February 2011. The total cost in 2011 to repair and replace affected materials and systems, located with customers and in the market, was $422 million. We do not expect to have any significant future adjustments related to this issue.

Borrowings

Borrowings	12 Months Ended
	Dec. 28, 2013
Borrowings [Abstract]	'
Borrowings [Text Block]	'
	Note 16: Borrowings
	Short-Term Debt
	As of December 28, 2013, short-term debt consisted of drafts payable of $257 million and notes payable of $24 million (drafts payable of $264 million and notes payable of $48 million as of December 29, 2012). We have an ongoing authorization from our Board of Directors to borrow up to $3.0 billion, including through the issuance of commercial paper. Maximum borrowings under our commercial paper program during 2013 were $300 million ($500 million during 2012). Our commercial paper was rated A-1+ by Standard & Poor’s and P-1 by Moody’s as of December 28, 2013.
	Long-Term Debt
	Our long-term debt at the end of each period was as follows:
	(In Millions)	Dec 28,			Dec 29,
		2013			2012
	2012 Senior notes due 2017 at 1.35%	$	2,997		$	2,997
	2012 Senior notes due 2022 at 2.70%	1,494			1,494
	2012 Senior notes due 2032 at 4.00%	744			743
	2012 Senior notes due 2042 at 4.25%	924			924
	2011 Senior notes due 2016 at 1.95%	1,499			1,498
	2011 Senior notes due 2021 at 3.30%	1,996			1,996
	2011 Senior notes due 2041 at 4.80%	1,490			1,489
	2009 Junior subordinated convertible debentures due 2039 at 3.25%	1,075			1,063
	2005 Junior subordinated convertible debentures due 2035 at 2.95%	946			932
	Total long-term debt	$	13,165		$	13,136
	Senior Notes
	In the fourth quarter of 2012, we issued $6.2 billion aggregate principal amount of senior unsecured notes for general corporate purposes and to repurchase shares of our common stock pursuant to our authorized common stock repurchase program. In the third quarter of 2011, we issued $5.0 billion aggregate principal amount of senior unsecured notes, primarily to repurchase shares of our common stock pursuant to our authorized common stock repurchase program, and for general corporate purposes.
	Our senior notes pay a fixed rate of interest semiannually. We may redeem our senior notes, in whole or in part, at any time at our option at specified redemption prices. The senior notes rank equally in right of payment with all of our other existing and future senior unsecured indebtedness and will effectively rank junior to all liabilities of our subsidiaries.
	Convertible Debentures
	In 2009, we issued $2.0 billion of junior subordinated convertible debentures (the 2009 debentures). In 2005, we issued $1.6 billion of junior subordinated convertible debentures (the 2005 debentures). Both the 2009 and 2005 debentures pay a fixed rate of interest semiannually.
		2009		2005
		Debentures		Debentures
	Annual coupon interest rate	3.25	%	2.95	%
	Annual effective interest rate	7.2	%	6.45	%
	Maximum amount of contingent interest that will accrue per year	0.5	%	0.4	%
	The effective interest rate is based on the rate for a similar instrument that does not have a conversion feature.
	Both the 2009 and 2005 debentures have a contingent interest component that requires us to pay interest based on certain thresholds or for certain events, commencing on August 1, 2019 for the 2009 debentures. As of December 28, 2013, we have not met any of the thresholds or events related to the 2005 debentures. The fair values of the related embedded derivatives were $10 million and $9 million as of December 28, 2013, for the 2009 and 2005 debentures, respectively ($6 million and zero as of December 29, 2012 for the 2009 and 2005 debentures, respectively).
	Both the 2009 and 2005 debentures are convertible, subject to certain conditions, into shares of our common stock. Holders can surrender the 2009 debentures for conversion if the closing price of Intel common stock has been at least 130% of the conversion price then in effect for at least 20 trading days during the 30 consecutive trading-day period ending on the last trading day of the preceding fiscal quarter. Holders can surrender the 2005 debentures for conversion at any time. We will settle any conversion or repurchase of the 2009 debentures in cash up to the face value, and any amount in excess of face value will be settled in cash or stock at our option. However, we can settle any conversion or repurchase of the 2005 debentures in cash or stock at our option. On or after August 5, 2019, we can redeem, for cash, all or part of the 2009 debentures for the principal amount, plus any accrued and unpaid interest, if the closing price of Intel common stock has been at least 150% of the conversion price then in effect for at least 20 trading days during any 30 consecutive trading-day period prior to the date on which we provide notice of redemption. We can redeem, for cash, all or part of the 2005 debentures for the principal amount, plus any accrued and unpaid interest, if the closing price of Intel common stock has been at least 130% of the conversion price then in effect for at least 20 trading days during any 30 consecutive trading-day period prior to the date on which we provide notice of redemption. If certain events occur in the future, the indentures governing the 2009 and 2005 debentures provide that each holder of the debentures can, for a pre-defined period of time, require us to repurchase the holder’s debentures for the principal amount plus any accrued and unpaid interest. Both the 2009 and 2005 debentures are subordinated in right of payment to any existing and future senior debt and to the other liabilities of our subsidiaries. We have concluded that both the 2009 and 2005 debentures are not conventional convertible debt instruments and that the embedded stock conversion options qualify as derivatives. In addition, we have concluded that the embedded conversion options would be classified in stockholders’ equity if they were freestanding derivative instruments. As such, the embedded conversion options are not accounted for separately as derivatives.
		2009 Debentures					2005 Debentures
	(In Millions, Except Per Share Amounts)	Dec 28,			Dec 29,		Dec 28,		Dec 29,
		2013			2012		2013		2012
	Outstanding principal	$	2,000		$	2,000	$	1,600	$	1,600
	Equity component carrying amount	$	613		$	613	$	466	$	466
	Unamortized discount	$	910		$	922	$	643	$	656
	Net debt carrying amount	$	1,075		$	1,063	$	946	$	932
	Conversion rate (shares of common stock per $1,000 principal amount of debentures)	45.57			45.05		34.6		33.86
	Effective conversion price (per share of common stock)	$	21.94		$	22.2	$	28.9	$	29.53
	In the preceding table, the remaining amortization periods for the unamortized discounts for the 2009 and 2005 debentures are approximately 26 and 22 years, respectively, as of December 28, 2013.
	The conversion rate adjusts for certain events outlined in the indentures governing the 2009 and 2005 debentures, such as quarterly dividend distributions in excess of $0.14 and $0.10 per share for the 2009 and 2005 debentures, respectively, but it does not adjust for accrued interest. In addition, the conversion rate will increase for a holder of either the 2009 or 2005 debentures who elects to convert the debentures in connection with certain share exchanges, mergers, or consolidations involving Intel.
	Arizona Bonds
	In 2007, we guaranteed repayment of principal and interest on bonds issued by the Industrial Development Authority of the City of Chandler, Arizona, which constituted an unsecured general obligation for Intel. The aggregate principal amount of the bonds issued in December 2007 was $125 million. The 2007 Arizona bonds were tendered and repaid in December 2012. These bonds bore interest at a fixed rate of 5.3%. In the future, we may re-market the bonds as either fixed-rate bonds for a specified period or as variable-rate bonds until their final maturity on December 1, 2037.
	Debt Maturities
	Our aggregate debt maturities based on outstanding principal as of December 28, 2013, by year payable, were as follows:
	(In Millions)
	2014	$	—
	2015	—
	2016	1,500
	2017	3,000
	2018	—
	2019 and thereafter	10,275
	Total	$	14,775
	Substantially all of the difference between the total aggregate debt maturities in the preceding table and the total carrying amount of our debt is due to the unamortized discount of our convertible debentures.

Retirement_Benefit_Plans

Retirement Benefit Plans	12 Months Ended
	Dec. 28, 2013
General Discussion of Pension and Other Postretirement Benefits [Abstract]	'
Retirement Benefit Plans [Text Block]	'
	Note 17: Retirement Benefit Plans
	Retirement Contribution Plans
	We provide tax-qualified retirement contribution plans for the benefit of eligible employees, former employees, and retirees in the U.S. and certain other countries. The plans are designed to provide employees with an accumulation of funds for retirement on a tax-deferred basis. Employees hired prior to January 1, 2011 are eligible for and receive discretionary employer contributions in the U.S. Intel Retirement Contribution Plan, while employees hired on or after January 1, 2011 receive discretionary employer contributions in the Intel 401(k) Savings Plan. Our Chief Executive Officer (CEO) determines the annual discretionary employer contribution amounts for the U.S. Intel Retirement Contribution Plan and the Intel 401(k) Savings Plan under delegation of authority from our Board of Directors, pursuant to the terms of the plans. As of December 28, 2013, 83% of our U.S. Intel Retirement Contribution Plan assets were invested in equities, and 17% were invested in fixed-income instruments. These assets are managed by external investment managers. The discretionary employer contributions made to the Intel 401(k) Savings Plan are participant-directed.
	For the benefit of eligible U.S. employees, we also provide a non-tax-qualified supplemental deferred compensation plan for certain highly compensated employees. This plan is designed to permit certain discretionary employer contributions and to permit employee deferral of a portion of compensation in addition to their Intel 401(k) Savings Plan deferrals. This plan is unfunded.
	We expensed $298 million for the qualified and non-qualified U.S. retirement contribution plans in 2013 ($357 million in 2012 and $340 million in 2011). In the first quarter of 2014, we funded $288 million for the 2013 contributions to the qualified U.S. retirement contribution plans.
	Pension and Postretirement Benefit Plans
	U.S. Pension Benefits. For employees hired prior to January 1, 2011, we provide a tax-qualified defined-benefit pension plan, the U.S. Intel Minimum Pension Plan, for eligible employees, former employees, and retirees in the U.S. The U.S. Intel Minimum Pension Plan benefit is determined by a participant’s years of service and final average compensation as defined by the plan document. The plan generates a minimum pension benefit if the participants’ U.S. Intel Minimum Pension Plan benefit exceeds the annuitized value of their U.S. Intel Retirement Contribution Plan benefit. If participant balances in the U.S. Intel Retirement Contribution Plan do not grow sufficiently, the projected benefit obligation of the U.S. Intel Minimum Pension Plan could increase significantly. Consistent with applicable law, assets of the U.S. Intel Minimum Pension Plan are held in trust, solely for the benefit of plan participants, and are not available for general corporate purposes.
	Non-U.S. Pension Benefits. We also provide defined-benefit pension plans in certain other countries, most significantly Ireland, Israel, Germany and Japan. Consistent with the requirements of local law, we deposit funds for certain plans with insurance companies, with third-party trustees, or into government-managed accounts, and/or accrue for the unfunded portion of the obligation. Effective June 20, 2012, Ireland closed its pension plan to employees hired on or after this date.
	U.S. Postretirement Medical Benefits. Upon retirement, eligible U.S. employees who were hired prior to January 1, 2014, are credited with a defined dollar amount, based on years of service, into a U.S. Sheltered Employee Retirement Medical Account (SERMA). These credits can be used to pay all or a portion of the cost to purchase coverage in the retiree’s choice of medical plan. If the available credits are not sufficient to pay the entire cost of the coverage, the remaining cost is the retiree’s responsibility. Effective January 1, 2014, employees hired on or after January 1, 2014, are not eligible to earn a SERMA benefit.
	Funding Policy. Our practice is to fund the various pension plans and the U.S. postretirement medical benefits plan in amounts sufficient to meet the minimum requirements of applicable local laws and regulations. Additional funding may be provided as deemed appropriate. Depending on the design of the plan, local customs, and market circumstances, the liabilities of a plan may exceed qualified plan assets.
	Benefit Obligation and Plan Assets
	The changes in the projected benefit obligations and plan assets for the plans described above were as follows:
		U.S. Pension Benefits								Non-U.S. Pension							U.S. Postretirement
										Benefits							Medical Benefits
	(In Millions)	2013				2012				2013			2012				2013				2012
	Beginning projected benefit obligation	$	1,742			$	1,480			$	1,412		$	1,121			$	484			$	369
	Service cost	119				98				78			64				27				30
	Interest cost	67				69				60			52				20				17
	Actuarial (gain) loss	(746		)		108				121			172				(56		)		75
	Other	(45		)		(13		)		24			3				34				(7		)
	Ending projected benefit obligation	$	1,137			$	1,742			$	1,695		$	1,412			$	509			$	484
		U.S. Pension Benefits								Non-U.S. Pension							U.S. Postretirement
										Benefits							Medical Benefits
	(In Millions)	2013				2012				2013			2012				2013				2012
	Beginning fair value of plan assets	$	684			$	648			$	838		$	722			$	191			$	116
	Actual return on plan assets	10				49				81			70				49				—
	Employer contributions	—				—				65			52				162				82
	Other	(45		)		(13		)		21			(6		)		(7		)		(7		)
	Ending fair value of plan assets	$	649			$	684			$	1,005		$	838			$	395			$	191
	The amounts recognized on the consolidated balance sheets at the end of each period were as follows:
		U.S. Pension Benefits								Non-U.S. Pension							U.S. Postretirement
										Benefits							Medical Benefits
	(In Millions)	Dec 28,				Dec 29,				Dec 28,			Dec 29,				Dec 28,				Dec 29,
		2013				2012				2013			2012				2013				2012
	Other long-term assets	$	—			$	—			$	16		$	1			$	—			$	—
	Other long-term liabilities	(488		)		(1,058		)		(706		)	(575		)		(114		)		(293		)
	Accumulated other comprehensive loss (income), before tax	255				1,050				520			477				43				138
	Net amount recognized	$	(233	)		$	(8	)		$	(170	)	$	(97	)		$	(71	)		$	(155	)
	The amounts recorded in accumulated other comprehensive income (loss) before taxes at the end of each period were as follows:
		U.S. Pension Benefits								Non-U.S. Pension							U.S. Postretirement
										Benefits							Medical Benefits
	(In Millions)	Dec 28,				Dec 29,				Dec 28,			Dec 29,				Dec 28,				Dec 29,
		2013				2012				2013			2012				2013				2012
	Net prior service credit (cost)	$	—			$	—			$	25		$	12			$	(54	)		$	(60	)
	Net actuarial gain (loss)	(255		)		(1,050		)		(545		)	(489		)		11				(78		)
	Accumulated other comprehensive income (loss), before tax	$	(255	)		$	(1,050	)		$	(520	)	$	(477	)		$	(43	)		$	(138	)
	As of December 28, 2013, the accumulated benefit obligation was $497 million for the U.S. Intel Minimum Pension Plan ($562 million as of December 29, 2012) and $1.3 billion for the non-U.S. defined-benefit pension plans ($1.1 billion as of December 29, 2012). Included in the aggregate data in the following tables are the amounts applicable to our pension plans, with accumulated benefit obligations in excess of plan assets, as well as plans with projected benefit obligations in excess of plan assets. Amounts related to such plans at the end of each period were as follows:
		U.S. Pension Benefits								Non-U.S. Pension
										Benefits
	(In Millions)	Dec 28,				Dec 29,				Dec 28,			Dec 29,
		2013				2012				2013			2012
	Plans with accumulated benefit obligations in excess of plan assets:
	Accumulated benefit obligations	$	—			$	—			$	900		$	813
	Plan assets	$	—			$	—			$	563		$	508
	Plans with projected benefit obligations in excess of plan assets:
	Projected benefit obligations	$	1,137			$	1,742			$	1,295		$	1,400
	Plan assets	$	649			$	684			$	588		$	825
	On a worldwide basis, our pension and postretirement benefit plans were 61% funded as of December 28, 2013. The U.S. Intel Minimum Pension Plan, which accounts for approximately 34% of the worldwide pension and postretirement benefit obligations, was 57% funded. Funded status is not indicative of our ability to pay ongoing pension benefits or of our obligation to fund retirement trusts. Required pension funding for U.S. retirement plans is determined in accordance with the Employee Retirement Income Security Act (ERISA) which sets required minimum contributions. Cumulative company funding to the U.S. Intel Minimum Pension Plan currently exceeds the minimum ERISA funding requirements.
	Assumptions
	Weighted average actuarial assumptions used to determine benefit obligations for the plans at the end of each period were as follows:
		U.S. Pension Benefits						Non-U.S. Pension					U.S. Postretirement
								Benefits					Medical Benefits
		Dec 28,			Dec 29,			Dec 28,			Dec 29,		Dec 28,			Dec 29,
2013		2012			2013			2012			2013		2012
Discount rate	4.8	%		3.9	%		4	%		4.2	%	4.6	%		3.6	%
Rate of compensation increase	3.8	%		4.1	%		3.9	%		4	%	n/a			n/a
Weighted average actuarial assumptions used to determine costs for the plans for each period were as follows:
	U.S. Pension Benefits									Non-U.S. Pension Benefits								U.S. Postretirement
																		Medical Benefits
	2013			2012			2011			2013		2012			2011			2013			2012		2011
Discount rate	3.9	%		4.7	%		5.8	%		4.2	%	5	%		5.3	%		4.2	%		4.6	%	5.6	%
Expected long-term rate of return on plan assets	4.5	%		5	%		5.5	%		5.2	%	5.9	%		6.3	%		7.7	%		3	%	3	%
Rate of compensation increase	4.1	%		4.5	%		4.7	%		4.3	%	4.1	%		4.3	%		n/a			n/a		n/a
For the U.S. plans, we developed the discount rate by calculating the benefit payment streams by year to determine when benefit payments will be due. We then matched the benefit payment streams by year to the AA corporate bond rates to match the timing and amount of the expected benefit payments and discounted back to the measurement date to determine the appropriate discount rate. For the non-U.S. plans, we used two approaches to develop the discount rate. In certain countries, we used a model consisting of a theoretical bond portfolio for which the timing and amount of cash flows approximated the estimated benefit payments of our pension plans. In other countries, we analyzed current market long-term bond rates and matched the bond maturity with the average duration of the pension liabilities.
The expected long-term rate of return on plan assets assumptions takes into consideration both duration and risk of the investment portfolios, and is developed through consensus and building-block methodologies. The consensus methodology includes unadjusted estimates by the fund manager on future market expectations by broad asset classes and geography. The building-block approach determines the rates of return implied by historical risk premiums across asset classes. In addition, we analyze rates of return relevant to the country where each plan is in effect and the investments applicable to the plan, expectations of future returns, local actuarial projections, and the projected long-term rates of return from external investment managers. The expected long-term rate of return on plan assets shown for the non-U.S. plan assets is weighted to reflect each country’s relative portion of the non-U.S. plan assets.
Net Periodic Benefit Cost
In 2013, the net periodic benefit cost for U.S. pension benefits, non-U.S. pension benefits, and U.S. postretirement medical benefits was $230 million ($210 million in 2012 and $88 million in 2011), $116 million ($88 million in 2012 and $80 million in 2011) and $77 million ($50 million in 2012 and $39 million in 2011), respectively.
The increase in the U.S. and non-U.S. pension benefit costs is primarily attributed to an increase in service costs compared to 2012. The increase in the U.S. postretirement medical benefits compared to 2012 is primarily attributed to special one-time termination benefit costs incurred in 2013.
U.S. Pension Plan Assets
In general, the investment strategy for U.S. Intel Minimum Pension Plan assets is to maximize risk-adjusted returns, taking into consideration the investment horizon and expected volatility, to ensure that there are sufficient assets available to pay pension benefits as they come due. The allocation to each asset class will fluctuate with market conditions, such as volatility and liquidity concerns, and will typically be rebalanced when outside the target ranges, which are 60% for fixed-income debt instrument investments and 40% for equity investments in 2013. The expected long-term rate of return for the U.S. Intel Minimum Pension Plan assets is 5.2%.
U.S. Intel Minimum Pension Plan assets measured at fair value on a recurring basis consisted of the following investment categories at the end of each period were as follows:
	28-Dec-13															Dec 29,
																2012
	Fair Value Measured at Reporting Date Using
(In Millions)	Level 1				Level 2				Level 3			Total				Total
Equity securities	$	15			$	205			$	—		$	220			$	92
Fixed income	88				255				72			415				582
Other investments	11				—				—			11				—
Total assets measured at fair value	$	114			$	460			$	72		$	646			$	674
Cash												3				10
Total U.S. pension plan assets at fair value												$	649			$	684
A substantial majority of the fixed income investments in the preceding table are corporate bonds, government bonds, and asset-backed securities. Corporate bonds include both U.S. and non-U.S. bonds with the majority held in high-quality bonds. Government bonds include bonds issued or deemed to be guaranteed by government entities and include instruments such as non-U.S. government bonds, U.S. Treasury securities, and U.S. agency securities. The Level 3 investments relate to our asset-backed securities, as we used unobservable inputs to the valuations that were significant to the fair value measurements.
Non-U.S. Plan Assets
The investments of the non-U.S. plans are managed by insurance companies, third-party trustees, or pension funds, consistent with regulations or market practice of the country where the assets are invested. The investment manager makes investment decisions within the guidelines set by Intel or local regulations. The investment manager evaluates performance by comparing the actual rate of return to the return on similar assets. Investments managed by qualified insurance companies or pension funds under standard contracts follow local regulations, and we are not actively involved in their investment strategies. For the assets that we have discretion to set investment guidelines, the assets are invested in developed country equities and fixed-income debt instruments, either through index funds or direct investment. In general, the investment strategy is designed to accumulate a diversified portfolio among markets, asset classes, or individual securities to reduce market risk and to assure that the pension assets are available to pay benefits as they come due. The target allocation of the non-U.S. plan assets that we have control over is 80% equity securities and 20% fixed-income instruments. The average expected long-term rate of return for the non-U.S. plan assets is 5.7%.
Non-U.S. plan assets measured at fair value on a recurring basis consisted of the following investment categories at the end of each period were as follows:
	28-Dec-13															Dec 29,
																2012
	Fair Value Measured at Reporting Date Using
(In Millions)	Level 1				Level 2				Level 3			Total				Total
Equity securities	$	287			$	63			$	11		$	361			$	248
Fixed income	—				521				33			554				574
Total assets measured at fair value	$	287			$	584			$	44		$	915			$	822
Cash												90				16
Total non-U.S. plan assets at fair value												$	1,005			$	838
Substantially all of the equity securities in the preceding table are invested in a diversified mix of equities of developed countries, including the U.S., and emerging markets throughout the world.
The majority of the fixed income securities in the preceding table are investments held by insurance companies and insurance contracts that are managed by qualified insurance companies. We do not have control over the target allocation or visibility of the investment strategies of those investments. Insurance contracts and investments held by insurance companies made up 38% of total non-U.S. plan assets as of December 28, 2013 (40% as of December 29, 2012).
U.S. Postretirement Medical Plan Assets
In general, the investment strategy for U.S. postretirement medical benefits plan assets is to invest primarily in liquid assets due to the level of expected future benefit payments. In 2012, we modified the investment strategy for plan assets from investing solely in a money market account to investing in a tax-aware global equity portfolio, which is actively managed by an external investment manager. The tax-aware global equity portfolio is comprised of a diversified mix of equities in developed countries, including the U.S., and emerging markets throughout the world. The expected long-term rate of return for the U.S. postretirement medical benefits plan assets is 7.4%. As of December 28, 2013, substantially all of the U.S. postretirement medical benefits plan assets were invested in exchange-traded equity securities and were measured at fair value using Level 1 inputs.
Concentrations of Risk
We manage a variety of risks, including market, credit, and liquidity risks, across our plan assets through our investment managers. We define a concentration of risk as an undiversified exposure to one of the aforementioned risks that unnecessarily increases the exposure to a loss of plan assets. We monitor exposure to such risks in both the U.S. and non-U.S. plans by monitoring the magnitude of the risk in each plan and diversifying our exposure to such risks across a variety of instruments, markets, and counterparties. As of December 28, 2013, we did not have concentrations of risk in any single entity, manager, counterparty, sector, industry, or country.
Funding Expectations
Under applicable law for the U.S. Intel Minimum Pension Plan and the U.S. postretirement medical benefits plan, we are not required to make any contributions during 2014. Our expected required funding for the non-U.S. plans during 2014 is approximately $62 million.
Estimated Future Benefit Payments
Estimated benefit payments over the next 10 fiscal years are as follows:
(In Millions)	U.S. Pension				Non-U.S.				U.S.
	Benefits				Pension				Postretirement
					Benefits				Medical
									Benefits
2014	$	42			$	33			$	23
2015	$	51			$	32			$	22
2016	$	63			$	32			$	24
2017	$	71			$	36			$	22
2018	$	88			$	38			$	21
2019-2023	$	691			$	219			$	99

Commitments

Commitments	12 Months Ended
	Dec. 28, 2013
Commitments [Abstract]	'
Commitments [Text Block]	'
	Note 18: Commitments
	A portion of our capital equipment and certain facilities are under operating leases that expire at various dates through 2028. Additionally, portions of our real property are under leases that expire at various dates through 2062. Rental expense was $270 million in 2013 ($214 million in 2012 and $178 million in 2011).
	Minimum rental commitments under all non-cancelable leases with an initial term in excess of one year were as follows as of December 28, 2013:
	(In Millions)
	2014	$	208
	2015	172
	2016	126
	2017	97
	2018	69
	2019 and thereafter	198
	Total	$	870
	Commitments for construction or purchase of property, plant and equipment totaled $5.5 billion as of December 28, 2013 ($4.6 billion as of December 29, 2012), substantially all of which will be due within the next year. Other purchase obligations and commitments totaled approximately $1.9 billion as of December 28, 2013 (approximately $2.0 billion as of December 29, 2012). Other purchase obligations and commitments include payments due under various types of licenses and agreements to purchase goods or services, as well as payments due under non-contingent funding obligations. Funding obligations include agreements to fund various projects with other companies. In addition, we have various contractual commitments with Micron and IMFT. For further information on these contractual commitments, see “Note 5: Cash and Investments.”
	During 2012, we entered into a series of agreements with ASML intended to accelerate the development of 450mm wafer technology and extreme ultraviolet lithography (EUV). Intel agreed to provide R&D funding totaling €829 million over five years and committed to advance purchase orders for a specified number of tools from ASML. Our remaining obligation, contingent upon ASML achieving certain milestones, is approximately €738 million, or $1.0 billion, as of December 28, 2013. As our obligation is contingent upon ASML achieving certain milestones, we have not included this obligation in the preceding other purchase obligations and commitments total.

Employee_Equity_Incentive_Plan

Employee Equity Incentive Plans	12 Months Ended
	Dec. 28, 2013
Employee Benefits and Share-based Compensation [Abstract]	'
Employee Equity Incentive Plans [Text Block]	'
	Note 19: Employee Equity Incentive Plans
	Our equity incentive plans are broad-based, long-term programs intended to attract and retain talented employees and align stockholder and employee interests.
	In May 2013, stockholders approved an extension of the 2006 Equity Incentive Plan (the 2006 Plan). Stockholders approved 123 million additional shares for issuance, increasing the total shares of common stock authorized for issuance as equity awards to employees and non-employee directors to 719 million shares. The approval also extended the expiration date of the 2006 Plan to June 2016. A maximum of 517 million of these shares can be awarded as non-vested shares (restricted stock) or non-vested share units (restricted stock units). As of December 28, 2013, 304 million shares remained available for future grant under the 2006 Plan.
	Going forward, we may assume the equity incentive plans and the outstanding equity awards of certain acquired companies. Once they are assumed, we do not grant additional shares under those plans. In connection with our completed acquisition of McAfee in 2011, we assumed McAfee’s equity incentive plan and issued replacement awards. The stock options and restricted stock units issued generally retain similar terms and conditions of the respective plan under which they were originally granted.
	We issue restricted stock units with both a market condition and a service condition (market-based restricted stock units), referred to in our 2013 Proxy Statement as outperformance stock units, to a small group of senior officers and non-employee directors. For market-based restricted stock units issued in 2013, the number of shares of Intel common stock to be received at vesting will range from 50% to 200% of the target amount, based on total stockholder return (TSR) on Intel common stock measured against the benchmark TSR of a peer group over a three-year period. TSR is a measure of stock price appreciation plus any dividends paid in this performance period. As of December 28, 2013, 3 million market-based restricted stock units were outstanding. These market-based restricted stock units accrue dividend equivalents and generally vest three years and one month from the grant date.
	Equity awards granted to employees in 2013 under our equity incentive plans generally vest over four years from the date of grant, and options expire seven years from the date of grant, with the exception of market-based restricted stock units, a small number of restricted stock units granted to executive-level employees, and replacement awards related to acquisitions.
	The 2006 Stock Purchase Plan allows eligible employees to purchase shares of our common stock at 85% of the value of our common stock on specific dates. In May 2011, stockholders approved an extension of the 2006 Stock Purchase Plan. Stockholders approved 133 million additional shares for issuance, increasing the total shares of common stock available for issuance to 373 million shares. The approval also extended the expiration date of the 2006 Stock Purchase Plan to August 2016. As of December 28, 2013, 216 million shares were available for issuance under the 2006 Stock Purchase Plan.
	Share-Based Compensation
	Share-based compensation recognized in 2013 was $1.1 billion ($1.1 billion in 2012 and $1.1 billion in 2011).
	On a quarterly basis, we assess changes to our estimate of expected equity award forfeitures based on our review of recent forfeiture activity and expected future employee turnover. We recognize the effect of adjustments made to the forfeiture rates, if any, in the period that we change the forfeiture estimate. The effect of forfeiture adjustments in 2013, 2012, and 2011 was not significant.
	The total share-based compensation cost capitalized as part of inventory as of December 28, 2013, was $38 million ($41 million as of December 29, 2012 and $38 million as of December 31, 2011). During 2013, the tax benefit that we realized for the tax deduction from share-based awards totaled $385 million ($510 million in 2012 and $327 million in 2011).
	We estimate the fair value of restricted stock unit awards with time-based vesting using the value of our common stock on the date of grant, reduced by the present value of dividends expected to be paid on our common stock prior to vesting. We estimate the fair value of market-based restricted stock units using a Monte Carlo simulation model on the date of grant. We based the weighted average estimated value of restricted stock unit grants, as well as the weighted average assumptions that we used in calculating the fair value, on estimates at the date of grant, for each period as follows:
			2013				2012				2011
	Estimated values		$	21.45			$	25.32			$	19.86
	Risk-free interest rate		0.2		%		0.3		%		0.7		%
	Dividend yield		3.8		%		3.3		%		3.4		%
	Volatility		25		%		26		%		27		%
	We use the Black-Scholes option pricing model to estimate the fair value of options granted under our equity incentive plans and rights to acquire stock granted under our stock purchase plan. We based the weighted average estimated value of employee stock option grants and rights granted under the stock purchase plan, as well as the weighted average assumptions used in calculating the fair value, on estimates at the date of grant, for each period as follows:
			Stock Options											Stock Purchase Plan
			2013				2012				2011			2013			2012				2011
	Estimated values		$	3.11			$	4.22			$	3.91		$	4.52		$	5.47			$	4.69
	Expected life (in years)		5.2				5.3				5.4			0.5			0.5				0.5
	Risk-free interest rate		0.8		%		1		%		2.2		%	0.1		%	0.1		%		0.2		%
	Dividend yield		3.9		%		3.3		%		3.4		%	4		%	3.3		%		3.6		%
	Volatility		25		%		25		%		27		%	22		%	24		%		26		%
	We base the expected volatility on implied volatility because we have determined that implied volatility is more reflective of market conditions and a better indicator of expected volatility than historical volatility. Prior to 2011, we used the simplified method of calculating expected life due to significant differences in the vesting terms and contractual life of current option grants compared to our historical grants. In 2011, we began using historical option exercise data as the basis for determining expected life, as we believe that we have sufficient historical data to provide a reasonable basis upon which to estimate the expected life input for valuing options using the Black-Scholes model.
	Restricted Stock Unit Awards
	Information with respect to outstanding RSU activity for each period was as follows:
			Number of			Weighted
			RSUs			Average
			(In Millions)			Grant-Date
						Fair Value
	December 25, 2010		99.8			$	18.56
	Granted		43.3			$	19.86
	Assumed in acquisition		5.8			$	20.8
	Vested		(37.5	)		$	18.6
	Forfeited		(4.4	)		$	19.07
	31-Dec-11		107			$	19.18
	Granted		49.9			$	25.32
	Vested		(43.2	)		$	18.88
	Forfeited		(4.4	)		$	20.93
	29-Dec-12		109.3			$	22.03
	Granted		53.4			$	21.45
	Vested		(44.5	)		$	20.21
	Forfeited		(4.9	)		$	22.06
	28-Dec-13		113.3			$	22.47
	Expected to vest as of December 28, 2013		107.3			$	22.49
	The aggregate fair value of awards that vested in 2013 was $1.0 billion ($1.2 billion in 2012 and $753 million in 2011), which represents the market value of Intel common stock on the date that the restricted stock units vested. The grant-date fair value of awards that vested in 2013 was $899 million ($816 million in 2012 and $697 million in 2011). The number of restricted stock units vested includes shares that we withheld on behalf of employees to satisfy the minimum statutory tax withholding requirements. Restricted stock units that are expected to vest are net of estimated future forfeitures.
	As of December 28, 2013, there was $1.6 billion in unrecognized compensation costs related to restricted stock units granted under our equity incentive plans. We expect to recognize those costs over a weighted average period of 1.2 years.
	Stock Option Awards
	As of December 28, 2013, options outstanding that have vested and are expected to vest were as follows:
			Number of			Weighted				Weighted		Aggregate
			Options			Average				Average		Intrinsic
			(In Millions)			Exercise				Remaining		Value
						Price				Contractual		(In Millions)
										Term
										(In Years)
	Vested		111.5			$	20.25			2.6		$	617
	Expected to vest		39.6			$	23.4			5.4		$	101
	Total		151.1			$	21.08			3.3		$	718
	Aggregate intrinsic value represents the difference between the exercise price and $25.60, the closing price of Intel common stock on December 27, 2013, as reported on The NASDAQ Global Select Market*, for all in-the-money options outstanding. Options outstanding that are expected to vest are net of estimated future option forfeitures.
	Options with a fair value of $186 million completed vesting during 2013 ($205 million during 2012 and $226 million during 2011). As of December 28, 2013, there was $75 million in unrecognized compensation costs related to stock options granted under our equity incentive plans. We expect to recognize those costs over a weighted average period of 1.1 years.
	Additional information with respect to stock option activity for each period was as follows:
		Number of			Weighted
		Options			Average
		(In Millions)			Exercise
					Price
25-Dec-10		386.4			$	20.45
Grants		14.7			$	21.49
Assumed in acquisition		12			$	15.8
Exercises		(86.3	)		$	20.06
Cancellations and forfeitures		(8.6	)		$	20.47
Expirations		(19.9	)		$	24.85
31-Dec-11		298.3			$	20.12
Grants		13.5			$	27.01
Exercises		(85.8	)		$	20.45
Cancellations and forfeitures		(3.9	)		$	21.17
Expirations		(19.3	)		$	22.45
29-Dec-12		202.8			$	20.2
Grants		20.1			$	22.99
Exercises		(65.0	)		$	18.76
Cancellations and forfeitures		(3.0	)		$	22.58
Expirations		(1.9	)		$	22.56
28-Dec-13		153			$	21.1
Options exercisable as of:
31-Dec-11		203.6			$	20.44
29-Dec-12		139.8			$	19.76
28-Dec-13		111.5			$	20.25
The aggregate intrinsic value of stock option exercises in 2013 was $265 million ($517 million in 2012 and $318 million in 2011), which represents the difference between the exercise price and the value of Intel common stock at the time of exercise.
The following table summarizes information about options outstanding as of December 28, 2013:
									Outstanding Options							Exercisable Options
Range of Exercise Prices									Number of			Weighted	Weighted			Number of			Weighted
									Shares			Average	Average			Shares			Average
									(In Millions)			Remaining	Exercise			(In Millions)			Exercise
												Contractual	Price						Price
												Life
												(In Years)
$	1.12		-	$	15				2.2			3.7	$	12.22		1.2			$	11.69
$	15.01		-	$	20				70.5			2.7	$	18.22		70.4			$	18.2
$	20.01		-	$	25				57.6			4.2	$	22.59		26.2			$	22.54
$	25.01		-	$	30				22.4			3	$	27.09		13.4			$	27.02
$	30.01		-	$	33.03				0.3			0.1	$	32.31		0.3			$	32.31
Total									153			3.3	$	21.1		111.5			$	20.25
These options will expire if they are not exercised by specific dates through April 2021. Option exercise prices for options exercised during the three-year period ended December 28, 2013, ranged from $1.12 to $28.15.
Stock Purchase Plan
Approximately 76% of our employees were participating in our 2006 Stock Purchase Plan as of December 28, 2013 (72% in 2012 and 70% in 2011). Employees purchased 20.5 million shares in 2013 for $369 million under the 2006 Stock Purchase Plan (17.4 million shares for $355 million in 2012 and 18.5 million shares for $318 million in 2011). As of December 28, 2013, there was $13 million in unrecognized compensation costs related to rights to acquire common stock under our stock purchase plan. We expect to recognize those costs over a period of approximately one and a half months.

Common_Stock_Repurchases

Common Stock Repurchases	12 Months Ended
	Dec. 28, 2013
Common Stock Repurchases [Abstract]	'
Common Stock Repurchases [Text Block]	'
	Note 20: Common Stock Repurchases
	Common Stock Repurchase Program
	We have an ongoing authorization, originally approved by our Board of Directors in October 2005, and subsequently amended, to repurchase up to $45 billion in shares of our common stock in open market or negotiated transactions. As of December 28, 2013, $3.2 billion remained available for repurchase under the existing repurchase authorization limit. During 2013, we repurchased 94.1 million shares of common stock at a cost of $2.1 billion (191.0 million shares of common stock at a cost of $4.8 billion in 2012 and 642.3 million shares of common stock at a cost of $14.1 billion in 2011). We have repurchased 4.4 billion shares at a cost of $91 billion since the program began in 1990.
	Restricted Stock Unit Withholdings
	We issue restricted stock units as part of our equity incentive plans. For the majority of restricted stock units granted, the number of shares issued on the date the restricted stock units vest is net of the minimum statutory withholding requirements that we pay in cash to the appropriate taxing authorities on behalf of our employees. In our consolidated financial statements, we also treat shares withheld for tax purposes on behalf of our employees in connection with the vesting of restricted stock units as common stock repurchases because they reduce the number of shares that would have been issued upon vesting. These withheld shares are not considered common stock repurchases under our authorized common stock repurchase plan. During 2013, we withheld 13.1 million shares to satisfy $293 million of employees’ tax obligations (12.6 million shares to satisfy $345 million during 2012 and 10.3 million shares to satisfy $207 million during 2011).

Gains_Losses_on_Equity_Investm

Gains (Losses) on Equity Investments, Net	12 Months Ended
	Dec. 28, 2013
Gains (Losses) on Equity Investments, Net [Abstract]	'
Gains (Losses) on Equity Investments, Net [Text Block]	'
	Note 21: Gains (Losses) on Equity Investments, Net
	Gains (losses) on equity investments, net for each period were as follows:
	(In Millions)	2013			2012			2011
	Share of equity method investee losses, net	$	(69	)	$	(81	)	$	(204	)
	Impairment charges	(123		)	(154		)	(132		)
	Gains on sales, net	515			183			303
	Dividends	46			—			—
	Other, net	102			193			145
	Total gains (losses) on equity investments, net	$	471		$	141		$	112
	Gains on sales, net for 2013 included gains of $439 million on the sales of our interest in Clearwire LLC and our shares in Clearwire Corporation in the third quarter of 2013. For further information on these transactions, see "Note 5: Cash and Investments."

Interest_and_Other_Net

Interest and Other, Net	12 Months Ended
	Dec. 28, 2013
Interest and Other, Net [Abstract]	'
Interest and Other, Net [Text Block]	'
	Note 22: Interest and Other, Net
	The components of interest and other, net for each period were as follows:
	(In Millions)	2013			2012			2011
	Interest income	$	104		$	97		$	98
	Interest expense	(244		)	(90		)	(41		)
	Other, net	(11		)	87			135
	Total interest and other, net	$	(151	)	$	94		$	192
	Interest expense in the preceding table is net of $246 million of interest capitalized in 2013 ($240 million in 2012 and $150 million in 2011). In 2011, we recognized a gain upon forming the Intel and GE joint venture, Care Innovations, of $164 million, which is included within “other, net,” in the preceding table. For further information, see “Note 5: Cash and Investments.”

Earnings_Per_Share

Earnings Per Share	12 Months Ended
	Dec. 28, 2013
Earnings Per Share [Abstract]	'
Earnings Per Share [Text Block]	'
	Note 23: Earnings Per Share
	We computed our basic and diluted earnings per common share for each period as follows:
	(In Millions, Except Per Share Amounts)	2013		2012		2011
	Net income available to common stockholders	$	9,620	$	11,005	$	12,942
	Weighted average common shares outstanding—basic	4,970		4,996		5,256
	Dilutive effect of employee equity incentive plans	68		100		101
	Dilutive effect of convertible debt	59		64		54
	Weighted average common shares outstanding—diluted	5,097		5,160		5,411
	Basic earnings per common share	$	1.94	$	2.2	$	2.46
	Diluted earnings per common share	$	1.89	$	2.13	$	2.39
	We computed basic earnings per common share using net income available to common stockholders and the weighted average number of common shares outstanding during the period. We computed diluted earnings per common share using net income available to common stockholders and the weighted average number of common shares outstanding plus potentially dilutive common shares outstanding during the period. Net income available to participating securities was insignificant for all periods presented.
	Potentially dilutive common shares from employee incentive plans are determined by applying the treasury stock method to the assumed exercise of outstanding stock options, the assumed vesting of outstanding restricted stock units, and the assumed issuance of common stock under the stock purchase plan. Potentially dilutive common shares are determined by applying the if-converted method for our 2005 debentures. However, as our 2009 debentures require settlement of the principal amount of the debt in cash upon conversion, with the conversion premium paid in cash or stock at our option, potentially dilutive common shares are determined by applying the treasury stock method. For further discussion on the specific conversion features of our 2005 and 2009 debentures, see “Note 16: Borrowings.”
	In 2013, we excluded on average 55 million outstanding stock options and restricted stock units (29 million in 2012 and 90 million in 2011) from the computation of diluted earnings per common share because these would have been antidilutive. These options could potentially be included in the dilutive earnings per common share calculation in the future if the average market value of the common shares increases and is greater than the exercise price of these options.
	In 2013, 2012, and 2011, we included our 2009 debentures in the calculation of diluted earnings per common share because the average market price was above the conversion price. We could potentially exclude the 2009 debentures again in the future if the average market price is below the conversion price.

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 28, 2013
Income Tax Disclosure [Abstract]	'
Taxes [Text Block]	'
	Note 24: Income Taxes
	Income Tax Provision
	Income before taxes and the provision for taxes consisted of the following:
	(Dollars in Millions)	2013				2012				2011
	Income before taxes:
	U.S.	$	9,374			$	10,042			$	14,659
	Non-U.S.	3,237				4,831				3,122
	Total income before taxes	$	12,611			$	14,873			$	17,781
	Provision for taxes:
	Current:
	Federal	$	2,730			$	2,539			$	3,212
	State	68				52				104
	Non-U.S.	716				1,135				374
	Total current provision for taxes	$	3,514			$	3,726			$	3,690
	Deferred:
	Federal	$	(412	)		$	129			$	1,175
	Other	(111		)		13				(26		)
	Total deferred provision for taxes	$	(523	)		$	142			$	1,149
	Total provision for taxes	$	2,991			$	3,868			$	4,839
	Effective tax rate	23.7		%		26		%		27.2		%
	The difference between the tax provision at the statutory federal income tax rate and the tax provision as a percentage of income before income taxes (effective tax rate) for each period was as follows:
		2013			2012			2011
	Statutory federal income tax rate	35	%		35	%		35	%
	Increase (reduction) in rate resulting from:
	Non-U.S. income taxed at different rates	(5.8	)		(7.3	)		(4.4	)
	Research and development tax credits	(3.5	)		—			(1.0	)
	Domestic manufacturing deduction benefit	(2.1	)		(2.1	)		(1.9	)
	Other	0.1			0.4			(0.5	)
	Effective tax rate	23.7	%		26	%		27.2	%
	The U.S. R&D tax credit was reenacted in January 2013 retroactive to the beginning of 2012. The full year 2012 impact of the U.S. R&D tax credit was recognized in the first quarter of 2013.
	Income in certain non-U.S. countries is fully exempt from income taxes for a limited period of time due to eligible activities and certain capital investment actions. These full tax exemptions expire at various dates through 2020; however, the exemptions in certain countries are eligible for renewal. In 2013, the tax benefit attributable to tax holidays was $213 million ($252 million for 2012 and $554 million for 2011) with a $0.04 impact on diluted earnings per share ($0.05 for 2012 and $0.10 for 2011).
	During 2013, net income tax benefits attributable to equity-based compensation transactions that were allocated to stockholders’ equity totaled $3 million (net benefits of $137 million in 2012 and net deficiencies of $18 million in 2011).
	Deferred and Current Income Taxes
	Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts for income tax purposes. Significant components of our deferred tax assets and liabilities at the end of each period were as follows:
	(In Millions)	Dec 28,				Dec 29,
		2013				2012
	Deferred tax assets:
	Accrued compensation and other benefits	$	1,047			$	1,125
	Share-based compensation	564				638
	Deferred income	672				637
	Inventory	733				506
	Unrealized losses on investments and derivatives	—				36
	State credits and net operating losses	378				297
	Other, net	654				654
	Gross deferred tax assets	4,048				3,893
	Valuation allowance	(456		)		(389		)
	Total deferred tax assets	$	3,592			$	3,504
	Deferred tax liabilities:
	Property, plant and equipment	$	(2,023	)		$	(2,325	)
	Licenses and intangibles	(687		)		(778		)
	Convertible debt	(911		)		(856		)
	Unrealized gains on investments and derivatives	(815		)		—
	Investment in non-U.S. subsidiaries	(244		)		(213		)
	Other, net	(281		)		(269		)
	Total deferred tax liabilities	$	(4,961	)		$	(4,441	)
	Net deferred tax assets (liabilities)	$	(1,369	)		$	(937	)
	Reported as:
	Current deferred tax assets	$	2,594			$	2,117
	Non-current deferred tax assets	434				358
	Non-current deferred tax liabilities	(4,397		)		(3,412		)
	Net deferred tax assets (liabilities)	$	(1,369	)		$	(937	)
	Non-current deferred tax assets are included within other long-term assets on the consolidated balance sheets.
	The valuation allowance is based on our assessment that it is more likely than not that certain deferred tax assets will not be realized in the foreseeable future. The valuation allowance as of December 28, 2013, included allowances related to unrealized state credit carryforwards of $364 million and matters related to our non-U.S. subsidiaries of $92 million.
As of December 28, 2013, our federal, state, and non-U.S. net operating loss carryforwards for income tax purposes were $239 million, $353 million, and $647 million, respectively. Approximately half of the non-U.S. net operating loss carryforwards have no expiration date. The remaining non-U.S. as well as the U.S. federal and state net operating loss carryforwards expire at various dates through 2033. A significant amount of the net operating loss carryforwards in the U.S. relates to acquisitions and, as a result, is limited in the amount that can be recognized in any one year. The non-U.S. net operating loss carryforwards include $342 million that is not likely to be recovered and has been reduced by a valuation allowance.
As of December 28, 2013, we had not recognized U.S. deferred income taxes on a cumulative total of $20.0 billion of undistributed earnings for certain non-U.S. subsidiaries and $2.4 billion of other basis differences of our investments in certain non-U.S. subsidiaries primarily related to McAfee. Determining the unrecognized deferred tax liability related to investments in these non-U.S. subsidiaries that are indefinitely reinvested is not practicable. We currently intend to indefinitely reinvest those earnings and other basis differences in operations outside the U.S.
Current income taxes receivable of $65 million as of December 28, 2013, ($866 million as of December 29, 2012) is included in other current assets. Current income taxes payable of $542 million as of December 28, 2013, ($711 million as of December 29, 2012) is included in other accrued liabilities.
Long-term income taxes payable of $188 million as of December 28, 2013, ($177 million as of December 29, 2012) within other long-term liabilities, includes uncertain tax positions, reduced by the associated federal deduction for state taxes and non-U.S. tax credits, and may also include other long-term tax liabilities that are not uncertain but have not yet been paid.
Uncertain Tax Positions
The aggregate changes in the balance of gross unrecognized tax benefits for each period were as follows:
(In Millions)	2013				2012				2011
Beginning gross unrecognized tax benefits	$	189			$	212			$	216
Settlements and effective settlements with tax authorities and related remeasurements	(2		)		(81		)		(63		)
Lapse of statute of limitations	—				(5		)		(17		)
Increases in balances related to tax positions taken during prior periods	21				56				91
Decreases in balances related to tax positions taken during prior periods	(9		)		(6		)		(21		)
Increases in balances related to tax positions taken during current period	8				13				6
Ending gross unrecognized tax benefits	$	207			$	189			$	212
During 2013, we settled and effectively settled matters with certain state and non-U.S. tax authorities relating to tax positions taken during prior periods. The result of the settlements, effective settlements, and re-measurements resulted in an insignificant reduction in the balance of our gross unrecognized tax benefits in 2013 ($81 million in 2012 and $63 million in 2011). The related tax benefit for settlements, effective settlements, and re-measurements is insignificant for 2013 ($7 million for 2012 and $61 million for 2011).
If the remaining balance of $207 million of unrecognized tax benefits as of December 28, 2013, ($189 million as of December 29, 2012) were realized in a future period, it would result in a tax benefit of $81 million and a reduction in the effective tax rate ($66 million as of December 29, 2012).
During all years presented, we recognized interest and penalties related to unrecognized tax benefits within the provision for taxes on the consolidated statements of income. Interest and penalties related to unrecognized tax benefits were insignificant in 2013 (insignificant in 2012 and $24 million in 2011). As of December 28, 2013, we had $73 million of accrued interest and penalties related to unrecognized tax benefits ($66 million as of December 29, 2012).
Although the timing of the resolutions and/or closures of audits is highly uncertain, it is reasonably possible that certain non-U.S. tax audits may be concluded within the next 12 months which could significantly increase or decrease the balance of our gross unrecognized tax benefits. However, the estimated impact to income tax expense and net income is not expected to be significant.
We file federal, state, and non-U.S. tax returns. For state and non-U.S. tax returns, we are generally no longer subject to tax examinations for years prior to 2001. For federal tax returns, we are no longer subject to tax examination for years prior to 2009.

Other_Comprehensive_Income_Los

Other Comprehensive Income (Loss)	12 Months Ended
	Dec. 28, 2013
Comprehensive Income (Loss) [Abstract]	'
Comprehensive Income [Text Block]	'
	Note 25: Other Comprehensive Income (Loss)
	The components of other comprehensive income (loss) and related tax effects for each period were as follows:
		2013									2012									2011
	(In Millions)	Before			Tax			Net of			Before			Tax			Net of			Before			Tax			Net of
		Tax						Tax			Tax						Tax			Tax						Tax
	Change in unrealized holding gains (losses) on available-for-sale investments	$	1,963		$	(687	)	$	1,276		$	909		$	(318	)	$	591		$	35		$	(13	)	$	22
	Less: adjustment for (gains) losses on available-for-sale investments included in net income	(146		)	51			(95		)	(187		)	66			(121		)	(299		)	107			(192		)
	Less: adjustment for (gains) losses on deferred tax asset valuation allowance included in net income	—			(26		)	(26		)	—			(11		)	(11		)	—			(99		)	(99		)
	Change in unrealized holding gains (losses) on derivatives	(166		)	76			(90		)	12			8			20			20			(16		)	4
	Less: adjustment for amortization of (gains) losses on derivatives	30			(29		)	1			78			(13		)	65			(161		)	38			(123		)
	Change in net prior service costs	17			(2		)	15			(4		)	1			(3		)	—			—			—
	Less: adjustment for amortization of net prior service costs	4			(1		)	3			5			(2		)	3			7			(3		)	4
	Change in actuarial valuation	725			(275		)	450			(321		)	91			(230		)	(900		)	284			(616		)
	Less: adjustment for amortization of actuarial (gains) losses	101			(31		)	70			90			(32		)	58			43			(15		)	28
	Change in net foreign currency translation adjustment	45			(7		)	38			12			(2		)	10			(155		)	13			(142		)
	Other comprehensive income (loss)	$	2,573		$	(931	)	$	1,642		$	594		$	(212	)	$	382		$	(1,410	)	$	296		$	(1,114	)
	In prior periods, we recorded a reversal of a portion of our deferred tax asset valuation allowance attributed to changes in unrealized holding gains on our available-for-sale investments. This amount is reduced and included in our provision for taxes as these investments mature or are sold, and is included in the preceding table as an adjustment for (gains) losses on deferred tax asset valuation allowance included in net income.
	The changes in accumulated other comprehensive income (loss) by component and related tax effects for each period were as follows:
	(In Millions)	Unrealized Holding Gains (Losses) on Available-for-Sale Investments			Deferred Tax Asset Valuation Allowance			Unrealized Holding Gains (Losses) on Derivatives			Prior Service Credits (Costs)			Actuarial Gains (Losses)			Foreign Currency Translation Adjustment			Total
	31-Dec-11	$	231		$	104		$	8		$	(32	)	$	(950	)	$	(142	)	$	(781	)
	Other comprehensive income before reclassifications	909			—			12			(4		)	(321		)	12			608
	Amounts reclassified out of accumulated other comprehensive income	(187		)	—			78			5			90			—			(14		)
	Tax effects	(252		)	(11		)	(5		)	(1		)	59			(2		)	(212		)
	Other comprehensive income (loss)	470			(11		)	85			—			(172		)	10			382
	29-Dec-12	$	701		$	93		$	93		$	(32	)	$	(1,122	)	$	(132	)	$	(399	)
	Other comprehensive income before reclassifications	1,963			—			(166		)	17			725			45			2,584
	Amounts reclassified out of accumulated other comprehensive income	(146		)	—			30			4			101			—			(11		)
	Tax effects	(636		)	(26		)	47			(3		)	(306		)	(7		)	(931		)
	Other comprehensive income (loss)	1,181			(26		)	(89		)	18			520			38			1,642
	28-Dec-13	$	1,882		$	67		$	4		$	(14	)	$	(602	)	$	(94	)	$	1,243
	The amounts reclassified out of accumulated other comprehensive income into the consolidated statements of income, with presentation location, for each period were as follows:
		2013			2012			2011
	Comprehensive Income Components	Income Before Taxes Impact (In Millions)									Location
	Unrealized holding gains (losses) on available-for-sale investments
		$	8		$	(8	)	$	(7	)	Interest and other, net
		138			195			306			Gains (losses) on equity investments, net
		146			187			299
	Unrealized holding gains (losses) on derivatives
	Currency forwards	(61		)	11			118			Cost of sales
		30			(63		)	20			Research and development
		—			(25		)	19			Marketing, general and administrative
	Other instruments	1			(1		)	4			Cost of sales
		(30		)	(78		)	161
	Amortization of pension and postretirement benefit components
	Prior service credits (costs)	(4		)	(5		)	(7		)
	Actuarial gains (losses)	(101		)	(90		)	(43		)
		(105		)	(95		)	(50		)
	Total amounts reclassified out of accumulated other comprehensive income	$	11		$	14		$	410
	The amortization of pension and postretirement benefit components are included in the "Net Periodic Benefit Cost" section of "Note 17: Retirement Benefit Plans". The estimated net prior service costs and net actuarial gains (losses) for the defined benefit plans that will be amortized from accumulated other comprehensive income (loss) into net periodic benefit cost during 2014 are $4 million and $39 million, respectively.
	We estimate that we will reclassify approximately $6 million (before taxes) of net derivative losses included in accumulated other comprehensive income (loss) into earnings within the next 12 months.

Contingencies

Contingencies	12 Months Ended
	Dec. 28, 2013
Contingencies [Abstract]	'
Contingencies Disclosure [Text Block]	'
	Note 26: Contingencies
	Legal Proceedings
	We are a party to various legal proceedings, including those noted in this section. Although management at present believes that the ultimate outcome of these proceedings, individually and in the aggregate, will not materially harm our financial position, results of operations, cash flows, or overall trends, legal proceedings and related government investigations are subject to inherent uncertainties, and unfavorable rulings or other events could occur. Unfavorable resolutions could include substantial monetary damages. In addition, in matters for which injunctive relief or other conduct remedies are sought, unfavorable resolutions could include an injunction or other order prohibiting us from selling one or more products at all or in particular ways, precluding particular business practices, or requiring other remedies. Were unfavorable outcomes to occur, the possibility exists for a material adverse impact on our business, results of operations, financial position, and overall trends. We might also conclude that settling one or more such matters is in the best interests of our stockholders, employees, and customers, and any such settlement could include substantial payments. However, we have not reached this conclusion with respect to any particular matter at this time.
	A number of proceedings generally have challenged and continue to challenge certain of our competitive practices. The allegations in these proceedings vary and are described in more detail in the following paragraphs. In general, they contend that we improperly conditioned price rebates and other discounts on our microprocessors on exclusive or near-exclusive dealing by some of our customers; and they allege that our software compiler business unfairly preferred Intel microprocessors over competing microprocessors and that, through the use of our compilers and other means, we have caused the dissemination of inaccurate and misleading benchmark results concerning our microprocessors. Based on the procedural posture of the various remaining competition matters, which we describe in subsequent paragraphs, our investment of resources to explain and defend our position has declined as compared to the period 2005-2011. Nonetheless, certain of the matters remain active, and these challenges could continue for a number of years, potentially requiring us to invest additional resources. We believe that we compete lawfully and that our marketing, business, intellectual property, and other challenged practices benefit our customers and our stockholders, and we will continue to conduct a vigorous defense in the remaining proceedings.
	Government Competition Matters and Related Consumer Class Actions
	In 2001, the European Commission (EC) commenced an investigation regarding claims by Advanced Micro Devices, Inc. (AMD) that we used unfair business practices to persuade customers to buy our microprocessors. We received numerous requests for information and documents from the EC and we responded to each of those requests. The EC issued a Statement of Objections in July 2007 and held a hearing on that Statement in March 2008. The EC issued a Supplemental Statement of Objections in July 2008.
	In May 2009, the EC issued a decision finding that we had violated Article 82 of the EC Treaty and Article 54 of the European Economic Area Agreement. In general, the EC found that we violated Article 82 (later renumbered as Article 102 by a new treaty) by offering alleged “conditional rebates and payments” that required our customers to purchase all or most of their x86 microprocessors from us. The EC also found that we violated Article 82 by making alleged “payments to prevent sales of specific rival products.” The EC imposed a fine in the amount of €1.06 billion ($1.447 billion as of May 2009), which we subsequently paid during the third quarter of 2009, and ordered us to “immediately bring to an end the infringement referred to in” the EC decision. In the second quarter of 2009, we recorded the related charge within marketing, general and administrative. We strongly disagree with the EC's decision, and we appealed the decision to the Court of First Instance (which has been renamed the General Court) in July 2009. The hearing of our appeal took place on July 3 through July 6, 2012. The court's decision is expected in 2014.
	The EC decision exceeds 500 pages but contains no specific direction on whether or how we should modify our business practices. Instead, the decision states that we should “cease and desist” from further conduct that, in the EC's opinion, would violate applicable law. We have taken steps, which are subject to the EC's ongoing review, to comply with that decision pending appeal. We had discussions with the EC to better understand the decision and to explain changes to our business practices. Based on our current understanding and expectations, we do not believe that any such changes will be material to our financial position, results, or cash flows.
	In June 2005, we received an inquiry from the Korea Fair Trade Commission (KFTC) requesting documents from our Korean subsidiary related to marketing and rebate programs that we entered into with Korean PC manufacturers. In February 2006, the KFTC initiated an inspection of documents at our offices in Korea. In September 2007, the KFTC served on us an Examination Report alleging that sales to two customers during parts of 2002-2005 violated Korea's Monopoly Regulation and Fair Trade Act. In December 2007, we submitted our written response to the KFTC. In February 2008, the KFTC's examiner submitted a written reply to our response. In March 2008, we submitted a further response. In April 2008, we participated in a pre-hearing conference before the KFTC, and we participated in formal hearings in May and June 2008. In June 2008, the KFTC announced its intent to fine us approximately $25 million for providing discounts to Samsung Electronics Co., Ltd. and TriGem Computer Inc. In November 2008, the KFTC issued a final written decision concluding that our discounts had violated Korean antitrust law and imposing a fine on us of approximately $20 million, which we paid in January 2009. In December 2008, we appealed this decision by filing a lawsuit in the Seoul High Court seeking to overturn the KFTC's decision. In June 2013, the Seoul High Court rejected Intel's appeal and affirmed the KFTC's findings, including the imposition of the fine.
	At least 82 separate class-action lawsuits have been filed in the U.S. District Courts for the Northern District of California, Southern District of California, District of Idaho, District of Nebraska, District of New Mexico, District of Maine, and District of Delaware, as well as in various California, Kansas, and Tennessee state courts. These actions generally repeat the allegations made in a now-settled lawsuit filed against us by AMD in June 2005 in the U.S. District Court for the District of Delaware (AMD litigation). Like the AMD litigation, these class-action lawsuits allege that we engaged in various actions in violation of the Sherman Act and other laws by, among other things: providing discounts and rebates to our manufacturer and distributor customers conditioned on exclusive or near-exclusive dealing that allegedly unfairly interfered with AMD's ability to sell its microprocessors; interfering with certain AMD product launches; and interfering with AMD's participation in certain industry standards-setting groups. The class actions allege various consumer injuries, including that consumers in various states have been injured by paying higher prices for computers containing our microprocessors. We dispute these class-action claims and intend to defend the lawsuits vigorously.
	All of the federal class actions and the Kansas and Tennessee state court class actions have been transferred by the Multidistrict Litigation Panel to the U.S. District Court in Delaware for all pre-trial proceedings and discovery (MDL proceedings). The Delaware district court appointed a Special Master to address issues in the MDL proceedings, as assigned by the court. In January 2010, the plaintiffs in the Delaware action filed a motion for sanctions for our alleged failure to preserve evidence. This motion largely copies a motion previously filed by AMD in the AMD litigation, which has settled. The plaintiffs in the MDL proceedings also moved for certification of a class of members who purchased certain PCs containing products sold by us. In July 2010, the Special Master issued a Report and Recommendation (Report) denying the motion to certify a class. The MDL plaintiffs filed objections to the Special Master's Report, and a hearing on those objections was held in March 2011. In September 2012, the court ruled that an evidentiary hearing would be necessary to enable the court to rule on the objections to the Special Master's Report, to resolve the motion to certify the class, and to resolve a separate motion to exclude certain testimony and evidence from the MDL plaintiffs' expert. The hearing occurred in July 2013, and we are awaiting the court's decision on the class certification issues.
	All California class actions have been consolidated in the Superior Court of California in Santa Clara County. The plaintiffs in the California actions have moved for class certification, which we are in the process of opposing. At our request, the court in the California actions has agreed to delay ruling on this motion until after the Delaware district court rules on the similar motion in the MDL proceedings. Given the procedural posture and the nature of these cases, including the fact that the Delaware district court has not determined whether the matters before it may proceed as a class action, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, arising from these matters.
	In re High Tech Employee Antitrust Litigation
	Between May and July 2011, former employees of Intel, Adobe Systems Incorporated, Apple Inc., Google Inc., Intuit Inc., Lucasfilm Ltd., and Pixar filed antitrust class action lawsuits in the California Superior Courts alleging that these companies had entered into a conspiracy to suppress the compensation of their employees. The California Superior Court lawsuits were removed to the United States District Court for the Northern District of California and were consolidated. The plaintiffs’ allegations referenced the 2009 and 2010 investigation by the Department of Justice (DOJ) into employment practices in the technology industry, as well as the DOJ’s complaints and subsequent stipulated final judgments with the seven companies named as defendants in the lawsuits. The plaintiffs allege that the defendants entered into certain unlawful agreements not to cold call employees of particular other defendants and that there was an overarching conspiracy among the defendants. Plaintiffs assert one such agreement specific to Intel, namely that Intel and Google entered into an agreement starting no later than September 2007, not to cold call each other’s employees.
	In September 2011, the plaintiffs filed a consolidated amended complaint, captioned In re High Tech Employee Antitrust Litigation, which asserts the same state law claims as the state court complaints, and also asserts claims under Section 1 of the Sherman Antitrust Act and Section 4 of the Clayton Antitrust Act. Plaintiffs’ consolidated amended complaint seeks a declaration that the defendants’ alleged actions violated the antitrust laws; damages, trebled as provided for by law under the Sherman Act or Clayton Act; restitution, and disgorgement; and attorneys’ fees and costs. In April 2012, the court granted the defendants’ motion to dismiss plaintiffs’ state law claims but denied defendants’ motion to dismiss the Sherman Act and Clayton Act claims.
	In October 2013, the court certified a class consisting of approximately 66,000 current or former employees of the seven defendants. This so-called “technical class” consists of a group of current and former technical, creative, and R&D employees at each of the defendants. In January 2014, Intel filed a motion for summary judgment which is scheduled for hearing in March 2014. Trial is scheduled to begin in late May 2014. Given the procedural posture and the nature of this case, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, that might arise from this matter. We dispute the plaintiffs’ claims and intend to defend the lawsuit vigorously.
	Lehman Brothers Holdings Inc. and Lehman Brothers OTC Derivatives Inc. v. Intel
	In May 2013, Lehman Brothers OTC Derivatives Inc. (LOTC) and Lehman Brothers Holdings Inc. (LBHI) filed an adversary complaint in the United States Bankruptcy Court in the Southern District of New York asserting claims against us arising from a 2008 contract between Intel and LOTC. Under the terms of the 2008 contract, we prepaid $1.0 billion to LOTC, in exchange for which LOTC was required to deliver to us on or before September 29, 2008, quantities of Intel common stock and cash determined by a formula set forth in the contract. LOTC's performance under the contract was secured by $1.0 billion of cash collateral. Under the terms of the contract, LOTC was obligated to deliver approximately 50 million shares of our common stock to us on September 29, 2008. LOTC failed to deliver any Intel common stock or cash, and we exercised our right of set-off against the $1.0 billion collateral. LOTC and LBHI acknowledge in their complaint that we were entitled to set off our losses against the collateral, but they assert that we withheld collateral in excess of our losses that should have been returned to LOTC. The complaint asserts a claim for breach of contract, a claim for “turnover” under section 542(a) of the Bankruptcy Code, and a claim for violation of the automatic stay under section 362(a)(3) of the Bankruptcy Code. The complaint does not expressly quantify the amount of damages claimed but does assert multiple theories of damages that impliedly seek up to $312 million of alleged excess collateral, plus interest based on LOTC's claimed cost of borrowing. In June 2013, we filed a motion to dismiss plaintiffs' bankruptcy claims and for a determination that the breach of contract claim is “non-core” under the Bankruptcy Code. The bankruptcy court granted our motion in its entirety in December 2013. In January 2014, based on the bankruptcy court’s ruling, we filed a motion in the United States District Court for the Southern District of New York requesting that the district court withdraw its reference to the bankruptcy court of plaintiffs’ adversary complaint. Given the procedural posture and the nature of this case, including that discovery has just begun, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, that might arise from this matter. We believe that we acted in a manner consistent with our contractual rights, and we intend to defend against any claim to the contrary.
	McAfee, Inc. Shareholder Litigation
	On August 19, 2010, we announced that we had agreed to acquire all of McAfee’s common stock for $48.00 per share. Four McAfee shareholders filed putative class-action lawsuits in Santa Clara County, California Superior Court challenging the proposed transaction. The cases were ordered consolidated in September 2010. Plaintiffs filed an amended complaint that named former McAfee board members, McAfee and Intel as defendants, and alleged that the McAfee board members breached their fiduciary duties and that McAfee and Intel aided and abetted those breaches of duty. The complaint requested rescission of the merger agreement, such other equitable relief as the court may deem proper, and an award of damages in an unspecified amount. In June 2012, the plaintiffs’ damages expert asserted that the value of a McAfee share for the purposes of assessing damages should be $62.08.
	In January 2012, the court certified the action as a class action, appointed the Central Pension Laborers’ Fund to act as the class representative, and scheduled trial to begin in January 2013. In March 2012, defendants filed a petition with the California Court of Appeal for a writ of mandate to reverse the class certification order; the petition was denied in June 2012. In March 2012, at defendants’ request, the court held that plaintiffs were not entitled to a jury trial, and ordered a bench trial. In April 2012, plaintiffs filed a petition with the California Court of Appeal for a writ of mandate to reverse that order, which the court of appeal denied in July 2012. In August 2012, defendants filed a motion for summary judgment. The trial court granted that motion in November 2012, and entered final judgment in the case in February 2013. In April 2013, plaintiffs filed a notice of appeal. Because the resolution of the appeal may materially impact the scope and nature of the proceeding, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, arising from this matter. We dispute the class-action claims and intend to continue to defend the lawsuit vigorously.
	X2Y Attenuators, LLC v. Intel et al
	In May 2011, X2Y Attenuators, LLC (X2Y) filed a patent infringement lawsuit in the U.S. District Court for the Western District of Pennsylvania and a complaint with the U.S. International Trade Commission (ITC) pursuant to Section 337 of the Tariff Act of 1930 against us and two of our customers, Apple and Hewlett-Packard Company, alleging infringement of five patents. X2Y subsequently added a sixth patent to both actions. The district court action is stayed pending resolution of the ITC proceeding. X2Y alleges that at least Intel® Core™ and Intel® Xeon® processor families infringe the asserted patents. X2Y also requests that the ITC issue permanent exclusion and cease-and-desist orders to, among other things, prohibit us from importing these microprocessors and Apple and Hewlett-Packard Company products that incorporate these microprocessors into the United States. In the district court action, X2Y seeks unspecified damages, including enhanced damages for alleged willful infringement, and injunctive relief. On June 13, 2012, the Administrative Law Judge issued an initial determination granting X2Y’s motion to partially terminate the ITC investigation with respect to three of the asserted patents. The Administrative Law Judge held a hearing on the remaining three patents in August 2012 and issued an initial determination in December 2012. In the initial determination, the Administrative Law Judge found that Intel, Apple, and Hewlett-Packard Company have not violated Section 337 of the Tariff Act of 1930 because they have not infringed any of the asserted claims of the three patents, and ruled that the asserted claims of two of the patents were invalid. In December 2012, the parties filed petitions for review of the initial determination by the ITC. In February 2013, the ITC determined to review in part the initial determination. On review, the ITC determined to reverse or vacate certain findings, and to terminate the investigation with a finding of no violation. In April 2013, X2Y filed a Notice of Appeal with the United States Court of Appeals for the Federal Circuit. Given the procedural posture and nature of the cases, including the fact that resolution of the appeal of the ITC's decision may materially impact the scope and nature of the proceeding, the fact that monetary damages are not an available remedy in the ITC, and that discovery regarding X2Y’s claimed damages has not commenced in the stayed district court action, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, arising from these matters. We dispute the claims and intend to defend the lawsuits vigorously.

Operating_Segments_and_Geograp

Operating Segments and Geographic Information	12 Months Ended
	Dec. 28, 2013
Operating Segment and Geographic Information [Abstract]	'
Operating Segment and Geographic Information [Text Block]	'
	Note 27: Operating Segments and Geographic Information
	Our operating segments in effect as of December 28, 2013, include:
	•    PC Client Group		•    Software and services operating segments:
	•    Data Center Group		•    McAfee
	•    Other Intel architecture operating segments:		•    Wind River Software Group
	•    Intelligent Systems Group		•    Software and Services Group
	•    Multi-Comm		•    All other:
	•    Phone Group		•    Non-Volatile Memory Solutions Group
	•    Service Provider Group
	•    Tablet Group
	•    Netbook Group
	•    New Devices Group
	In 2013, we completed a reorganization that transferred a portion of our wired connectivity business formerly included within DCG to PCCG, as the technology from that portion of the business is primarily used for client connectivity. Prior period amounts have been adjusted retrospectively to reflect this new organization structure.
	We reorganized our IMC businesses within the "other Intel architecture" operating segments to segment our focus on the phone business. As part of this reorganization, we separated the feature and entry phone component business into the existing Phone Group operating segment and renamed the remaining business, primarily discrete modems, as the Multi-Comm operating segment.
	In May 2013, Brian Krzanich became our CEO and a member of Intel's Board of Directors, succeeding Paul S. Otellini, who retired from the Board and as CEO. Since his appointment as CEO, Mr. Krzanich made management organizational changes which did not result in a change to the businesses comprising our operating segments or to the conclusion that the Chief Operating Decision Maker (CODM) is the CEO. The CODM allocates resources to and assesses the performance of each operating segment using information about its revenue and operating income (loss).
	PCCG and DCG are our reportable operating segments. We also aggregate and disclose the financial results of our non-reportable operating segments within “other Intel architecture operating segments” and “software and services operating segments” as shown in the above operating segments list. Each of these aggregated operating segments does not meet the quantitative thresholds to qualify as a reportable operating segment; however, we have elected to disclose the aggregation of these non-reportable operating segments. Revenue for our reportable and aggregated non-reportable operating segments is primarily related to the following product lines:
	•	PC Client Group. Includes platforms designed for the notebook (including Ultrabook™ devices and 2 in 1 systems), desktop (including all-in-ones and high-end enthusiast PCs), and certain tablet market segments; and wireless and wired connectivity products.
	•	Data Center Group. Includes platforms designed for the server, workstation, and storage computing market segments; and wired network connectivity products.
	•	Other Intel architecture operating segments. Includes platforms designed for embedded applications for communications, medical, automotive, industrial, retail, and other market segments; mobile components such as baseband processors, radio frequency transceivers, WiFi, Bluetooth®, global navigation satellite system, and power management chips; platforms designed for the tablet market segment; platforms designed for the smartphone market segment; gateway and set-top box components; and platforms designed for the netbook market segment; delivering reference devices and technology platforms ready to be used by customers as well as System-on-Chip architecture specifically designed for wearable and other emerging compute opportunities.
	•	Software and services operating segments. Includes software products for endpoint security, network and content security, risk and compliance, and consumer and mobile security from our McAfee business; software optimized products for the embedded and mobile market segments; and software products and services that promote Intel architecture as the platform of choice for software development.
	We have sales and marketing, manufacturing, finance, and administration groups. Expenses for these groups are generally allocated to the operating segments, and the expenses are included in the operating results reported below.
	The “all other” category includes revenue, expenses, and charges such as:
	•	results of operations from our Non-Volatile Memory Solutions Group that includes NAND flash memory products for use in a variety of devices;
	•	amounts included within restructuring and asset impairment charges;
	•	a portion of profit-dependent compensation and other expenses not allocated to the operating segments;
	•	divested businesses for which discrete operating results are not reviewed by our CODM;
	•	results of operations of start-up businesses that support our initiatives, including our foundry business; and
	•	acquisition-related costs, including amortization and any impairment of acquisition-related intangibles and goodwill.
	The CODM does not evaluate operating segments using discrete asset information. Based on the interchangeable nature of our manufacturing and assembly and test assets, most of the related depreciation expense is not directly identifiable within our operating segments as it is included in overhead cost pools and subsequently absorbed into inventory as each product passes through our manufacturing process. As our products are then sold across multiple operating segments, it is impracticable to determine the total depreciation expense included as a component of each operating segment’s operating income (loss) results. Operating segments do not record inter-segment revenue. We do not allocate gains and losses from equity investments, interest and other income, or taxes to operating segments. Although the CODM uses operating income to evaluate the segments, operating costs included in one segment may benefit other segments. Except for these differences, the accounting policies for segment reporting are the same as for Intel as a whole.
	Net revenue and operating income (loss) for each period were as follows:
	(In Millions)		2013			2012			2011
	Net revenue:
	PC Client Group		$	33,039		$	34,504		$	35,624
	Data Center Group		11,238			10,511			9,911
	Other Intel architecture operating segments		4,092			4,378			5,005
	Software and services operating segments		2,502			2,381			1,870
	All other		1,837			1,567			1,589
	Total net revenue		$	52,708		$	53,341		$	53,999
	Operating income (loss):
	PC Client Group		$	11,827		$	13,106		$	14,840
	Data Center Group		5,164			5,020			5,053
	Other Intel architecture operating segments		(2,445		)	(1,377		)	(577		)
	Software and services operating segments		1			(11		)	(32		)
	All other		(2,256		)	(2,100		)	(1,807		)
	Total operating income		$	12,291		$	14,638		$	17,477
	In 2013, Hewlett-Packard Company accounted for 17% of our net revenue (18% in 2012 and 19% in 2011), Dell Inc. accounted for 15% of our net revenue (14% in 2012 and 15% in 2011), and Lenovo Group Limited accounted for 12% of our net revenue (11% in 2012 and 9% in 2011). The majority of the revenue from these customers was from the sale of platforms and other components by the PCCG and the DCG operating segments.
	Most of our revenue in the PCCG and DCG operating segments is generated from the sale of platforms.
	Net revenue by country for the three years ended December 28, 2013, is based on the billing location of the customer. Certain prior-period amounts have been reclassified to conform to the current year’s presentation. Revenue from unaffiliated customers for each period were as follows:
	(In Millions)		2013			2012			2011
	Singapore		$	10,997		$	12,622		$	13,626
	China (including Hong Kong)		9,890			8,299			7,133
	United States		9,091			8,348			9,005
	Taiwan		8,888			9,327			8,534
	Japan		3,725			4,303			4,538
	Other countries		10,117			10,442			11,163
	Total net revenue		$	52,708		$	53,341		$	53,999
	Revenue from unaffiliated customers outside the U.S. totaled $43.6 billion in 2013 ($45.0 billion in 2012 and $45.0 billion in 2011).
	Net property, plant and equipment by country at the end of each period was as follows:
	(In Millions)		Dec 28,			Dec 29,			Dec 31,
			2013			2012			2011
	United States		$	23,624		$	20,542		$	16,448
	Ireland		2,986			1,523			1,198
	Israel		2,667			3,389			3,356
Other countries		2,151			2,529			2,625
Total property, plant and equipment, net		$	31,428		$	27,983		$	23,627
Net property, plant and equipment outside the U.S. totaled $7.8 billion as of December 28, 2013 ($7.4 billion as of December 29, 2012 and $7.2 billion as of December 31, 2011).

Valuation_and_Qualifying_Accou

Valuation and Qualifying Accounts	12 Months Ended
	Dec. 28, 2013
Valuation and Qualifying Accounts [Abstract]	'
SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS [Text Block]	'
	INTEL CORPORATION
	SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS
	Three Years Ended December 28, 2013	Balance at Beginning of Year		Additions Charged to Expenses/		Net			Balance at
	(In Millions)			Other Accounts		(Deductions)			End of Year
						Recoveries
	Allowance for doubtful receivables
	2013	$	38	$	5	$	(5	)	$	38
	2012	$	36	$	3	$	(1	)	$	38
	2011	$	28	$	8	$	—		$	36
	Valuation allowance for deferred tax assets
	2013	$	389	$	88	$	(21	)	$	456
	2012	$	373	$	77	$	(61	)	$	389
	2011	$	252	$	121	$	—		$	373
	Deductions in allowance for doubtful receivables represent uncollectible accounts written off, net of recoveries.

Accounting_Policies_Policies

Accounting Policies (Policies)	12 Months Ended
	Dec. 28, 2013
Accounting Policies (Policies) [Abstract]	'
Use of Estimates [Policy Text Block]	'
	Use of Estimates
	The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires us to make estimates and judgments that affect the amounts reported in our consolidated financial statements and the accompanying notes. The accounting estimates that require our most significant, difficult, and subjective judgments include:
	•	the valuation of non-marketable equity investments and the determination of other-than-temporary impairments;
	•	the assessment of recoverability of long-lived assets (property, plant and equipment; goodwill; and identified intangibles);
	•	the recognition and measurement of current and deferred income taxes (including the measurement of uncertain tax positions);
	•	the valuation of inventory; and
	•	the recognition and measurement of loss contingencies.
	The actual results that we experience may differ materially from our estimates.
Fair Value [Policy Text Block]	'
	Fair Value
	Fair value is the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining fair value, we consider the principal or most advantageous market in which we would transact, and we consider assumptions that market participants would use when pricing the asset or liability. Our financial assets are measured and recorded at fair value, except for equity method investments, cost method investments, cost method loans receivable, and reverse repurchase agreements with original maturities greater than approximately three months. Most of our liabilities are not measured and recorded at fair value.
	Fair Value Hierarchy
	The three levels of inputs that may be used to measure fair value are as follows:
	Level 1. Quoted prices in active markets for identical assets or liabilities.
	Level 2. Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in less active markets, or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated with observable market data for substantially the full term of the assets or liabilities. Level 2 inputs also include non-binding market consensus prices that can be corroborated with observable market data, as well as quoted prices that were adjusted for security-specific restrictions.
	Level 3. Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of assets or liabilities. Level 3 inputs also include non-binding market consensus prices or non-binding broker quotes that we were unable to corroborate with observable market data.
	For further discussion of fair value, see “Note 4: Fair Value” and “Note 17: Retirement Benefit Plans.”
Cash Equivalents, Policy [Policy Text Block]	'
	Cash Equivalents
	We consider all highly liquid debt investments with original maturities from the date of purchase of approximately three months or less as cash equivalents. Cash equivalents can include investments such as asset-backed securities, bank deposits, commercial paper, corporate bonds, government bonds, money market fund deposits, municipal bonds, and reverse repurchase agreements classified as cash equivalents. See "Note 4: Fair Value" for the instruments held as cash equivalents.
Trading Assets [Policy Text Block]	'
	Trading Assets
	Marketable debt instruments are generally designated as trading assets when a market risk is economically hedged at inception with a related derivative instrument, or when the marketable debt instrument itself is used to economically hedge foreign exchange rate risk from remeasurement. Investments designated as trading assets are reported at fair value. The gains or losses of these investments arising from changes in fair value due to interest rate and currency market fluctuations and credit market volatility, largely offset by losses or gains on the related derivative instruments and balance sheet remeasurement, are recorded in interest and other, net. We also designate certain floating-rate securitized financial instruments, primarily asset-backed securities, as trading assets.
Available-for-Sale Investments [Policy Text Block]	'
	Available-for-Sale Investments
	We consider all liquid available-for-sale debt instruments with original maturities from the date of purchase of approximately three months or less to be cash and cash equivalents. Available-for-sale debt instruments with original maturities at the date of purchase greater than approximately three months and remaining maturities of less than one year are classified as short-term investments. Available-for-sale debt instruments with remaining maturities beyond one year are classified as other long-term investments.
	Investments that we designate as available-for-sale are reported at fair value, with unrealized gains and losses, net of tax, recorded in accumulated other comprehensive income (loss), except as noted in the “Other-Than-Temporary Impairment” section that follows. We determine the cost of the investment sold based on an average cost basis at the individual security level. Our available-for-sale investments include:
	•	Marketable debt instruments when the interest rate and foreign currency risks are not hedged at the inception of the investment or when our criteria for designation as trading assets are not met. We generally hold these debt instruments to generate a return commensurate with the U.S.-dollar three-month LIBOR. We record the interest income and realized gains and losses on the sale of these instruments in interest and other, net.
	•	Marketable equity securities when there is no plan to sell or hedge the investment at the time of original classification. We acquire these equity investments to promote business and strategic objectives. To the extent that these investments continue to have strategic value, we typically do not attempt to reduce or eliminate the equity market risks through hedging activities. We record the realized gains or losses on the sale or exchange of marketable equity securities in gains (losses) on equity investments, net.
Non-Marketable and Other Equity Investments [Policy Text Block]	'
	Non-Marketable and Other Equity Investments
	Our non-marketable equity and other equity investments are included in other long-term assets. We account for non-marketable equity and other equity investments for which we do not have control over the investee as:
	•	Equity method investments when we have the ability to exercise significant influence, but not control, over the investee. Equity method investments include marketable and non-marketable investments. Our proportionate share of the income or loss is recognized on a one-quarter lag and is recorded in gains (losses) on equity investments, net.
	•	Non-marketable cost method investments when the equity method does not apply. We record the realized gains or losses on the sale of non-marketable cost method investments in gains (losses) on equity investments, net.
Other-Than-Temporary Impairment [Policy Text Block]	'
	Other-Than-Temporary Impairment
	Our available-for-sale investments and non-marketable and other equity investments are subject to a periodic impairment review. Investments are considered impaired when the fair value is below the investment’s adjusted cost basis. Impairments affect earnings as follows:
	•	Marketable debt instruments when the fair value is below amortized cost and we intend to sell the instrument, or when it is more likely than not that we will be required to sell the instrument before recovery of its amortized cost basis, or when we do not expect to recover the entire amortized cost basis of the instrument (that is, a credit loss exists). When we do not expect to recover the entire amortized cost basis of the instrument, we separate other-than-temporary impairments into amounts representing credit losses, which are recognized in interest and other, net, and amounts related to all other factors, which are recognized in other comprehensive income (loss).
	•	Marketable equity securities based on the specific facts and circumstances present at the time of assessment, which include the consideration of general market conditions, the duration and extent to which the fair value is below cost, and our ability and intent to hold the investment for a sufficient period of time to allow for recovery of value in the foreseeable future. We also consider specific adverse conditions related to the financial health of, and the business outlook for, the investee, which may include industry and sector performance, changes in technology, operational and financing cash flow factors, and changes in the investee’s credit rating. We record other-than-temporary impairment charges on marketable equity securities and marketable equity method investments in gains (losses) on equity investments, net.
	•	Non-marketable equity investments based on our assessment of the severity and duration of the impairment, and qualitative and quantitative analysis, including:
	•	the investee’s revenue and earnings trends relative to pre-defined milestones and overall business prospects;
	•	the technological feasibility of the investee’s products and technologies;
	•	the general market conditions in the investee’s industry or geographic area, including adverse regulatory or economic changes;
	•	factors related to the investee’s ability to remain in business, such as the investee’s liquidity and debt ratios, and the rate at which the investee is using its cash; and
	•	the investee’s receipt of additional funding at a lower valuation.
	We record other-than-temporary impairment charges for non-marketable cost method investments and equity method investments in gains (losses) on equity investments, net.
Derivative Financial Instruments [Policy Text Block]	'
	Derivative Financial Instruments
	Our primary objective for holding derivative financial instruments is to manage currency exchange rate and interest rate risk, and, to a lesser extent, equity market risk, commodity price risk, and credit risk. Our derivative financial instruments are recorded at fair value and are included in other current assets, other long-term assets, other accrued liabilities, or other long-term liabilities.
	Our accounting policies for derivative financial instruments are based on whether they meet the criteria for designation as a cash flow hedge. A designated hedge with exposure to variability in the functional currency equivalent of the future foreign currency cash flows of a forecasted transaction is one example of a cash flow hedge. The criteria for designating a derivative as a cash flow hedge include the assessment of the instrument’s effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction, and the assessment of the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the after-tax gain or loss from the effective portion of the hedge as a component of accumulated other comprehensive income (loss) and reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings, and in the same line item on the consolidated statements of income as the impact of the hedged transaction. Derivatives that we designate as cash flow hedges are classified in the consolidated statements of cash flows in the same section as the underlying item, primarily within cash flows from operating activities.
	We recognize gains and losses from changes in fair value of derivatives that are not designated as hedges for accounting purposes in the line item on the consolidated statements of income most closely associated with the related exposures, primarily in interest and other, net and gains (losses) on equity investments, net. As part of our strategic investment program, we also acquire equity derivative instruments, such as equity conversion rights associated with debt instruments, that we do not designate as hedging instruments. We recognize the gains or losses from changes in fair value of these equity derivative instruments in gains (losses) on equity investments, net. Gains and losses from derivatives not designated as hedges are classified in the consolidated statements of cash flows within cash flows from operating activities.
	Measurement of Effectiveness
	•	Effectiveness for forwards is generally measured by comparing the cumulative change in the fair value of the hedge contract with the cumulative change in the fair value of the forecasted cash flows of the hedged item. For currency forward contracts used in cash flow hedging strategies related to capital purchases, forward points are excluded, and effectiveness is measured using spot rates to value both the hedge contract and the hedged item. For currency forward contracts used in cash flow hedging strategies related to operating expenditures, forward points are included and effectiveness is measured using forward rates to value both the hedge contract and the hedged item.
	•	Effectiveness for options is generally measured by comparing the cumulative change in the intrinsic value of the hedge contract with the cumulative change in the intrinsic value of an option instrument representing the hedged risks in the hedged item. Time value is excluded and effectiveness is measured using spot rates to value both the hedge contract and the hedged item.
	•	Effectiveness for interest rate swaps and commodity swaps is generally measured by comparing the cumulative change in fair value of the swap with the cumulative change in the fair value of the hedged item.
	If a cash flow hedge is discontinued because it is probable that the original hedged transaction will not occur as previously anticipated, the cumulative unrealized gain or loss on the related derivative is reclassified from accumulated other comprehensive income (loss) into earnings. Subsequent gains or losses on the related derivative instrument are recognized in interest and other, net in each period until the instrument matures, is terminated, is re-designated as a qualified cash flow hedge, or is sold. Ineffective portions of cash flow hedges, as well as amounts excluded from the assessment of effectiveness, are recognized in earnings in interest and other, net. For further discussion of our derivative instruments and risk management programs, see “Note 6: Derivative Financial Instruments.”
Securities Lending [Policy Text Block]	'
	Securities Lending
	We may enter into securities lending agreements with financial institutions, generally to facilitate hedging and certain investment transactions. Selected securities may be loaned, secured by collateral in the form of cash or securities. The loaned securities continue to be carried as investment assets on our consolidated balance sheets. For lending agreements collateralized by cash and cash equivalents, collateral is recorded as an asset with a corresponding liability. For lending agreements collateralized by other securities, we do not record the collateral as an asset or a liability, unless the collateral is repledged.
Loans Receivable [Policy Text Block]	'
	Loans Receivable
	We make loans to third parties that are classified within other current assets or other long-term assets. We may elect the fair value option for loans when the interest rate or foreign currency exchange rate risk is economically hedged at inception with a related derivative instrument. We record the gains or losses on these loans arising from changes in fair value due to interest rate, currency, and counterparty credit changes, largely offset by losses or gains on the related derivative instruments, in interest and other, net. Loans that are denominated in U.S. dollars and have a floating-rate coupon are carried at amortized cost. We measure interest income for all loans receivable using the interest method, which is based on the effective yield of the loans rather than the stated coupon rate. For further discussion of our loans receivable, see “Note 4: Fair Value.”
Inventories [Policy Text Block]	'
	Inventories
	We compute inventory cost on a first-in, first-out basis. Costs incurred to manufacture our products are included in the valuation of inventory beginning in the quarter in which a product meets the technical criteria to qualify for sale to customers. Prior to qualification for sale, costs that do not meet the criteria for research and development (R&D) are included in cost of sales in the period incurred. Inventories at the end of each period were as follows:
	(In Millions)		Dec 28,			Dec 29,
			2013			2012
	Raw materials		$	458		$	478
	Work in process		1,998			2,219
	Finished goods		1,716			2,037
	Total inventories		$	4,172		$	4,734
Property, Plant and Equipment [Policy Text Block]	'
	Property, Plant and Equipment
	Property, plant and equipment, net at the end of each period were as follows:
	(In Millions)		Dec 28,			Dec 29,
			2013			2012
	Land and buildings		$	21,098		$	18,807
	Machinery and equipment		40,540			39,033
	Construction in progress		11,778			8,206
	Total property, plant and equipment, gross		73,416			66,046
	Less: accumulated depreciation		(41,988		)	(38,063		)
	Total property, plant and equipment, net		$	31,428		$	27,983
	We compute depreciation for financial reporting purposes using the straight-line method. Substantially all of our depreciable property, plant and equipment assets are depreciated over the following estimated useful lives: machinery and equipment, 2 to 4 years; buildings, 10 to 25 years.
	We capitalize a majority of interest on borrowings related to eligible capital expenditures. Capitalized interest is added to the cost of qualified assets and amortized over the estimated useful lives of the assets. We record capital-related government grants earned as a reduction to property, plant and equipment.
Goodwill [Policy Text Block]	'
	Goodwill
	We record goodwill when the purchase price of an acquisition exceeds the fair value of the net tangible and identified intangible assets as of the date of acquisition, assigning the goodwill to our applicable reporting units based on the relative expected fair value provided by the acquisition. We perform a quarterly review of goodwill for indicators of impairment. During the fourth quarter of each year, we perform an impairment assessment for each reporting unit, and we perform impairment tests using a fair value approach when necessary. The reporting unit’s carrying value used in an impairment test represents the assignment of various assets and liabilities, excluding certain corporate assets and liabilities, such as cash, investments, and debt. For further discussion of goodwill, see “Note 10: Goodwill.”
Identified Intangible Assets [Policy Text Block]	'
	Identified Intangible Assets
	Licensed technology and patents are generally amortized on a straight-line basis over the periods of benefit. We amortize all acquisition-related intangible assets that are subject to amortization over their estimated useful life based on economic benefit. Acquisition-related in-process R&D assets represent the fair value of incomplete R&D projects that had not reached technological feasibility as of the date of acquisition; initially, these are classified as “other intangible assets” that are not subject to amortization. Assets related to projects that have been completed are transferred from “other intangible assets” to “acquisition-related developed technology;” these are subject to amortization, while assets related to projects that have been abandoned are impaired and expensed to R&D. In the quarter following the period in which identified intangible assets become fully amortized, we remove the fully amortized balances from the gross asset and accumulated amortization amounts.
	The estimated useful life ranges for substantially all identified intangible assets that are subject to amortization as of December 28, 2013, were as follows:
	(In Years)		Estimated
			Useful Life
	Acquisition-related developed technology		4	–	9
	Acquisition-related customer relationships		5	–	8
	Acquisition-related trade names		4	–	8
	Licensed technology and patents		5	–	17
	We perform a quarterly review of finite-lived identified intangible assets to determine whether facts and circumstances indicate that the useful life is shorter than we had originally estimated or that the carrying amount of assets may not be recoverable. If such facts and circumstances exist, we assess recoverability by comparing the projected undiscounted net cash flows associated with the related asset or group of assets over their remaining lives against their respective carrying amounts. Impairments, if any, are based on the excess of the carrying amount over the fair value of those assets. If an asset’s useful life is shorter than originally estimated, we accelerate the rate of amortization and amortize the remaining carrying value over the new shorter useful life. We perform an annual impairment assessment in the fourth quarter of each year for indefinite-lived intangible assets, or more frequently if indicators of potential impairment exist, to determine whether it is more likely than not that the carrying value of the assets may not be recoverable. If necessary, a quantitative impairment test is performed to compare the fair value of the indefinite-lived intangible asset with its carrying value. Impairments, if any, are based on the excess of the carrying amount over the fair value of those assets.
	For further discussion of identified intangible assets, see “Note 11: Identified Intangible Assets.”
Product Warranty [Policy Text Block]	'
	Product Warranty
	The vast majority of our products are sold with a limited warranty on product quality and a limited indemnification for customers against intellectual property (IP) rights infringement claims related to our products. The accrual and the related expense for known product warranty issues were not significant during the periods presented. Due to product testing, the short time typically between product shipment and the detection and correction of product failures, and the historical rate of payments on indemnification claims, the accrual and related expense for estimated incurred but unidentified issues were not significant during the periods presented.
Revenue Recognition [Policy Text Block]	'
	Revenue Recognition
	We recognize net product revenue when the earnings process is complete, as evidenced by an agreement with the customer, delivery has occurred, and acceptance, if applicable, as well as fixed pricing and probable collectibility. We record pricing allowances, including discounts based on contractual arrangements with customers, when we recognize revenue as a reduction to both accounts receivable and net revenue. Because of frequent sales price reductions and rapid technology obsolescence in the industry, we defer product revenue and related costs of sales from component sales made to distributors under agreements allowing price protection or right of return until the distributors sell the merchandise. The right of return granted generally consists of a stock rotation program in which distributors are able to exchange certain products based on the number of qualified purchases made by the distributor. Under the price protection program, we give distributors credits for the difference between the original price paid and the current price that we offer. We include shipping charges billed to customers in net revenue, and include the related shipping costs in cost of sales.
	Revenue from license agreements with our McAfee business generally includes service and support agreements for which the related revenue is deferred and recognized ratably over the performance period. Revenue derived from online subscription products is deferred and recognized ratably over the performance period. Professional services revenue is recognized as services are performed or, if required, upon customer acceptance. For arrangements with multiple elements, including software licenses, maintenance, and/or services, revenue is allocated across the separately identified deliverables and may be recognized or deferred. When vendor-specific objective evidence (VSOE) does not exist for undelivered elements such as maintenance and support, the entire arrangement fee is recognized ratably over the performance period. Direct costs, such as costs related to revenue-sharing and royalty arrangements associated with license arrangements, as well as component costs associated with product revenue and sales commissions, are deferred and amortized over the same period that the related revenue is recognized.
	We record deferred revenue offset by the related cost of sales on our consolidated balance sheets as deferred income.
Advertising [Policy Text Block]	'
	Advertising
	Cooperative advertising programs reimburse customers for marketing activities for certain of our products, subject to defined criteria. We accrue cooperative advertising obligations and record the costs at the same time that the related revenue is recognized. We record cooperative advertising costs as marketing, general and administrative (MG&A) expenses to the extent that an advertising benefit separate from the revenue transaction can be identified and the fair value of that advertising benefit received is determinable. We record any excess in cash paid over the fair value of the advertising benefit received as a reduction in revenue. Advertising costs, including direct marketing costs, recorded within MG&A expenses were $1.9 billion in 2013 ($2.0 billion in 2012 and $2.1 billion in 2011).
Employee Equity Incentive Plans [Policy Text Block]	'
	Employee Equity Incentive Plans
	We have employee equity incentive plans, which are described more fully in “Note 19: Employee Equity Incentive Plans.” We use the straight-line attribution method to recognize share-based compensation over the service period of the award. Upon exercise, cancellation, forfeiture, or expiration of stock options, or upon vesting or forfeiture of restricted stock units (RSUs), we eliminate deferred tax assets for options and restricted stock units with multiple vesting dates for each vesting period on a first-in, first-out basis as if each vesting period were a separate award.
Income Taxes [Policy Text Block]	'
	Income Taxes
	We compute the provision for income taxes using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating losses and tax credit carryforwards. We measure deferred tax assets and liabilities using the currently enacted tax rates that apply to taxable income in effect for the years in which those tax assets are expected to be realized or settled. We record a valuation allowance to reduce deferred tax assets to the amount that it is believed more likely than not to be realized.
	We recognize tax benefits from uncertain tax positions only if that tax position is more likely than not to be sustained on examination by the taxing authorities, based on the technical merits of the position. We then measure the tax benefits recognized in the financial statements from such positions based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. We recognize interest and penalties related to unrecognized tax benefits within the provision for taxes on the consolidated statements of income. For more information about income taxes, see “Note 24: Income Taxes.”

Accounting_Policies_Tables

Accounting Policies (Tables)	12 Months Ended
	Dec. 28, 2013
Accounting Policies (Tables) [Abstract]	'
Inventories [Table Text Block]	'
	Inventories at the end of each period were as follows:
	(In Millions)	Dec 28,			Dec 29,
		2013			2012
	Raw materials	$	458		$	478
	Work in process	1,998			2,219
	Finished goods	1,716			2,037
	Total inventories	$	4,172		$	4,734
Property, Plant and Equipment [Table Text Block]	'
	Property, plant and equipment, net at the end of each period were as follows:
	(In Millions)	Dec 28,			Dec 29,
		2013			2012
	Land and buildings	$	21,098		$	18,807
	Machinery and equipment	40,540			39,033
	Construction in progress	11,778			8,206
	Total property, plant and equipment, gross	73,416			66,046
	Less: accumulated depreciation	(41,988		)	(38,063		)
	Total property, plant and equipment, net	$	31,428		$	27,983
Schedule Of Useful Life Ranges For Identified Intangible Assets [Table Text Block]	'
	The estimated useful life ranges for substantially all identified intangible assets that are subject to amortization as of December 28, 2013, were as follows:
	(In Years)	Estimated
		Useful Life
	Acquisition-related developed technology	4	–	9
	Acquisition-related customer relationships	5	–	8
	Acquisition-related trade names	4	–	8
	Licensed technology and patents	5	–	17

Fair_Value_Tables

Fair Value (Tables)	12 Months Ended
	Dec. 28, 2013
Fair Value (Tables) [Abstract]	'
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	'
	Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following types of instruments at the end of each period were as follows:
		28-Dec-13								29-Dec-12
		Fair Value Measured and						Total		Fair Value Measured and						Total
		Recorded at Reporting Date Using								Recorded at Reporting Date Using
	(In Millions)	Level 1		Level 2		Level 3				Level 1		Level 2		Level 3
	Assets
	Cash equivalents:
	Bank deposits	$	—	$	1,017	$	—	$	1,017	$	—	$	822	$	—	$	822
	Commercial paper	—		2,341		—		2,341		—		2,711		—		2,711
	Corporate bonds	—		21		—		21		—		—		—		—
	Government bonds	—		—		—		—		400		66		—		466
	Money market fund deposits	1,041		—		—		1,041		1,086		—		—		1,086
	Reverse repurchase agreements	—		400		—		400		—		2,800		—		2,800
	Short-term investments:
	Bank deposits	—		1,782		—		1,782		—		540		—		540
	Commercial paper	—		2,123		—		2,123		—		1,474		—		1,474
	Corporate bonds	383		1,121		19		1,523		75		292		21		388
	Government bonds	268		276		—		544		1,307		290		—		1,597
	Trading assets:
	Asset-backed securities	—		684		4		688		—		—		68		68
	Bank deposits	—		92		—		92		—		247		—		247
	Commercial paper	—		240		—		240		—		336		—		336
	Corporate bonds	2,625		773		—		3,398		482		1,109		—		1,591
	Government bonds	2,267		1,618		—		3,885		1,743		1,479		—		3,222
	Money market fund deposits	82		—		—		82		18		—		—		18
	Municipal bonds	—		56		—		56		—		203		—		203
	Other current assets:
	Derivative assets	48		309		—		357		12		208		1		221
	Loans receivable	—		103		—		103		—		203		—		203
	Marketable equity securities	6,221		—		—		6,221		4,424		—		—		4,424
	Other long-term investments:
	Asset-backed securities	—		—		9		9		—		—		11		11
	Bank deposits	—		157		—		157		—		56		—		56
	Corporate bonds	282		518		27		827		10		218		26		254
	Government bonds	295		185		—		480		59		113		—		172
	Other long-term assets:
	Derivative assets	—		7		29		36		—		20		18		38
	Loans receivable	—		702		—		702		—		577		—		577
	Total assets measured and recorded at fair value	$	13,512	$	14,525	$	88	$	28,125	$	9,616	$	13,764	$	145	$	23,525
	Liabilities
	Other accrued liabilities:
	Derivative liabilities	$	—	$	372	$	—	$	372	$	1	$	291	$	—	$	292
	Other long-term liabilities:
	Derivative liabilities	—		50		—		50		—		20		—		20
	Total liabilities measured and recorded at fair value	$	—	$	422	$	—	$	422	$	1	$	311	$	—	$	312
Financial Instruments Not Recorded At Fair Value On Recurring Basis [Table Text Block]	'
	The carrying amounts and fair values of certain financial instruments not recorded at fair value on a recurring basis at the end of each period were as follows:
		December 28, 2013
		Carrying		Fair Value Measured Using						Fair Value
	(In Millions)	Amount		Level 1		Level 2		Level 3
	Non-marketable cost method investments	$	1,270	$	—	$	—	$	2,105	$	2,105
	Loans receivable	$	267	$	—	$	250	$	17	$	267
	Reverse repurchase agreements	$	400	$	—	$	400	$	—	$	400
	Grants receivable	$	416	$	—	$	481	$	—	$	481
	Long-term debt	$	13,165	$	10,937	$	2,601	$	—	$	13,538
	Short-term debt	$	24	$	—	$	24	$	—	$	24
	NVIDIA Corporation cross-license agreement liability	$	587	$	—	$	597	$	—	$	597
		December 29, 2012
		Carrying		Fair Value Measured Using						Fair Value
	(In Millions)	Amount		Level 1		Level 2		Level 3
	Non-marketable cost method investments	$	1,202	$	—	$	—	$	1,766	$	1,766
	Loans receivable	$	199	$	—	$	150	$	48	$	198
	Reverse repurchase agreements	$	50	$	—	$	50	$	—	$	50
	Grants receivable	$	198	$	—	$	205	$	—	$	205
	Long-term debt	$	13,136	$	11,442	$	2,926	$	—	$	14,368
	Short-term debt	$	48	$	—	$	48	$	—	$	48
	NVIDIA Corporation cross-license agreement liability	$	875	$	—	$	890	$	—	$	890

Cash_and_Investments_Tables

Cash and Investments (Tables)	12 Months Ended
	Dec. 28, 2013
Cash and Cash Equivalents [Abstract]	'
Schedule of Total Cash and Investments [Table Text Block]	'
	Cash and investments at the end of each period were as follows:
	(In Millions)	Dec 28,		Dec 29,
		2013		2012
	Available-for-sale investments	$	18,086	$	14,001
	Cash	854		593
	Equity method investments	1,038		992
	Loans receivable	1,072		979
	Non-marketable cost method investments	1,270		1,202
	Reverse repurchase agreements	800		2,850
	Trading assets	8,441		5,685
	Total cash and investments	$	31,561	$	26,302

Cash_and_Investments_Available

Cash and Investments, Available-for-Sale Investments (Tables)	12 Months Ended
	Dec. 28, 2013
Schedule of Available-for-sale Securities [Line Items]	'
Schedule of Available-for-sale Securities Reconciliation [Table Text Block]	'
	Available-for-sale investments at the end of each period were as follows:
		December 28, 2013									December 29, 2012
	(In Millions)	Adjusted		Gross		Gross			Fair		Adjusted		Gross		Gross			Fair
		Cost		Unrealized		Unrealized			Value		Cost		Unrealized		Unrealized			Value
				Gains		Losses							Gains		Losses
	Asset-backed securities	$	11	$	—	$	(2	)	$	9	$	14	$	—	$	(3	)	$	11
	Bank deposits	2,951		6		(1		)	2,956		1,417		1		—			1,418
	Commercial paper	4,464		—		—			4,464		4,184		1		—			4,185
	Corporate bonds	2,359		15		(3		)	2,371		635		8		(1		)	642
	Government bonds	1,024		—		—			1,024		2,235		—		—			2,235
	Marketable equity securities	3,340		2,881		—			6,221		3,356		1,069		(1		)	4,424
	Money market fund deposits	1,042		—		(1		)	1,041		1,086		—		—			1,086
	Total available-for-sale investments	$	15,191	$	2,902	$	(7	)	$	18,086	$	12,927	$	1,079	$	(5	)	$	14,001
Available-for-sale Securities [Member]	'
Schedule of Available-for-sale Securities [Line Items]	'
Investments Classified by Contractual Maturity Date [Table Text Block]	'
	The amortized cost and fair value of available-for-sale debt investments, by contractual maturity, as of December 28, 2013, were as follows:
	(In Millions)	Cost		Fair Value
	Due in 1 year or less	$	9,170	$	9,188
	Due in 1–2 years	979		978
	Due in 2–5 years	421		421
	Instruments not due at a single maturity date	1,281		1,278
	Total	$	11,851	$	11,865

Cash_and_Investments_Equity_Me

Cash and Investments, Equity Method and Cost Method Investments (Tables)	12 Months Ended
	Dec. 28, 2013
Equity Method And Cost Method Investments [Abstract]	'
Equity Method Investments [Table Text Block]	'
	Equity method investments, classified within other long-term assets, at the end of each period were as follows:
		December 28, 2013				December 29, 2012
	(Dollars In Millions)	Carrying		Ownership		Carrying		Ownership
		Value		Percentage		Value		Percentage
	IM Flash Technologies, LLC	$	646	49	%	$	642	49	%
	Intel-GE Care Innovations, LLC	117		50	%	146		50	%
	Clearwire Communications, LLC	—		—	%	—		6	%
	Other equity method investments	275				204
	Total	$	1,038			$	992

Derivative_Financial_Instrumen1

Derivative Financial Instruments (Tables)	12 Months Ended
	Dec. 28, 2013
Derivative Financial Instruments (Tables) [Abstract]	'
Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]	'
	Total gross notional amounts for outstanding derivatives (recorded at fair value) at the end of each period were as follows:
	(In Millions)	Dec 28,				Dec 29,				Dec 31,
		2013				2012				2011
	Currency forwards	$	13,404			$	13,117			$	11,203
	Currency interest rate swaps	4,377				2,711				1,650
	Embedded debt derivatives	3,600				3,600				3,600
	Interest rate swaps	1,377				1,101				1,837
	Total return swaps	914				807				761
	Other	67				127				182
	Total	$	23,739			$	21,463			$	19,233
	The gross notional amounts for currency forwards and currency interest rate swaps (presented by currency) at the end of each period were as follows:
	(In Millions)	Dec 28,				Dec 29,				Dec 31,
		2013				2012				2011
	British pound sterling	$	549			$	308			$	459
	Chinese yuan	1,116				647				688
	Euro	6,874				5,994				3,904
	Israeli shekel	2,244				2,256				2,168
	Japanese yen	4,116				4,389				3,477
	Malaysian ringgit	506				442				805
	Swiss franc	1,189				657				209
	Other	1,187				1,135				1,143
	Total	$	17,781			$	15,828			$	12,853
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]	'
	The fair value of our derivative instruments at the end of each period were as follows:
		December 28, 2013														December 29, 2012
	(In Millions)	Other				Other				Other				Other		Other		Other		Other		Other
		Current				Long-Term				Accrued				Long-Term		Current		Long-Term		Accrued		Long-Term
		Assets				Assets				Liabilities				Liabilities		Assets		Assets		Liabilities		Liabilities
	Derivatives designated as hedging instruments:
	Currency forwards	$	114			$	1			$	118			$	2	$	91	$	2	$	127	$	—
	Total derivatives designated as hedging instruments	$	114			$	1			$	118			$	2	$	91	$	2	$	127	$	—
	Derivatives not designated as hedging instruments:
	Currency forwards	$	66			$	—			$	63			$	—	$	85	$	—	$	58	$	—
	Currency interest rate swaps	124				6				163				29		33		18		72		14
	Embedded debt derivatives	—				—				—				19		—		—		—		6
	Interest rate swaps	5				—				28				—		—		—		34		—
	Total return swaps	48				—				—				—		11		—		—		—
	Other	—				29				—				—		1		18		1		—
	Total derivatives not designated as hedging instruments	$	243			$	35			$	254			$	48	$	130	$	36	$	165	$	20
	Total derivatives	$	357			$	36			$	372			$	50	$	221	$	38	$	292	$	20
Schedule Of Derivative Instruments In Cash Flow Hedging Relationships [Table Text Block]	'
	The before-tax gains (losses), attributed to the effective portion of cash flow hedges, recognized in other comprehensive income (loss) for each period were as follows:
		Gains (Losses)
		Recognized in OCI on
		Derivatives (Effective Portion)
	(In Millions)	2013				2012				2011
	Currency forwards	$	(167	)		$	4			$	20
	Other	1				9				—
	Total	$	(166	)		$	13			$	20
Not Designated as Hedging Instrument [Member]	'
Derivative Financial Instruments (Tables) [Abstract]	'
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Table Text Block]	'
	The effects of derivative instruments not designated as hedging instruments on the consolidated statements of income for each period were as follows:
	(In Millions)	Location of Gains (Losses)		2013				2012				2011
		Recognized in Income on Derivatives
	Currency forwards	Interest and other, net		$	44			$	3			$	58
	Currency interest rate swaps	Interest and other, net		29				(71		)		(17		)
	Equity options	Gains (losses) on equity investments, net		1				(1		)		(67		)
	Interest rate swaps	Interest and other, net		—				31				(26		)
	Total return swaps	Various		140				77				(13		)
	Other	Gains (losses) on equity investments, net		5				(7		)		4
	Other	Interest and other, net		—				3				—
	Total			$	219			$	35			$	(61	)

Acquisitions_Tables

Acquisitions (Tables)	12 Months Ended
	Dec. 28, 2013
Series of Individually Immaterial Business Acquisitions [Member]	'
Acquisitions (Tables) [Abstract]	'
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	'
	The fair value of the assets acquired and liabilities assumed by major class in the acquisitions completed during 2011, excluding McAfee, was allocated as follows:
	(In Millions)
	Fair value of net tangible assets acquired	$	206
	Goodwill	517
	Identified intangible assets	1,409
	Total	$	2,132
Schedule Of Intangible Assets Acquired As Part Of Business Combination [Table Text Block]	'
	The identified intangible assets assumed in the acquisitions completed during 2011, excluding McAfee, were recognized as follows:
			Fair Value		Estimated
			(In Millions)		Useful Life
					(In Years)
	Developed technology		$	1,102	3	–	9
	Customer relationships		144		5	–	8
	Other intangible assets		44		2	–	7
	Total identified intangible assets subject to amortization		$	1,290
	In-process research and development		119
	Total identified intangible assets		$	1,409
McAfee, Inc. [Member]	'
Acquisitions (Tables) [Abstract]	'
Consideration To Acquire Company [Table Text Block]	'
	Total consideration to acquire McAfee was $6.7 billion (net of $943 million of cash and cash equivalents acquired) and comprised the following:
	(In Millions)
	Cash	$	6,652
	Share-based awards assumed	48
	Total	$	6,700
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	'
	The fair value of the assets acquired and liabilities assumed by major class in the acquisition of McAfee was recognized as follows:
	(In Millions)
	Marketable debt securities	$	329
	Goodwill	4,299
	Identified intangible assets	3,552
	Deferred tax assets	738
	Other assets	417
	Deferred income	(1,049		)
	Deferred tax liabilities	(1,191		)
	Other liabilities	(395		)
	Total	$	6,700
Schedule Of Intangible Assets Acquired As Part Of Business Combination [Table Text Block]	'
	The identified intangible assets assumed in the acquisition of McAfee were recognized as follows based upon their fair value as of February 28, 2011:
			Fair Value		Estimated
			(In Millions)		Useful Life
					(In Years)
	Developed technology		$	1,221	4
	Customer relationships		1,418		2	–	7
	Total identified intangible assets subject to amortization		$	2,639
	In-process research and development		92
	Trade names		821
	Total identified intangible assets		$	3,552
McAfee, Inc. and Series of Individually Immaterial Business Acquisitions [Member]	'
Acquisitions (Tables) [Abstract]	'
Business Acquisition, Pro Forma Information [Table Text Block]	'
	(In Millions, Except Per Share Amounts—Unaudited)		2011
	Net revenue		$	54,738
	Net income		$	13,028
	Diluted earnings per share		$	2.41

Goodwill_Tables

Goodwill (Tables)	12 Months Ended
	Dec. 28, 2013
Goodwill (Tables) [Abstract]	'
Schedule of Goodwill [Table Text Block]	'
	Goodwill activity for each period was as follows:
	(In Millions)	PC Client Group		Data Center Group			Other Intel			Software and Services Operating Segments		Total
							Architecture
							Operating
							Segments
	31-Dec-11	$	2,918	$	1,553		$	844		$	3,939	$	9,254
	Additions due to acquisitions	44		286			78			44		452
	Impairments	—		—			(6		)	—		(6		)
	Effect of exchange rate fluctuations	—		—			—			10		10
	29-Dec-12	$	2,962	$	1,839		$	916		$	3,993	$	9,710
	Additions due to acquisitions	62		14			171			504		751
	Transfers	34		(22		)	(12		)	—		—
	Effect of exchange rate fluctuations	—		—			—			52		52
	28-Dec-13	$	3,058	$	1,831		$	1,075		$	4,549	$	10,513

Identified_Intangible_Assets_T

Identified Intangible Assets (Tables)	12 Months Ended
	Dec. 28, 2013
Identified Intangible Assets (Tables) [Abstract]	'
Schedule Of Intangible Assets By Major Class [Table Text Block]	'
	Identified intangible assets at the end of December 28, 2013, were as follows:
	(In Millions)	Gross		Accumulated			Net
		Assets		Amortization
	Acquisition-related developed technology	$	2,922	$	(1,691	)	$	1,231
	Acquisition-related customer relationships	1,760		(828		)	932
	Acquisition-related trade names	65		(44		)	21
	Licensed technology and patents	3,093		(974		)	2,119
	Identified intangible assets subject to amortization	7,840		(3,537		)	4,303
	Acquisition-related trade names	818		—			818
	Other intangible assets	29		—			29
	Identified intangible assets not subject to amortization	847		—			847
	Total identified intangible assets	$	8,687	$	(3,537	)	$	5,150
	As a result of our acquisitions in 2013, we recorded acquisition-related developed technology of $114 million with a weighted average useful life of five years and acquisition-related customer relationships of $60 million with a weighted average useful life of seven years. During 2013, we purchased licensed technology and patents of $36 million with a weighted average useful life of 10 years.
	Identified intangible assets at the end of December 29, 2012 were as follows:
	(In Millions)	Gross		Accumulated			Net
		Assets		Amortization
	Acquisition-related developed technology	$	2,778	$	(1,116	)	$	1,662
	Acquisition-related customer relationships	1,712		(551		)	1,161
	Acquisition-related trade names	68		(33		)	35
	Licensed technology and patents	2,986		(699		)	2,287
	Other intangible assets	238		(86		)	152
	Identified intangible assets subject to amortization	7,782		(2,485		)	5,297
	Acquisition-related trade names	809		—			809
	Other intangible assets	129		—			129
	Identified intangible assets not subject to amortization	938		—			938
	Total identified intangible assets	$	8,720	$	(2,485	)	$	6,235
Identified Intangible Assets, Amortization Expenses [Table Text Block]	'
	Amortization expenses for each period were as follows:
	(In Millions)	2013		2012			2011
	Acquisition-related developed technology	$	576	$	557		$	482
	Acquisition-related customer relationships	279		296			250
	Acquisition-related trade names	12		12			10
	Licensed technology and patents	272		214			181
	Other intangible assets	103		86			—
	Total amortization expenses	$	1,242	$	1,165		$	923
Schedule of Expected Amortization Expense [Table Text Block]	'
	Based on identified intangible assets that are subject to amortization as of December 28, 2013, we expect future amortization expense for each period to be as follows:
	(In Millions)	2014		2015			2016		2017		2018
	Acquisition-related developed technology	$	579	$	303		$	211	$	63	$	41
	Acquisition-related customer relationships	268		251			233		142		29
	Acquisition-related trade names	10		9			3		—		—
	Licensed technology and patents	270		252			238		199		158
	Total future amortization expenses	$	1,127	$	815		$	685	$	404	$	228

Other_LongTerm_Assets_Tables

Other Long-Term Assets (Tables) (Other Long-Term Assets [Member])	12 Months Ended
	Dec. 28, 2013
Other Long-Term Assets [Member]	'
Other Long-Term Assets (Tables) [Abstract]	'
Schedule of Other Assets and Other Liabilities [Table Text Block]	'
	Other long-term assets at the end of each period were as follows:
	(In Millions)	Dec 28,		Dec 29,
		2013		2012
	Equity method investments	$	1,038	$	992
	Non-marketable cost method investments	1,270		1,202
	Non-current deferred tax assets	434		358
	Loans receivable	952		644
	Other	1,795		952
	Total other long-term assets	$	5,489	$	4,148

Recovered_Sheet1

Restructuring And Asset Impairment Charges (Tables)	12 Months Ended
	Dec. 28, 2013
Restructuring and Asset Impairment Charges [Abstract]	'
Restructuring And Asset Impairment Charges [Table Text Block]	'
	Restructuring and asset impairment charges for each period were as follows:
	(In Millions)	2013			2012			2011
	Employee severance and benefit arrangements	$	201		$	—		$	—
	Asset impairments	39			—			—
	Total restructuring and asset impairment charges	$	240		$	—		$	—
Restructuring And Asset Impairment Activity [Table Text Block]	'
	The restructuring and asset impairment activity for 2013 was as follows:
	(In Millions)	Employee Severance and Benefits			Asset Impairments			Total
	Accrued restructuring balance as of December 29, 2012	$	—		$	—		$	—
	Additional accruals	195			39			234
	Adjustments	6			—			6
	Cash payments	(18		)	—			(18		)
	Non-cash settlements	—			(39		)	(39		)
	Accrued restructuring balance as of December 28, 2013	$	183		$	—		$	183

Deferred_Income_Tables

Deferred Income (Tables)	12 Months Ended
	Dec. 28, 2013
Deferred Income (Tables) [Abstract]	'
Deferred Income By Arrangement Disclosure [Table Text Block]	'
	Deferred income at the end of each period was as follows:
	(In Millions)	Dec 28,		Dec 29,
		2013		2012
	Deferred income on shipments of components to distributors	$	852	$	694
	Deferred income from software and services operating segments	1,244		1,238
	Current deferred income	$	2,096	$	1,932
	Non-current deferred income from software and services operating segments	506		473
	Total deferred income	$	2,602	$	2,405

Borrowings_Tables

Borrowings (Tables)	12 Months Ended
	Dec. 28, 2013
Borrowings (Tables) [Abstract]	'
Schedule of Long-term Debt Instruments [Table Text Block]	'
	Our long-term debt at the end of each period was as follows:
	(In Millions)	Dec 28,			Dec 29,
		2013			2012
	2012 Senior notes due 2017 at 1.35%	$	2,997		$	2,997
	2012 Senior notes due 2022 at 2.70%	1,494			1,494
	2012 Senior notes due 2032 at 4.00%	744			743
	2012 Senior notes due 2042 at 4.25%	924			924
	2011 Senior notes due 2016 at 1.95%	1,499			1,498
	2011 Senior notes due 2021 at 3.30%	1,996			1,996
	2011 Senior notes due 2041 at 4.80%	1,490			1,489
	2009 Junior subordinated convertible debentures due 2039 at 3.25%	1,075			1,063
	2005 Junior subordinated convertible debentures due 2035 at 2.95%	946			932
	Total long-term debt	$	13,165		$	13,136
Convertible Debentures Interest Rates [Table Text Block]	'
		2009		2005
		Debentures		Debentures
	Annual coupon interest rate	3.25	%	2.95	%
	Annual effective interest rate	7.2	%	6.45	%
	Maximum amount of contingent interest that will accrue per year	0.5	%	0.4	%
Convertible Debentures Other Details [Table Text Block]	'
		2009 Debentures					2005 Debentures
	(In Millions, Except Per Share Amounts)	Dec 28,			Dec 29,		Dec 28,		Dec 29,
		2013			2012		2013		2012
	Outstanding principal	$	2,000		$	2,000	$	1,600	$	1,600
	Equity component carrying amount	$	613		$	613	$	466	$	466
	Unamortized discount	$	910		$	922	$	643	$	656
	Net debt carrying amount	$	1,075		$	1,063	$	946	$	932
	Conversion rate (shares of common stock per $1,000 principal amount of debentures)	45.57			45.05		34.6		33.86
	Effective conversion price (per share of common stock)	$	21.94		$	22.2	$	28.9	$	29.53
Aggregate Debt Maturities [Table Text Block]	'
	Our aggregate debt maturities based on outstanding principal as of December 28, 2013, by year payable, were as follows:
	(In Millions)
	2014	$	—
	2015	—
	2016	1,500
	2017	3,000
	2018	—
	2019 and thereafter	10,275
	Total	$	14,775

Retirement_Benefit_Plans_Table

Retirement Benefit Plans (Tables)	12 Months Ended
	Dec. 28, 2013
Retirement Benefit Plans (Tables) [Abstract]	'
Schedule of Changes in Projected Benefit Obligations [Table Text Block]	'
		U.S. Pension Benefits								Non-U.S. Pension							U.S. Postretirement
										Benefits							Medical Benefits
	(In Millions)	2013				2012				2013			2012				2013				2012
	Beginning projected benefit obligation	$	1,742			$	1,480			$	1,412		$	1,121			$	484			$	369
	Service cost	119				98				78			64				27				30
	Interest cost	67				69				60			52				20				17
	Actuarial (gain) loss	(746		)		108				121			172				(56		)		75
	Other	(45		)		(13		)		24			3				34				(7		)
	Ending projected benefit obligation	$	1,137			$	1,742			$	1,695		$	1,412			$	509			$	484
Schedule of Changes in Fair Value of Plan Assets [Table Text Block]	'
		U.S. Pension Benefits								Non-U.S. Pension							U.S. Postretirement
										Benefits							Medical Benefits
	(In Millions)	2013				2012				2013			2012				2013				2012
	Beginning fair value of plan assets	$	684			$	648			$	838		$	722			$	191			$	116
	Actual return on plan assets	10				49				81			70				49				—
	Employer contributions	—				—				65			52				162				82
	Other	(45		)		(13		)		21			(6		)		(7		)		(7		)
	Ending fair value of plan assets	$	649			$	684			$	1,005		$	838			$	395			$	191
Schedule of Amounts Recognized in Balance Sheet [Table Text Block]	'
	The amounts recognized on the consolidated balance sheets at the end of each period were as follows:
		U.S. Pension Benefits								Non-U.S. Pension							U.S. Postretirement
										Benefits							Medical Benefits
	(In Millions)	Dec 28,				Dec 29,				Dec 28,			Dec 29,				Dec 28,				Dec 29,
		2013				2012				2013			2012				2013				2012
	Other long-term assets	$	—			$	—			$	16		$	1			$	—			$	—
	Other long-term liabilities	(488		)		(1,058		)		(706		)	(575		)		(114		)		(293		)
	Accumulated other comprehensive loss (income), before tax	255				1,050				520			477				43				138
	Net amount recognized	$	(233	)		$	(8	)		$	(170	)	$	(97	)		$	(71	)		$	(155	)
Schedule of Net Periodic Benefit Cost Not yet Recognized [Table Text Block]	'
	The amounts recorded in accumulated other comprehensive income (loss) before taxes at the end of each period were as follows:
		U.S. Pension Benefits								Non-U.S. Pension							U.S. Postretirement
										Benefits							Medical Benefits
	(In Millions)	Dec 28,				Dec 29,				Dec 28,			Dec 29,				Dec 28,				Dec 29,
		2013				2012				2013			2012				2013				2012
	Net prior service credit (cost)	$	—			$	—			$	25		$	12			$	(54	)		$	(60	)
	Net actuarial gain (loss)	(255		)		(1,050		)		(545		)	(489		)		11				(78		)
	Accumulated other comprehensive income (loss), before tax	$	(255	)		$	(1,050	)		$	(520	)	$	(477	)		$	(43	)		$	(138	)
Schedule of Benefit Obligations in Excess of Fair Value of Plan Assets [Table Text Block]	'
	As of December 28, 2013, the accumulated benefit obligation was $497 million for the U.S. Intel Minimum Pension Plan ($562 million as of December 29, 2012) and $1.3 billion for the non-U.S. defined-benefit pension plans ($1.1 billion as of December 29, 2012). Included in the aggregate data in the following tables are the amounts applicable to our pension plans, with accumulated benefit obligations in excess of plan assets, as well as plans with projected benefit obligations in excess of plan assets. Amounts related to such plans at the end of each period were as follows:
		U.S. Pension Benefits								Non-U.S. Pension
										Benefits
	(In Millions)	Dec 28,				Dec 29,				Dec 28,			Dec 29,
		2013				2012				2013			2012
	Plans with accumulated benefit obligations in excess of plan assets:
	Accumulated benefit obligations	$	—			$	—			$	900		$	813
	Plan assets	$	—			$	—			$	563		$	508
	Plans with projected benefit obligations in excess of plan assets:
	Projected benefit obligations	$	1,137			$	1,742			$	1,295		$	1,400
	Plan assets	$	649			$	684			$	588		$	825
Schedule of Assumptions Used [Table Text Block]	'
	Weighted average actuarial assumptions used to determine benefit obligations for the plans at the end of each period were as follows:
		U.S. Pension Benefits						Non-U.S. Pension					U.S. Postretirement
								Benefits					Medical Benefits
		Dec 28,			Dec 29,			Dec 28,			Dec 29,		Dec 28,			Dec 29,
		2013			2012			2013			2012		2013			2012
	Discount rate	4.8	%		3.9	%		4	%		4.2	%	4.6	%		3.6	%
	Rate of compensation increase	3.8	%		4.1	%		3.9	%		4	%	n/a			n/a
	Weighted average actuarial assumptions used to determine costs for the plans for each period were as follows:
		U.S. Pension Benefits									Non-U.S. Pension Benefits								U.S. Postretirement
																			Medical Benefits
		2013			2012			2011			2013		2012			2011			2013			2012		2011
	Discount rate	3.9	%		4.7	%		5.8	%		4.2	%	5	%		5.3	%		4.2	%		4.6	%	5.6	%
	Expected long-term rate of return on plan assets	4.5	%		5	%		5.5	%		5.2	%	5.9	%		6.3	%		7.7	%		3	%	3	%
	Rate of compensation increase	4.1	%		4.5	%		4.7	%		4.3	%	4.1	%		4.3	%		n/a			n/a		n/a
Schedule of Expected Benefit Payments [Table Text Block]	'
	Estimated benefit payments over the next 10 fiscal years are as follows:
	(In Millions)	U.S. Pension				Non-U.S.				U.S.
		Benefits				Pension				Postretirement
						Benefits				Medical
										Benefits
	2014	$	42			$	33			$	23
	2015	$	51			$	32			$	22
	2016	$	63			$	32			$	24
	2017	$	71			$	36			$	22
	2018	$	88			$	38			$	21
	2019-2023	$	691			$	219			$	99
U.S. Pension Benefits [Member]	'
Retirement Benefit Plans (Tables) [Abstract]	'
Schedule of Allocation of Plan Assets [Table Text Block]	'
	U.S. Intel Minimum Pension Plan assets measured at fair value on a recurring basis consisted of the following investment categories at the end of each period were as follows:
		28-Dec-13															Dec 29,
																	2012
		Fair Value Measured at Reporting Date Using
	(In Millions)	Level 1				Level 2				Level 3			Total				Total
	Equity securities	$	15			$	205			$	—		$	220			$	92
	Fixed income	88				255				72			415				582
	Other investments	11				—				—			11				—
	Total assets measured at fair value	$	114			$	460			$	72		$	646			$	674
	Cash												3				10
	Total U.S. pension plan assets at fair value												$	649			$	684
Non-U.S. Pension Benefits [Member]	'
Retirement Benefit Plans (Tables) [Abstract]	'
Schedule of Allocation of Plan Assets [Table Text Block]	'
	Non-U.S. plan assets measured at fair value on a recurring basis consisted of the following investment categories at the end of each period were as follows:
		28-Dec-13															Dec 29,
																	2012
		Fair Value Measured at Reporting Date Using
	(In Millions)	Level 1				Level 2				Level 3			Total				Total
	Equity securities	$	287			$	63			$	11		$	361			$	248
	Fixed income	—				521				33			554				574
	Total assets measured at fair value	$	287			$	584			$	44		$	915			$	822
	Cash												90				16
	Total non-U.S. plan assets at fair value												$	1,005			$	838

Commitments_Tables

Commitments (Tables)	12 Months Ended
	Dec. 28, 2013
Commitments (Tables) [Abstract]	'
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	'
	Minimum rental commitments under all non-cancelable leases with an initial term in excess of one year were as follows as of December 28, 2013:
	(In Millions)
	2014	$	208
	2015	172
	2016	126
	2017	97
	2018	69
	2019 and thereafter	198
	Total	$	870

Employee_Equity_Incentive_Plan1

Employee Equity Incentive Plans (Tables)	12 Months Ended
	Dec. 28, 2013
Employee Equity Incentive Plans (Tables) [Abstract]	'
Restricted Stock Units Estimated Values And Weighted Average Assumptions [Table Text Block]	'
	We estimate the fair value of restricted stock unit awards with time-based vesting using the value of our common stock on the date of grant, reduced by the present value of dividends expected to be paid on our common stock prior to vesting. We estimate the fair value of market-based restricted stock units using a Monte Carlo simulation model on the date of grant. We based the weighted average estimated value of restricted stock unit grants, as well as the weighted average assumptions that we used in calculating the fair value, on estimates at the date of grant, for each period as follows:
			2013				2012				2011
	Estimated values		$	21.45			$	25.32			$	19.86
	Risk-free interest rate		0.2		%		0.3		%		0.7		%
	Dividend yield		3.8		%		3.3		%		3.4		%
	Volatility		25		%		26		%		27		%
Stock Options And Stock Purchase Plan Estimated Values And Weighted Average Assumptions [Table Text Block]	'
	We use the Black-Scholes option pricing model to estimate the fair value of options granted under our equity incentive plans and rights to acquire stock granted under our stock purchase plan. We based the weighted average estimated value of employee stock option grants and rights granted under the stock purchase plan, as well as the weighted average assumptions used in calculating the fair value, on estimates at the date of grant, for each period as follows:
			Stock Options											Stock Purchase Plan
			2013				2012				2011			2013			2012				2011
	Estimated values		$	3.11			$	4.22			$	3.91		$	4.52		$	5.47			$	4.69
	Expected life (in years)		5.2				5.3				5.4			0.5			0.5				0.5
	Risk-free interest rate		0.8		%		1		%		2.2		%	0.1		%	0.1		%		0.2		%
	Dividend yield		3.9		%		3.3		%		3.4		%	4		%	3.3		%		3.6		%
	Volatility		25		%		25		%		27		%	22		%	24		%		26		%
Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]	'
	Information with respect to outstanding RSU activity for each period was as follows:
			Number of			Weighted
			RSUs			Average
			(In Millions)			Grant-Date
						Fair Value
	December 25, 2010		99.8			$	18.56
	Granted		43.3			$	19.86
	Assumed in acquisition		5.8			$	20.8
	Vested		(37.5	)		$	18.6
	Forfeited		(4.4	)		$	19.07
	31-Dec-11		107			$	19.18
	Granted		49.9			$	25.32
	Vested		(43.2	)		$	18.88
	Forfeited		(4.4	)		$	20.93
	29-Dec-12		109.3			$	22.03
	Granted		53.4			$	21.45
	Vested		(44.5	)		$	20.21
	Forfeited		(4.9	)		$	22.06
	28-Dec-13		113.3			$	22.47
	Expected to vest as of December 28, 2013		107.3			$	22.49
Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding [Table Text Block]	'
	As of December 28, 2013, options outstanding that have vested and are expected to vest were as follows:
			Number of			Weighted				Weighted		Aggregate
			Options			Average				Average		Intrinsic
			(In Millions)			Exercise				Remaining		Value
						Price				Contractual		(In Millions)
										Term
										(In Years)
	Vested		111.5			$	20.25			2.6		$	617
	Expected to vest		39.6			$	23.4			5.4		$	101
	Total		151.1			$	21.08			3.3		$	718
Schedule of Stock Options Roll Forward [Table Text Block]	'
	Additional information with respect to stock option activity for each period was as follows:
			Number of			Weighted
			Options			Average
			(In Millions)			Exercise
						Price
	25-Dec-10		386.4			$	20.45
	Grants		14.7			$	21.49
	Assumed in acquisition		12			$	15.8
	Exercises		(86.3	)		$	20.06
	Cancellations and forfeitures		(8.6	)		$	20.47
	Expirations		(19.9	)		$	24.85
	31-Dec-11		298.3			$	20.12
	Grants		13.5			$	27.01
	Exercises		(85.8	)		$	20.45
	Cancellations and forfeitures		(3.9	)		$	21.17
	Expirations		(19.3	)		$	22.45
	29-Dec-12		202.8			$	20.2
	Grants		20.1			$	22.99
	Exercises		(65.0	)		$	18.76
	Cancellations and forfeitures		(3.0	)		$	22.58
	Expirations		(1.9	)		$	22.56
	28-Dec-13		153			$	21.1
	Options exercisable as of:
	31-Dec-11		203.6			$	20.44
	29-Dec-12		139.8			$	19.76
	28-Dec-13		111.5			$	20.25
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]	'
	The following table summarizes information about options outstanding as of December 28, 2013:
										Outstanding Options							Exercisable Options
	Range of Exercise Prices									Number of			Weighted	Weighted			Number of			Weighted
										Shares			Average	Average			Shares			Average
										(In Millions)			Remaining	Exercise			(In Millions)			Exercise
													Contractual	Price						Price
													Life
													(In Years)
	$	1.12		-	$	15				2.2			3.7	$	12.22		1.2			$	11.69
	$	15.01		-	$	20				70.5			2.7	$	18.22		70.4			$	18.2
	$	20.01		-	$	25				57.6			4.2	$	22.59		26.2			$	22.54
	$	25.01		-	$	30				22.4			3	$	27.09		13.4			$	27.02
	$	30.01		-	$	33.03				0.3			0.1	$	32.31		0.3			$	32.31
	Total									153			3.3	$	21.1		111.5			$	20.25

Gains_Losses_on_Equity_Investm1

Gains (Losses) on Equity Investments, Net (Tables)	12 Months Ended
	Dec. 28, 2013
Gains (Losses) on Equity Investments, Net (Tables) [Abstract]	'
Schedule Of Gains (Losses) On Equity Investments, Net [Table Text Block]	'
	Gains (losses) on equity investments, net for each period were as follows:
	(In Millions)	2013			2012			2011
	Share of equity method investee losses, net	$	(69	)	$	(81	)	$	(204	)
	Impairment charges	(123		)	(154		)	(132		)
	Gains on sales, net	515			183			303
	Dividends	46			—			—
	Other, net	102			193			145
	Total gains (losses) on equity investments, net	$	471		$	141		$	112

Interest_and_Other_Net_Tables

Interest and Other, Net (Tables)	12 Months Ended
	Dec. 28, 2013
Interest and Other, Net (Tables) [Abstract]	'
Interest And Other, Net [Table Text Block]	'
	The components of interest and other, net for each period were as follows:
	(In Millions)	2013			2012			2011
	Interest income	$	104		$	97		$	98
	Interest expense	(244		)	(90		)	(41		)
	Other, net	(11		)	87			135
	Total interest and other, net	$	(151	)	$	94		$	192

Earnings_Per_Share_Tables

Earnings Per Share (Tables)	12 Months Ended
	Dec. 28, 2013
Earnings Per Share [Abstract]	'
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	'
	We computed our basic and diluted earnings per common share for each period as follows:
	(In Millions, Except Per Share Amounts)	2013		2012		2011
	Net income available to common stockholders	$	9,620	$	11,005	$	12,942
	Weighted average common shares outstanding—basic	4,970		4,996		5,256
	Dilutive effect of employee equity incentive plans	68		100		101
	Dilutive effect of convertible debt	59		64		54
	Weighted average common shares outstanding—diluted	5,097		5,160		5,411
	Basic earnings per common share	$	1.94	$	2.2	$	2.46
	Diluted earnings per common share	$	1.89	$	2.13	$	2.39

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 28, 2013
Taxes (Tables) [Abstract]	'
Income Before Taxes And Provisions For Taxes [Table Text Block]	'
	Income before taxes and the provision for taxes consisted of the following:
	(Dollars in Millions)	2013				2012				2011
	Income before taxes:
	U.S.	$	9,374			$	10,042			$	14,659
	Non-U.S.	3,237				4,831				3,122
	Total income before taxes	$	12,611			$	14,873			$	17,781
	Provision for taxes:
	Current:
	Federal	$	2,730			$	2,539			$	3,212
	State	68				52				104
	Non-U.S.	716				1,135				374
	Total current provision for taxes	$	3,514			$	3,726			$	3,690
	Deferred:
	Federal	$	(412	)		$	129			$	1,175
	Other	(111		)		13				(26		)
	Total deferred provision for taxes	$	(523	)		$	142			$	1,149
	Total provision for taxes	$	2,991			$	3,868			$	4,839
	Effective tax rate	23.7		%		26		%		27.2		%
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	'
	The difference between the tax provision at the statutory federal income tax rate and the tax provision as a percentage of income before income taxes (effective tax rate) for each period was as follows:
		2013			2012			2011
	Statutory federal income tax rate	35	%		35	%		35	%
	Increase (reduction) in rate resulting from:
	Non-U.S. income taxed at different rates	(5.8	)		(7.3	)		(4.4	)
	Research and development tax credits	(3.5	)		—			(1.0	)
	Domestic manufacturing deduction benefit	(2.1	)		(2.1	)		(1.9	)
	Other	0.1			0.4			(0.5	)
	Effective tax rate	23.7	%		26	%		27.2	%
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	'
	Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts for income tax purposes. Significant components of our deferred tax assets and liabilities at the end of each period were as follows:
	(In Millions)	Dec 28,				Dec 29,
		2013				2012
	Deferred tax assets:
	Accrued compensation and other benefits	$	1,047			$	1,125
	Share-based compensation	564				638
	Deferred income	672				637
	Inventory	733				506
	Unrealized losses on investments and derivatives	—				36
	State credits and net operating losses	378				297
	Other, net	654				654
	Gross deferred tax assets	4,048				3,893
	Valuation allowance	(456		)		(389		)
	Total deferred tax assets	$	3,592			$	3,504
	Deferred tax liabilities:
	Property, plant and equipment	$	(2,023	)		$	(2,325	)
	Licenses and intangibles	(687		)		(778		)
	Convertible debt	(911		)		(856		)
	Unrealized gains on investments and derivatives	(815		)		—
	Investment in non-U.S. subsidiaries	(244		)		(213		)
	Other, net	(281		)		(269		)
	Total deferred tax liabilities	$	(4,961	)		$	(4,441	)
	Net deferred tax assets (liabilities)	$	(1,369	)		$	(937	)
	Reported as:
	Current deferred tax assets	$	2,594			$	2,117
	Non-current deferred tax assets	434				358
	Non-current deferred tax liabilities	(4,397		)		(3,412		)
	Net deferred tax assets (liabilities)	$	(1,369	)		$	(937	)
Changes In Gross Unrecognized Tax Benefits [Table Text Block]	'
	The aggregate changes in the balance of gross unrecognized tax benefits for each period were as follows:
	(In Millions)	2013				2012				2011
	Beginning gross unrecognized tax benefits	$	189			$	212			$	216
	Settlements and effective settlements with tax authorities and related remeasurements	(2		)		(81		)		(63		)
	Lapse of statute of limitations	—				(5		)		(17		)
	Increases in balances related to tax positions taken during prior periods	21				56				91
	Decreases in balances related to tax positions taken during prior periods	(9		)		(6		)		(21		)
	Increases in balances related to tax positions taken during current period	8				13				6
	Ending gross unrecognized tax benefits	$	207			$	189			$	212

Other_Comprehensive_Income_Los1

Other Comprehensive Income (Loss) (Tables)	12 Months Ended
	Dec. 28, 2013
Comprehensive Income (Tables) [Abstract]	'
Components Of Other Comprehensive Income (Loss) [Table Text Block]	'
	The components of other comprehensive income (loss) and related tax effects for each period were as follows:
		2013									2012									2011
	(In Millions)	Before			Tax			Net of			Before			Tax			Net of			Before			Tax			Net of
		Tax						Tax			Tax						Tax			Tax						Tax
	Change in unrealized holding gains (losses) on available-for-sale investments	$	1,963		$	(687	)	$	1,276		$	909		$	(318	)	$	591		$	35		$	(13	)	$	22
	Less: adjustment for (gains) losses on available-for-sale investments included in net income	(146		)	51			(95		)	(187		)	66			(121		)	(299		)	107			(192		)
	Less: adjustment for (gains) losses on deferred tax asset valuation allowance included in net income	—			(26		)	(26		)	—			(11		)	(11		)	—			(99		)	(99		)
	Change in unrealized holding gains (losses) on derivatives	(166		)	76			(90		)	12			8			20			20			(16		)	4
	Less: adjustment for amortization of (gains) losses on derivatives	30			(29		)	1			78			(13		)	65			(161		)	38			(123		)
	Change in net prior service costs	17			(2		)	15			(4		)	1			(3		)	—			—			—
	Less: adjustment for amortization of net prior service costs	4			(1		)	3			5			(2		)	3			7			(3		)	4
	Change in actuarial valuation	725			(275		)	450			(321		)	91			(230		)	(900		)	284			(616		)
	Less: adjustment for amortization of actuarial (gains) losses	101			(31		)	70			90			(32		)	58			43			(15		)	28
	Change in net foreign currency translation adjustment	45			(7		)	38			12			(2		)	10			(155		)	13			(142		)
	Other comprehensive income (loss)	$	2,573		$	(931	)	$	1,642		$	594		$	(212	)	$	382		$	(1,410	)	$	296		$	(1,114	)
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	'
	The changes in accumulated other comprehensive income (loss) by component and related tax effects for each period were as follows:
	(In Millions)	Unrealized Holding Gains (Losses) on Available-for-Sale Investments			Deferred Tax Asset Valuation Allowance			Unrealized Holding Gains (Losses) on Derivatives			Prior Service Credits (Costs)			Actuarial Gains (Losses)			Foreign Currency Translation Adjustment			Total
	31-Dec-11	$	231		$	104		$	8		$	(32	)	$	(950	)	$	(142	)	$	(781	)
	Other comprehensive income before reclassifications	909			—			12			(4		)	(321		)	12			608
	Amounts reclassified out of accumulated other comprehensive income	(187		)	—			78			5			90			—			(14		)
	Tax effects	(252		)	(11		)	(5		)	(1		)	59			(2		)	(212		)
	Other comprehensive income (loss)	470			(11		)	85			—			(172		)	10			382
	29-Dec-12	$	701		$	93		$	93		$	(32	)	$	(1,122	)	$	(132	)	$	(399	)
	Other comprehensive income before reclassifications	1,963			—			(166		)	17			725			45			2,584
	Amounts reclassified out of accumulated other comprehensive income	(146		)	—			30			4			101			—			(11		)
	Tax effects	(636		)	(26		)	47			(3		)	(306		)	(7		)	(931		)
	Other comprehensive income (loss)	1,181			(26		)	(89		)	18			520			38			1,642
	28-Dec-13	$	1,882		$	67		$	4		$	(14	)	$	(602	)	$	(94	)	$	1,243
Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]	'
	The amounts reclassified out of accumulated other comprehensive income into the consolidated statements of income, with presentation location, for each period were as follows:
		2013			2012			2011
	Comprehensive Income Components	Income Before Taxes Impact (In Millions)									Location
	Unrealized holding gains (losses) on available-for-sale investments
		$	8		$	(8	)	$	(7	)	Interest and other, net
		138			195			306			Gains (losses) on equity investments, net
		146			187			299
	Unrealized holding gains (losses) on derivatives
	Currency forwards	(61		)	11			118			Cost of sales
		30			(63		)	20			Research and development
		—			(25		)	19			Marketing, general and administrative
	Other instruments	1			(1		)	4			Cost of sales
		(30		)	(78		)	161
	Amortization of pension and postretirement benefit components
	Prior service credits (costs)	(4		)	(5		)	(7		)
	Actuarial gains (losses)	(101		)	(90		)	(43		)
		(105		)	(95		)	(50		)
	Total amounts reclassified out of accumulated other comprehensive income	$	11		$	14		$	410

Operating_Segments_and_Geograp1

Operating Segments and Geographic Information (Tables)	12 Months Ended
	Dec. 28, 2013
Operating Segment And Geographic Information (Tables) [Abstract]	'
Schedule of Segment Reporting Information, by Segment [Table Text Block]	'
	Net revenue and operating income (loss) for each period were as follows:
	(In Millions)	2013			2012			2011
	Net revenue:
	PC Client Group	$	33,039		$	34,504		$	35,624
	Data Center Group	11,238			10,511			9,911
	Other Intel architecture operating segments	4,092			4,378			5,005
	Software and services operating segments	2,502			2,381			1,870
	All other	1,837			1,567			1,589
	Total net revenue	$	52,708		$	53,341		$	53,999
	Operating income (loss):
	PC Client Group	$	11,827		$	13,106		$	14,840
	Data Center Group	5,164			5,020			5,053
	Other Intel architecture operating segments	(2,445		)	(1,377		)	(577		)
	Software and services operating segments	1			(11		)	(32		)
	All other	(2,256		)	(2,100		)	(1,807		)
	Total operating income	$	12,291		$	14,638		$	17,477
Schedule of Revenues from External Customers, By Country [Table Text Block]	'
	Net revenue by country for the three years ended December 28, 2013, is based on the billing location of the customer. Certain prior-period amounts have been reclassified to conform to the current year’s presentation. Revenue from unaffiliated customers for each period were as follows:
	(In Millions)	2013			2012			2011
	Singapore	$	10,997		$	12,622		$	13,626
	China (including Hong Kong)	9,890			8,299			7,133
	United States	9,091			8,348			9,005
	Taiwan	8,888			9,327			8,534
	Japan	3,725			4,303			4,538
	Other countries	10,117			10,442			11,163
	Total net revenue	$	52,708		$	53,341		$	53,999
Schedule Of Long-Lived Assets [Table Text Block]	'
	Net property, plant and equipment by country at the end of each period was as follows:
	(In Millions)	Dec 28,			Dec 29,			Dec 31,
		2013			2012			2011
	United States	$	23,624		$	20,542		$	16,448
	Ireland	2,986			1,523			1,198
	Israel	2,667			3,389			3,356
	Other countries	2,151			2,529			2,625
	Total property, plant and equipment, net	$	31,428		$	27,983		$	23,627

Accounting_Policies_Detail

Accounting Policies (Detail) (USD $)

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

Dec. 28, 2013

Dec. 29, 2012

Dec. 31, 2011

Feb. 28, 2011

Dec. 28, 2013

Feb. 28, 2011

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Feb. 28, 2011

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 28, 2013

Acquisition-related Developed Technology [Member]

Minimum [Member]

Minimum [Member]

Minimum [Member]

Minimum [Member]

Minimum [Member]

Maximum [Member]

Maximum [Member]

Maximum [Member]

Maximum [Member]

Maximum [Member]

Land And Buildings [Member]

Land And Buildings [Member]

Machinery And Equipment [Member]

Machinery And Equipment [Member]

Machinery And Equipment [Member]

Machinery And Equipment [Member]

Construction In Progress [Member]

Construction In Progress [Member]

Building [Member]

Building [Member]

Acquisition-related Developed Technology [Member]

Acquisition-related Customer Relationships [Member]

Acquisition-related Customer Relationships [Member]

Acquisition-related Trade Names [Member]

Licensed Technology and Patents [Member]

Acquisition-related Developed Technology [Member]

Acquisition-related Customer Relationships [Member]

Acquisition-related Customer Relationships [Member]

Acquisition-related Trade Names [Member]

Licensed Technology and Patents [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

Inventory Net Items Net Of Reserve Alternative [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Raw materials

$458,000,000

$478,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Work in process

1,998,000,000

2,219,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Finished goods

1,716,000,000

2,037,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Total Inventories

4,172,000,000

4,734,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Property, Plant and Equipment [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Property, plant and equipment, gross

73,416,000,000

66,046,000,000

'

'

'

'

'

'

'

'

'

'

'

'

21,098,000,000

18,807,000,000

40,540,000,000

39,033,000,000

'

'

11,778,000,000

8,206,000,000

'

'

Less: accumulated depreciation

-41,988,000,000

-38,063,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Total property, plant and equipment, net

31,428,000,000

27,983,000,000

23,627,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Property, Plant and Equipment, Useful Life (in years)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'2 years

'4 years

'

'

'10 years

'25 years

Identified Intangible Assets [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Finite-Lived Intangible Assets, Useful Life (in years)

'

'

'

'4 years

'4 years

'2 years

'5 years

'4 years

'5 years

'9 years

'7 years

'8 years

'8 years

'17 years

'

'

'

'

'

'

'

'

'

'

Advertising [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Advertising Expense

$1,900,000,000

$2,000,000,000

$2,100,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Fair_Value_Detail

Fair Value (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 28, 2013	Dec. 29, 2012	Dec. 31, 2011
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Loans Receivable, Fair Value Disclosure	$805	$780	'
Non-Marketable Cost Method Investments	1,270	1,202	'
Loans receivable	1,072	979	'
Reverse repurchase agreements	800	2,850	'
NVIDIA cross-license agreement [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Notes Payable	587	'	'
Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Assets, Fair Value Disclosure, Recurring	28,125	23,525	'
Liabilities, Fair Value Disclosure	422	312	'
Fair Value, Measurements, Nonrecurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Fair Value, Non-Marketable Equity Investments, Gains (Losses)	-106	-68	-62
Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Reverse Repurchase Agreements, Fair Value Disclosure	400	2,800	'
Other Current Assets [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Derivative Assets, Fair Value Disclosure	357	221	'
Loans Receivable, Fair Value Disclosure	103	203	'
Other Long-Term Assets [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Derivative Assets, Fair Value Disclosure	36	38	'
Loans Receivable, Fair Value Disclosure	702	577	'
Other Accrued Liabilities [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Derivative Financial Instruments, Liabilities, Fair Value Disclosure	372	292	'
Other Long-Term Liabilities [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Derivative Financial Instruments, Liabilities, Fair Value Disclosure	50	20	'
Carrying Amount [Member] | Not Recorded At Fair Value On Recurring Basis [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Non-Marketable Cost Method Investments	1,270	1,202	'
Loans receivable	267	199	'
Reverse repurchase agreements	400	50	'
Grants Receivable	416	198	'
Long-term debt	13,165	13,136	'
Short-term Debt	24	48	'
Carrying Amount [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | NVIDIA cross-license agreement [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Notes Payable	587	875	'
Fair Value [Member] | Not Recorded At Fair Value On Recurring Basis [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Non-Marketable Cost Method Investments, Fair Value Disclosure	2,105	1,766	'
Loans receivable	267	198	'
Reverse repurchase agreements	400	50	'
Grants Receivable, Fair Value Disclosure	481	205	'
Long-term debt	13,538	14,368	'
Short-term Debt, Fair Value	24	48	'
Fair Value [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | NVIDIA cross-license agreement [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Notes Payable, Fair Value Disclosure	597	890	'
Bank Deposits [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Trading Securities, Fair Value Disclosure	92	247	'
Bank Deposits [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	1,017	822	'
Bank Deposits [Member] | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	1,782	540	'
Bank Deposits [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	157	56	'
Commercial Paper [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Trading Securities, Fair Value Disclosure	240	336	'
Commercial Paper [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	2,341	2,711	'
Commercial Paper [Member] | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	2,123	1,474	'
Corporate Bonds [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Trading Securities, Fair Value Disclosure	3,398	1,591	'
Corporate Bonds [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	21	0	'
Corporate Bonds [Member] | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	1,523	388	'
Corporate Bonds [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	827	254	'
Government Bonds [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Trading Securities, Fair Value Disclosure	3,885	3,222	'
Government Bonds [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	0	466	'
Government Bonds [Member] | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	544	1,597	'
Government Bonds [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	480	172	'
Money Market Fund Deposits [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Trading Securities, Fair Value Disclosure	82	18	'
Money Market Fund Deposits [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	1,041	1,086	'
Municipal Bonds [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Trading Securities, Fair Value Disclosure	56	203	'
Marketable Equity Securities [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	6,221	4,424	'
Asset-Backed Securities [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Trading Securities, Fair Value Disclosure	688	68	'
Asset-Backed Securities [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	9	11	'
Level 1 [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Assets, Fair Value Disclosure, Recurring	13,512	9,616	'
Liabilities, Fair Value Disclosure	0	1	'
Level 1 [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Reverse Repurchase Agreements, Fair Value Disclosure	0	0	'
Level 1 [Member] | Other Current Assets [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Derivative Assets, Fair Value Disclosure	48	12	'
Loans Receivable, Fair Value Disclosure	0	0	'
Level 1 [Member] | Other Long-Term Assets [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Derivative Assets, Fair Value Disclosure	0	0	'
Loans Receivable, Fair Value Disclosure	0	0	'
Level 1 [Member] | Other Accrued Liabilities [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Derivative Financial Instruments, Liabilities, Fair Value Disclosure	0	1	'
Level 1 [Member] | Other Long-Term Liabilities [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Derivative Financial Instruments, Liabilities, Fair Value Disclosure	0	0	'
Level 1 [Member] | Fair Value [Member] | Not Recorded At Fair Value On Recurring Basis [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Non-Marketable Cost Method Investments, Fair Value Disclosure	0	0	'
Loans receivable	0	0	'
Reverse repurchase agreements	0	0	'
Grants Receivable, Fair Value Disclosure	0	0	'
Long-term debt	10,937	11,442	'
Short-term Debt, Fair Value	0	0	'
Level 1 [Member] | Fair Value [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | NVIDIA cross-license agreement [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Notes Payable, Fair Value Disclosure	0	0	'
Level 1 [Member] | Bank Deposits [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Trading Securities, Fair Value Disclosure	0	0	'
Level 1 [Member] | Bank Deposits [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	0	0	'
Level 1 [Member] | Bank Deposits [Member] | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	0	0	'
Level 1 [Member] | Bank Deposits [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	0	0	'
Level 1 [Member] | Commercial Paper [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Trading Securities, Fair Value Disclosure	0	0	'
Level 1 [Member] | Commercial Paper [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	0	0	'
Level 1 [Member] | Commercial Paper [Member] | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	0	0	'
Level 1 [Member] | Corporate Bonds [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Trading Securities, Fair Value Disclosure	2,625	482	'
Level 1 [Member] | Corporate Bonds [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	0	0	'
Level 1 [Member] | Corporate Bonds [Member] | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	383	75	'
Level 1 [Member] | Corporate Bonds [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	282	10	'
Level 1 [Member] | Government Bonds [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Trading Securities, Fair Value Disclosure	2,267	1,743	'
Level 1 [Member] | Government Bonds [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	0	400	'
Level 1 [Member] | Government Bonds [Member] | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	268	1,307	'
Level 1 [Member] | Government Bonds [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	295	59	'
Level 1 [Member] | Money Market Fund Deposits [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Trading Securities, Fair Value Disclosure	82	18	'
Level 1 [Member] | Money Market Fund Deposits [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	1,041	1,086	'
Level 1 [Member] | Municipal Bonds [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Trading Securities, Fair Value Disclosure	0	0	'
Level 1 [Member] | Marketable Equity Securities [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	6,221	4,424	'
Level 1 [Member] | Asset-Backed Securities [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Trading Securities, Fair Value Disclosure	0	0	'
Level 1 [Member] | Asset-Backed Securities [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	0	0	'
Level 2 [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Assets, Fair Value Disclosure, Recurring	14,525	13,764	'
Liabilities, Fair Value Disclosure	422	311	'
Level 2 [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Reverse Repurchase Agreements, Fair Value Disclosure	400	2,800	'
Level 2 [Member] | Other Current Assets [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Derivative Assets, Fair Value Disclosure	309	208	'
Loans Receivable, Fair Value Disclosure	103	203	'
Level 2 [Member] | Other Long-Term Assets [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Derivative Assets, Fair Value Disclosure	7	20	'
Loans Receivable, Fair Value Disclosure	702	577	'
Level 2 [Member] | Other Accrued Liabilities [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Derivative Financial Instruments, Liabilities, Fair Value Disclosure	372	291	'
Level 2 [Member] | Other Long-Term Liabilities [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Derivative Financial Instruments, Liabilities, Fair Value Disclosure	50	20	'
Level 2 [Member] | Fair Value [Member] | Not Recorded At Fair Value On Recurring Basis [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Non-Marketable Cost Method Investments, Fair Value Disclosure	0	0	'
Loans receivable	250	150	'
Reverse repurchase agreements	400	50	'
Grants Receivable, Fair Value Disclosure	481	205	'
Long-term debt	2,601	2,926	'
Short-term Debt, Fair Value	24	48	'
Level 2 [Member] | Fair Value [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | NVIDIA cross-license agreement [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Notes Payable, Fair Value Disclosure	597	890	'
Level 2 [Member] | Bank Deposits [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Trading Securities, Fair Value Disclosure	92	247	'
Level 2 [Member] | Bank Deposits [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	1,017	822	'
Level 2 [Member] | Bank Deposits [Member] | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	1,782	540	'
Level 2 [Member] | Bank Deposits [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	157	56	'
Level 2 [Member] | Commercial Paper [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Trading Securities, Fair Value Disclosure	240	336	'
Level 2 [Member] | Commercial Paper [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	2,341	2,711	'
Level 2 [Member] | Commercial Paper [Member] | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	2,123	1,474	'
Level 2 [Member] | Corporate Bonds [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Trading Securities, Fair Value Disclosure	773	1,109	'
Level 2 [Member] | Corporate Bonds [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	21	0	'
Level 2 [Member] | Corporate Bonds [Member] | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	1,121	292	'
Level 2 [Member] | Corporate Bonds [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	518	218	'
Level 2 [Member] | Government Bonds [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Trading Securities, Fair Value Disclosure	1,618	1,479	'
Level 2 [Member] | Government Bonds [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	0	66	'
Level 2 [Member] | Government Bonds [Member] | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	276	290	'
Level 2 [Member] | Government Bonds [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	185	113	'
Level 2 [Member] | Money Market Fund Deposits [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Trading Securities, Fair Value Disclosure	0	0	'
Level 2 [Member] | Money Market Fund Deposits [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	0	0	'
Level 2 [Member] | Municipal Bonds [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Trading Securities, Fair Value Disclosure	56	203	'
Level 2 [Member] | Marketable Equity Securities [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	0	0	'
Level 2 [Member] | Asset-Backed Securities [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Trading Securities, Fair Value Disclosure	684	0	'
Level 2 [Member] | Asset-Backed Securities [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	0	0	'
Level 3 [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Assets, Fair Value Disclosure, Recurring	88	145	'
Liabilities, Fair Value Disclosure	0	0	'
Level 3 [Member] | Fair Value, Measurements, Nonrecurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Non-Marketable Equity Investments	47	73	69
Level 3 [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Reverse Repurchase Agreements, Fair Value Disclosure	0	0	'
Level 3 [Member] | Other Current Assets [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Derivative Assets, Fair Value Disclosure	0	1	'
Loans Receivable, Fair Value Disclosure	0	0	'
Level 3 [Member] | Other Long-Term Assets [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Derivative Assets, Fair Value Disclosure	29	18	'
Loans Receivable, Fair Value Disclosure	0	0	'
Level 3 [Member] | Other Accrued Liabilities [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Derivative Financial Instruments, Liabilities, Fair Value Disclosure	0	0	'
Level 3 [Member] | Other Long-Term Liabilities [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Derivative Financial Instruments, Liabilities, Fair Value Disclosure	0	0	'
Level 3 [Member] | Fair Value [Member] | Not Recorded At Fair Value On Recurring Basis [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Non-Marketable Cost Method Investments, Fair Value Disclosure	2,105	1,766	'
Loans receivable	17	48	'
Reverse repurchase agreements	0	0	'
Grants Receivable, Fair Value Disclosure	0	0	'
Long-term debt	0	0	'
Short-term Debt, Fair Value	0	0	'
Level 3 [Member] | Fair Value [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | NVIDIA cross-license agreement [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Notes Payable, Fair Value Disclosure	0	0	'
Level 3 [Member] | Bank Deposits [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Trading Securities, Fair Value Disclosure	0	0	'
Level 3 [Member] | Bank Deposits [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	0	0	'
Level 3 [Member] | Bank Deposits [Member] | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	0	0	'
Level 3 [Member] | Bank Deposits [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	0	0	'
Level 3 [Member] | Commercial Paper [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Trading Securities, Fair Value Disclosure	0	0	'
Level 3 [Member] | Commercial Paper [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	0	0	'
Level 3 [Member] | Commercial Paper [Member] | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	0	0	'
Level 3 [Member] | Corporate Bonds [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Trading Securities, Fair Value Disclosure	0	0	'
Level 3 [Member] | Corporate Bonds [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	0	0	'
Level 3 [Member] | Corporate Bonds [Member] | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	19	21	'
Level 3 [Member] | Corporate Bonds [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	27	26	'
Level 3 [Member] | Government Bonds [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Trading Securities, Fair Value Disclosure	0	0	'
Level 3 [Member] | Government Bonds [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	0	0	'
Level 3 [Member] | Government Bonds [Member] | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	0	0	'
Level 3 [Member] | Government Bonds [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	0	0	'
Level 3 [Member] | Money Market Fund Deposits [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Trading Securities, Fair Value Disclosure	0	0	'
Level 3 [Member] | Money Market Fund Deposits [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	0	0	'
Level 3 [Member] | Municipal Bonds [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Trading Securities, Fair Value Disclosure	0	0	'
Level 3 [Member] | Marketable Equity Securities [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	0	0	'
Level 3 [Member] | Asset-Backed Securities [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Trading Securities, Fair Value Disclosure	4	68	'
Level 3 [Member] | Asset-Backed Securities [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Investments, Fair Value Disclosure	$9	$11	'

Cash_and_Investment_Detail

Cash and Investment (Detail) (USD $)	Dec. 28, 2013	Dec. 29, 2012
In Millions, unless otherwise specified
Cash and Invesments [Abstract]	'	'
Available-for-sale investments	$18,086	$14,001
Cash	854	593
Equity method investments	1,038	992
Loans receivable	1,072	979
Non-marketable cost method investments	1,270	1,202
Reverse repurchase agreements	800	2,850
Trading assets	8,441	5,685
Total cash and investments	$31,561	$26,302

Cash_and_Investments_Combined_

Cash and Investments, Combined Investment Classification (Detail) (Interest In Clearwire, LLC And Shares In Clearwire Corporation [Member], USD $)	3 Months Ended
In Millions, unless otherwise specified	Sep. 28, 2013
Interest In Clearwire, LLC And Shares In Clearwire Corporation [Member]	'
Combined Investment [Line Items]	'
Proceeds from Sale, Maturity and Collection of Investments	$470
Gain (Loss) On Sale Of Combined Investment	$439

Cash_and_Investments_Available1

Cash and Investments, Available For Sale Investments Detail (Detail) (USD $)

12 Months Ended

3 Months Ended

12 Months Ended

Dec. 28, 2013

Dec. 29, 2012

Dec. 31, 2011

Dec. 28, 2013

Sep. 29, 2012

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 29, 2012

Clearwire Corporation [Member]

Asml Holding Nv [Member]

Asset-Backed Securities [Member]

Asset-Backed Securities [Member]

Bank Deposits [Member]

Bank Deposits [Member]

Commercial Paper [Member]

Commercial Paper [Member]

Corporate Bonds [Member]

Corporate Bonds [Member]

Government Bonds [Member]

Government Bonds [Member]

Marketable Equity Securities [Member]

Marketable Equity Securities [Member]

Money Market Fund Deposits [Member]

Money Market Fund Deposits [Member]

Schedule of Available-for-sale Securities [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Adjusted Cost

'

'

'

'

'

$11,000,000

$14,000,000

$2,951,000,000

$1,417,000,000

$4,464,000,000

$4,184,000,000

$2,359,000,000

$635,000,000

$1,024,000,000

$2,235,000,000

'

'

$1,042,000,000

$1,086,000,000

Gross Unrealized Gains

2,902,000,000

1,079,000,000

'

'

'

0

0

6,000,000

1,000,000

0

1,000,000

15,000,000

8,000,000

0

0

2,881,000,000

1,069,000,000

0

0

Gross Unrealized Losses

-7,000,000

-5,000,000

'

'

'

-2,000,000

-3,000,000

-1,000,000

0

0

0

-3,000,000

-1,000,000

0

0

0

-1,000,000

-1,000,000

0

Fair Value

11,865,000,000

'

'

'

'

9,000,000

11,000,000

2,956,000,000

1,418,000,000

4,464,000,000

4,185,000,000

2,371,000,000

642,000,000

1,024,000,000

2,235,000,000

'

'

1,041,000,000

1,086,000,000

Adjusted Cost

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3,340,000,000

3,356,000,000

'

'

Fair Value

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

6,221,000,000

4,424,000,000

'

'

Adjusted Cost, Total

15,191,000,000

12,927,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Fair Value, Total

18,086,000,000

14,001,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Payments to Acquire Available-for-sale Securities, Equity

'

'

'

'

3,200,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Available-for-sale Securities, Gross Realized Gains (Losses), Sale Proceeds

934,000,000

2,300,000,000

9,100,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Sale, Maturity and Collection of Investments

'

'

'

142,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Available-for-sale Securities, Gross Realized Gains

146,000,000

166,000,000

268,000,000

111,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net, Available-for-sale Securities

14,000,000

36,000,000

73,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Due in 1 year or less, Cost

9,170,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Due in 1-2 years, Cost

979,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Due in 2-5 years, Cost

421,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Instruments not due at a single maturity date, Cost

1,281,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Cost, Total

11,851,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Due in 1 year or less, Fair Value

9,188,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Due in 1-2 years, Fair Value

978,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Due in 2-5 years, Fair Value

421,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Instruments not due at a single maturity date, Fair Value

$1,278,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Cash_and_Investments_Equity_Me1

Cash and Investments, Equity Method and Cost Method Investments Detail (Detail) (USD $)

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

In Millions, unless otherwise specified

Dec. 28, 2013

Dec. 29, 2012

Dec. 31, 2011

Dec. 28, 2013

Dec. 29, 2012

Dec. 31, 2011

Apr. 02, 2011

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 29, 2012

Dec. 31, 2011

Jun. 30, 2012

Dec. 28, 2013

Dec. 29, 2012

Dec. 31, 2011

Sep. 28, 2013

Dec. 31, 2011

IM Flash Technologies, LLC [Member]

IM Flash Technologies, LLC [Member]

IM Flash Technologies, LLC [Member]

Intel Ge Care Innovations Llc [Member]

Intel Ge Care Innovations Llc [Member]

Intel Ge Care Innovations Llc [Member]

Clearwire Communications Llc [Member]

Clearwire Communications Llc [Member]

Other Equity Method Investments [Member]

Other Equity Method Investments [Member]

IM Flash Technologies, LLC and IM Flash Singapore, LLP [Member]

IM Flash Technologies, LLC and IM Flash Singapore, LLP [Member]

IM Flash Technologies, LLC and IM Flash Singapore, LLP [Member]

IM Flash Technologies, LLC and IM Flash Singapore, LLP [Member]

IM Flash Technologies, LLC and IM Flash Singapore, LLP [Member]

Clearwire, LLC [Member]

Clearwire, LLC [Member]

Micron Technology, Inc. [Member]

Micron Technology, Inc. [Member]

Micron Technology, Inc. [Member]

Micron Technology, Inc. [Member]

Schedule of Equity Method Investments [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Equity Method Investments

$1,038

$992

'

$646

$642

'

'

$117

$146

$0

$0

$275

$204

'

'

'

'

'

'

'

Equity Method Investment, Ownership Percentage

'

'

'

49.00%

49.00%

'

'

50.00%

50.00%

0.00%

6.00%

'

'

'

'

'

'

'

'

'

Proceeds From Sale Of Certain Assets Of Joint Ventures To Counterparty

'

'

'

'

'

'

'

'

'

'

'

'

'

'

605

0

605

0

'

'

Amount Provided To Counterparty As Part Of Modification Of Our Joint Venture Relationship

'

'

'

'

'

'

'

'

'

'

'

'

'

'

365

'

'

'

'

'

Related Party Transaction, Purchases from Related Party

'

'

'

380

705

'

'

'

'

'

'

'

'

985

'

'

'

'

'

'

Due to Related Parties

'

'

'

75

90

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Equity Method Investment, Dividends or Distributions, Return of Capital

45

137

263

45

137

263

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Percentage Of Purchase Commitment Of Production Output And Production Related Services

'

'

'

49.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal

0

0

164

'

'

'

164

'

'

'

'

'

'

'

'

'

'

'

'

'

Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount

'

'

'

646

'

'

'

117

'

'

'

'

'

'

'

'

'

'

'

'

Income (Loss) from Equity Method Investments

-69

-81

-204

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-145

Proceeds from (Payments for) Other Financing Activities

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

328

'

Equity Method Investment, Realized Gain (Loss) on Disposal

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

328

'

Non-marketable cost method investments

$1,270

$1,202

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Cash_and_Investments_NonMarket

Cash and Investments, Non-Marketable Cost Method Investments (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 28, 2013	Dec. 29, 2012	Dec. 31, 2011
Schedule of Cost-method Investments [Line Items]	'	'	'
Non-marketable cost method investments	$1,270	$1,202	'
Cost-method Investments [Member]	'	'	'
Schedule of Cost-method Investments [Line Items]	'	'	'
Other than Temporary Impairment Losses, Investments	$103	$104	$56

Cash_and_Investments_Trading_A

Cash and Investments, Trading Assets (Detail) (Debt Securities [Member], USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 28, 2013	Dec. 29, 2012	Dec. 31, 2011
Debt Securities [Member]	'	'	'
Schedule Of Trading Securities And Other Trading Assets [Line Items]	'	'	'
Trading Securities, Change in Unrealized Holding Gain (Loss)	($70)	$16	($71)
Net gains (losses) on derivatives related to trading securities	$86	$11	$58

Derivative_Financial_Instrumen2

Derivative Financial Instruments (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 28, 2013	Dec. 29, 2012	Dec. 31, 2011
Derivative [Line Items]	'	'	'
Deferred Compensation Liability, Current and Noncurrent	$1,100	$859	'
Gross Notional Amounts [Abstract]	'	'	'
Derivative, Notional Amount	23,739	21,463	19,233
Schedule of Derivative Instruments in Cash Flow Hedging Relationships [Abstract]	'	'	'
Gains (Losses) Recognized in OCI on Derivatives (Effective Portion)	-166	13	20
Not Designated as Hedging Instrument [Member]	'	'	'
Schedule of Derivative Instruments Not Designated as Hedging Instruments [Abstract]	'	'	'
Gains (Losses) Recognized in Income on Derivatives	219	35	-61
Currency Forwards [Member]	'	'	'
Gross Notional Amounts [Abstract]	'	'	'
Derivative, Notional Amount	13,404	13,117	11,203
Schedule of Derivative Instruments in Cash Flow Hedging Relationships [Abstract]	'	'	'
Gains (Losses) Recognized in OCI on Derivatives (Effective Portion)	-167	4	20
Currency Interest Rate Swaps [Member]	'	'	'
Gross Notional Amounts [Abstract]	'	'	'
Derivative, Notional Amount	4,377	2,711	1,650
Embedded Debt Derivatives [Member]	'	'	'
Gross Notional Amounts [Abstract]	'	'	'
Derivative, Notional Amount	3,600	3,600	3,600
Interest Rate Swaps [Member]	'	'	'
Gross Notional Amounts [Abstract]	'	'	'
Derivative, Notional Amount	1,377	1,101	1,837
Total Return Swaps [Member]	'	'	'
Gross Notional Amounts [Abstract]	'	'	'
Derivative, Notional Amount	914	807	761
Other Derivative Instruments [Member]	'	'	'
Gross Notional Amounts [Abstract]	'	'	'
Derivative, Notional Amount	67	127	182
Schedule of Derivative Instruments in Cash Flow Hedging Relationships [Abstract]	'	'	'
Gains (Losses) Recognized in OCI on Derivatives (Effective Portion)	1	9	0
British Pound Sterling [Member]	'	'	'
Gross Notional Amounts [Abstract]	'	'	'
Derivative, Notional Amount	549	308	459
Chinese Yuan [Member]	'	'	'
Gross Notional Amounts [Abstract]	'	'	'
Derivative, Notional Amount	1,116	647	688
Euro [Member]	'	'	'
Gross Notional Amounts [Abstract]	'	'	'
Derivative, Notional Amount	6,874	5,994	3,904
Israeli Shekel [Member]	'	'	'
Gross Notional Amounts [Abstract]	'	'	'
Derivative, Notional Amount	2,244	2,256	2,168
Japanese Yen [Member]	'	'	'
Gross Notional Amounts [Abstract]	'	'	'
Derivative, Notional Amount	4,116	4,389	3,477
Malaysian Ringgit [Member]	'	'	'
Gross Notional Amounts [Abstract]	'	'	'
Derivative, Notional Amount	506	442	805
Swiss Franc [Member]	'	'	'
Gross Notional Amounts [Abstract]	'	'	'
Derivative, Notional Amount	1,189	657	209
Other Currencies [Member]	'	'	'
Gross Notional Amounts [Abstract]	'	'	'
Derivative, Notional Amount	1,187	1,135	1,143
Total Currency Exchange Rate Derivatives [Member]	'	'	'
Gross Notional Amounts [Abstract]	'	'	'
Derivative, Notional Amount	17,781	15,828	12,853
Other Current Assets [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Asset, Fair Value, Gross Asset	357	221	'
Other Current Assets [Member] | Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Asset, Fair Value, Gross Asset	114	91	'
Other Current Assets [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Asset, Fair Value, Gross Asset	243	130	'
Other Current Assets [Member] | Currency Forwards [Member] | Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Asset, Fair Value, Gross Asset	114	91	'
Other Current Assets [Member] | Currency Forwards [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Asset, Fair Value, Gross Asset	66	85	'
Other Current Assets [Member] | Currency Interest Rate Swaps [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Asset, Fair Value, Gross Asset	124	33	'
Other Current Assets [Member] | Embedded Debt Derivatives [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Asset, Fair Value, Gross Asset	0	0	'
Other Current Assets [Member] | Interest Rate Swaps [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Asset, Fair Value, Gross Asset	5	0	'
Other Current Assets [Member] | Total Return Swaps [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Asset, Fair Value, Gross Asset	48	11	'
Other Current Assets [Member] | Other Derivative Instruments [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Asset, Fair Value, Gross Asset	0	1	'
Other Long-Term Assets [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Asset, Fair Value, Gross Asset	36	38	'
Other Long-Term Assets [Member] | Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Asset, Fair Value, Gross Asset	1	2	'
Other Long-Term Assets [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Asset, Fair Value, Gross Asset	35	36	'
Other Long-Term Assets [Member] | Currency Forwards [Member] | Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Asset, Fair Value, Gross Asset	1	2	'
Other Long-Term Assets [Member] | Currency Forwards [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Asset, Fair Value, Gross Asset	0	0	'
Other Long-Term Assets [Member] | Currency Interest Rate Swaps [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Asset, Fair Value, Gross Asset	6	18	'
Other Long-Term Assets [Member] | Embedded Debt Derivatives [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Asset, Fair Value, Gross Asset	0	0	'
Other Long-Term Assets [Member] | Interest Rate Swaps [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Asset, Fair Value, Gross Asset	0	0	'
Other Long-Term Assets [Member] | Total Return Swaps [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Asset, Fair Value, Gross Asset	0	0	'
Other Long-Term Assets [Member] | Other Derivative Instruments [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Asset, Fair Value, Gross Asset	29	18	'
Other Accrued Liabilities [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Liability, Fair Value, Gross Liability	372	292	'
Other Accrued Liabilities [Member] | Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Liability, Fair Value, Gross Liability	118	127	'
Other Accrued Liabilities [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Liability, Fair Value, Gross Liability	254	165	'
Other Accrued Liabilities [Member] | Currency Forwards [Member] | Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Liability, Fair Value, Gross Liability	118	127	'
Other Accrued Liabilities [Member] | Currency Forwards [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Liability, Fair Value, Gross Liability	63	58	'
Other Accrued Liabilities [Member] | Currency Interest Rate Swaps [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Liability, Fair Value, Gross Liability	163	72	'
Other Accrued Liabilities [Member] | Embedded Debt Derivatives [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Liability, Fair Value, Gross Liability	0	0	'
Other Accrued Liabilities [Member] | Interest Rate Swaps [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Liability, Fair Value, Gross Liability	28	34	'
Other Accrued Liabilities [Member] | Total Return Swaps [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Liability, Fair Value, Gross Liability	0	0	'
Other Accrued Liabilities [Member] | Other Derivative Instruments [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Liability, Fair Value, Gross Liability	0	1	'
Other Long-Term Liabilities [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Liability, Fair Value, Gross Liability	50	20	'
Other Long-Term Liabilities [Member] | Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Liability, Fair Value, Gross Liability	2	0	'
Other Long-Term Liabilities [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Liability, Fair Value, Gross Liability	48	20	'
Other Long-Term Liabilities [Member] | Currency Forwards [Member] | Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Liability, Fair Value, Gross Liability	2	0	'
Other Long-Term Liabilities [Member] | Currency Forwards [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Liability, Fair Value, Gross Liability	0	0	'
Other Long-Term Liabilities [Member] | Currency Interest Rate Swaps [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Liability, Fair Value, Gross Liability	29	14	'
Other Long-Term Liabilities [Member] | Embedded Debt Derivatives [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Liability, Fair Value, Gross Liability	19	6	'
Other Long-Term Liabilities [Member] | Interest Rate Swaps [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Liability, Fair Value, Gross Liability	0	0	'
Other Long-Term Liabilities [Member] | Total Return Swaps [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Liability, Fair Value, Gross Liability	0	0	'
Other Long-Term Liabilities [Member] | Other Derivative Instruments [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]	'	'	'
Derivative Liability, Fair Value, Gross Liability	0	0	'
Interest and Other, Net [Member] | Currency Forwards [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Schedule of Derivative Instruments Not Designated as Hedging Instruments [Abstract]	'	'	'
Gains (Losses) Recognized in Income on Derivatives	44	3	58
Interest and Other, Net [Member] | Currency Interest Rate Swaps [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Schedule of Derivative Instruments Not Designated as Hedging Instruments [Abstract]	'	'	'
Gains (Losses) Recognized in Income on Derivatives	29	-71	-17
Interest and Other, Net [Member] | Interest Rate Swaps [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Schedule of Derivative Instruments Not Designated as Hedging Instruments [Abstract]	'	'	'
Gains (Losses) Recognized in Income on Derivatives	0	31	-26
Interest and Other, Net [Member] | Other Derivative Instruments [Member]	'	'	'
Schedule of Derivative Instruments Not Designated as Hedging Instruments [Abstract]	'	'	'
Gains (Losses) Recognized in Income on Derivatives	0	3	0
Gains (Losses) On Equity Investments, Net [Member] | Equity Options [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Schedule of Derivative Instruments Not Designated as Hedging Instruments [Abstract]	'	'	'
Gains (Losses) Recognized in Income on Derivatives	1	-1	-67
Gains (Losses) On Equity Investments, Net [Member] | Other Derivative Instruments [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Schedule of Derivative Instruments Not Designated as Hedging Instruments [Abstract]	'	'	'
Gains (Losses) Recognized in Income on Derivatives	5	-7	4
Various [Member] | Total Return Swaps [Member] | Not Designated as Hedging Instrument [Member]	'	'	'
Schedule of Derivative Instruments Not Designated as Hedging Instruments [Abstract]	'	'	'
Gains (Losses) Recognized in Income on Derivatives	$140	$77	($13)

Concentrations_of_Credit_Risk_

Concentrations of Credit Risk (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 28, 2013	Dec. 29, 2012	Dec. 31, 2011
Total Credit Exposure To Any Single Counterparty, Excluding Japan Government Bonds [Member]	'	'	'
Concentration Risk [Line Items]	'	'	'
Concentration Risk, Credit Risk, Maximum Exposure End of Period	750	'	'
Customer Concentration Risk [Member]	'	'	'
Concentration Risk [Line Items]	'	'	'
Concentration Risk, Percentage	44.00%	43.00%	43.00%
Accounts Receivable Customer Concentration Risk [Member]	'	'	'
Concentration Risk [Line Items]	'	'	'
Concentration Risk, Percentage	34.00%	33.00%	'

Acquisitions_Detail

Acquisitions (Detail) (USD $)

1 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

12 Months Ended

Feb. 28, 2011

Dec. 28, 2013

Dec. 29, 2012

Dec. 31, 2011

Sep. 28, 2013

Dec. 31, 2011

Feb. 28, 2011

Dec. 31, 2011

Dec. 31, 2011

Feb. 28, 2011

Feb. 28, 2011

Feb. 28, 2011

Dec. 28, 2013

Dec. 31, 2011

Dec. 28, 2013

Dec. 31, 2011

Dec. 31, 2011

Feb. 28, 2011

Feb. 28, 2011

Dec. 28, 2013

Dec. 31, 2011

Feb. 28, 2011

Dec. 28, 2013

Dec. 31, 2011

Dec. 31, 2011

Feb. 28, 2011

Dec. 31, 2011

Dec. 31, 2011

Dec. 31, 2011

Dec. 31, 2011

Feb. 28, 2011

Series of Individually Immaterial Business Acquisitions [Member]

Series of Individually Immaterial Business Acquisitions [Member]

Series of Individually Immaterial Business Acquisitions [Member]

Stonesoft Oyj [Member]

Infineon's Wireless Solutions Business [Member]

McAfee, Inc. [Member]

McAfee, Inc. and Series of Individually Immaterial Business Acquisitions [Member]

In-Process Research And Development [Member]

In-Process Research And Development [Member]

Trade Names [Member]

Acquisition-related Developed Technology [Member]

Acquisition-related Developed Technology [Member]

Acquisition-related Developed Technology [Member]

Acquisition-related Developed Technology [Member]

Acquisition-related Developed Technology [Member]

Acquisition-related Developed Technology [Member]

Acquisition-related Developed Technology [Member]

Customer Relationships [Member]

Customer Relationships [Member]

Customer Relationships [Member]

Customer Relationships [Member]

Customer Relationships [Member]

Customer Relationships [Member]

Customer Relationships [Member]

Customer Relationships [Member]

Other Intangible Assets [Member]

Other Intangible Assets [Member]

Other Intangible Assets [Member]

Total Finite Lived Intangible Assets [Member]

Total Finite Lived Intangible Assets [Member]

Series of Individually Immaterial Business Acquisitions [Member]

McAfee, Inc. [Member]

McAfee, Inc. [Member]

Minimum [Member]

Minimum [Member]

Maximum [Member]

Maximum [Member]

Series of Individually Immaterial Business Acquisitions [Member]

McAfee, Inc. [Member]

Minimum [Member]

Minimum [Member]

Minimum [Member]

Maximum [Member]

Maximum [Member]

Maximum [Member]

Series of Individually Immaterial Business Acquisitions [Member]

McAfee, Inc. [Member]

Minimum [Member]

Maximum [Member]

Series of Individually Immaterial Business Acquisitions [Member]

Series of Individually Immaterial Business Acquisitions [Member]

McAfee, Inc. [Member]

Acquisitions [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Business Acquisition, Effective Date of Acquisition

28-Feb-11

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Cash Acquired From Acquisition

'

'

'

'

'

'

$943,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Cash

'

'

'

'

'

1,400,000,000

6,652,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based awards assumed

'

'

'

'

'

'

48,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Total Consideration

'

925,000,000

638,000,000

2,132,000,000

381,000,000

'

6,700,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Marketable debt securities

'

'

'

'

'

'

329,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Goodwill

'

'

'

517,000,000

'

'

4,299,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Identified intangible assets

'

'

'

1,409,000,000

'

'

3,552,000,000

'

119,000,000

92,000,000

821,000,000

'

'

'

'

'

1,102,000,000

1,221,000,000

'

'

'

'

'

'

144,000,000

1,418,000,000

'

'

44,000,000

1,290,000,000

2,639,000,000

Deferred tax assets

'

'

'

'

'

'

738,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Other assets

'

'

'

'

'

'

417,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Deferred income

'

'

'

'

'

'

-1,049,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Deferred tax liabilities

'

'

'

'

'

'

-1,191,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Other liabilities

'

'

'

'

'

'

-395,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Total fair value of the assets acquired and liabilities assumed

'

'

'

2,132,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Estimated useful life (in years)

'

'

'

'

'

'

'

'

'

'

'

'4 years

'4 years

'

'9 years

'

'

'

'2 years

'5 years

'

'7 years

'8 years

'

'

'

'

'

'

'

'

Fair value of net tangible assets acquired

'

'

'

206,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Estimated useful life (in years)

'

'

'

'

'

'

'

'

'

'

'

'

'

'3 years

'

'9 years

'

'

'

'

'5 years

'

'

'8 years

'

'

'2 years

'7 years

'

'

'

Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual

'

'

'

'

'

'

'

3,600,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual

'

'

'

'

'

'

'

275,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net revenue

'

'

'

'

'

'

'

54,738,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net income

'

'

'

'

'

'

'

$13,028,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Diluted earnings per share

'

'

'

'

'

'

'

$2.41

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Divestitures_Detail

Divestitures (Detail) (USD $)	12 Months Ended			3 Months Ended
In Millions, unless otherwise specified	Dec. 28, 2013	Dec. 29, 2012	Dec. 31, 2011	Apr. 02, 2011
				Intel-GE Care Innovations, LLC [Member]
Schedule of Equity Method Investments [Line Items]	'	'	'	'
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal	$0	$0	$164	$164

Goodwill_Detail

Goodwill (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 28, 2013	Dec. 29, 2012
Goodwill [Roll Forward]	'	'
Goodwill, Beginning Balance	$9,710	$9,254
Goodwill, Impairments	'	-6
Goodwill, Transfers	0	'
Goodwill, Effect of exchange rate fluctuations	52	10
Goodwill, Ending Balance	10,513	9,710
Goodwill, Impaired, Accumulated Impairment Loss	719	'
Series of Individually Immaterial Business Acquisitions [Member]	'	'
Goodwill [Roll Forward]	'	'
Goodwill, Additions due to acquisitions	751	452
PC Client Group [Member]	'	'
Goodwill [Roll Forward]	'	'
Goodwill, Beginning Balance	2,962	2,918
Goodwill, Impairments	'	0
Goodwill, Transfers	34	'
Goodwill, Effect of exchange rate fluctuations	0	0
Goodwill, Ending Balance	3,058	2,962
Goodwill, Impaired, Accumulated Impairment Loss	346	'
PC Client Group [Member] | Series of Individually Immaterial Business Acquisitions [Member]	'	'
Goodwill [Roll Forward]	'	'
Goodwill, Additions due to acquisitions	62	44
Data Center Group [Member]	'	'
Goodwill [Roll Forward]	'	'
Goodwill, Beginning Balance	1,839	1,553
Goodwill, Impairments	'	0
Goodwill, Transfers	-22	'
Goodwill, Effect of exchange rate fluctuations	0	0
Goodwill, Ending Balance	1,831	1,839
Goodwill, Impaired, Accumulated Impairment Loss	275	'
Data Center Group [Member] | Series of Individually Immaterial Business Acquisitions [Member]	'	'
Goodwill [Roll Forward]	'	'
Goodwill, Additions due to acquisitions	14	286
Other Intel Architecture Operating Segments [Member]	'	'
Goodwill [Roll Forward]	'	'
Goodwill, Beginning Balance	916	844
Goodwill, Impairments	'	-6
Goodwill, Transfers	-12	'
Goodwill, Effect of exchange rate fluctuations	0	0
Goodwill, Ending Balance	1,075	916
Goodwill, Impaired, Accumulated Impairment Loss	98	'
Other Intel Architecture Operating Segments [Member] | Series of Individually Immaterial Business Acquisitions [Member]	'	'
Goodwill [Roll Forward]	'	'
Goodwill, Additions due to acquisitions	171	78
Software and Services Operating Segments [Member]	'	'
Goodwill [Roll Forward]	'	'
Goodwill, Beginning Balance	3,993	3,939
Goodwill, Impairments	'	0
Goodwill, Transfers	0	'
Goodwill, Effect of exchange rate fluctuations	52	10
Goodwill, Ending Balance	4,549	3,993
Software and Services Operating Segments [Member] | Series of Individually Immaterial Business Acquisitions [Member]	'	'
Goodwill [Roll Forward]	'	'
Goodwill, Additions due to acquisitions	$504	$44

Identified_Intangible_Assets_F

Identified Intangible Assets, Finite-Lived Intangible Assets (Detail) (USD $)

12 Months Ended

1 Months Ended

3 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

3 Months Ended

Dec. 28, 2013

Dec. 29, 2012

Dec. 31, 2011

Jan. 31, 2011

Dec. 25, 2010

Dec. 28, 2013

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 29, 2012

Dec. 31, 2011

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 29, 2012

Dec. 31, 2011

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 29, 2012

Dec. 31, 2011

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 29, 2012

Dec. 31, 2011

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 29, 2012

Dec. 31, 2011

Dec. 29, 2012

Dec. 29, 2012

Dec. 31, 2011

Apr. 02, 2011

NVIDIA cross-license agreement [Member]

NVIDIA cross-license agreement [Member]

NVIDIA cross-license agreement [Member]

Finite-Lived Intangible Assets [Member]

Finite-Lived Intangible Assets [Member]

Acquisition-related Developed Technology [Member]

Acquisition-related Developed Technology [Member]

Acquisition-related Developed Technology [Member]

Acquisition-related Developed Technology [Member]

Acquisition-related Developed Technology [Member]

Acquisition-related Customer Relationships [Member]

Acquisition-related Customer Relationships [Member]

Acquisition-related Customer Relationships [Member]

Acquisition-related Customer Relationships [Member]

Acquisition-related Customer Relationships [Member]

Acquisition-related Trade Names [Member]

Acquisition-related Trade Names [Member]

Acquisition-related Trade Names [Member]

Acquisition-related Trade Names [Member]

Acquisition-related Trade Names [Member]

Licensed Technology and Patents [Member]

Licensed Technology and Patents [Member]

Licensed Technology and Patents [Member]

Licensed Technology and Patents [Member]

Licensed Technology and Patents [Member]

Other Intangible Assets [Member]

Other Intangible Assets [Member]

Other Intangible Assets [Member]

Other Intangible Assets [Member]

Patents [Member]

Licensing Technology [Member]

Licensing Technology [Member]

Finite-Lived Intangible Assets [Member]

Finite-Lived Intangible Assets [Member]

Finite-Lived Intangible Assets [Member]

Finite-Lived Intangible Assets [Member]

Finite-Lived Intangible Assets [Member]

Finite-Lived Intangible Assets [Member]

Finite-Lived Intangible Assets [Member]

Finite-Lived Intangible Assets [Member]

Finite-Lived Intangible Assets [Member]

Interdigital, Inc. [Member]

NVIDIA cross-license agreement [Member]

NVIDIA cross-license agreement [Member]

Identified Intangible Assets By Major Class [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Gross Assets, Finite-lived Intangible Assets

'

'

'

'

'

'

$7,840,000,000

$7,782,000,000

'

'

'

$2,922,000,000

$2,778,000,000

'

'

'

$1,760,000,000

$1,712,000,000

'

'

'

$65,000,000

$68,000,000

'

'

'

$3,093,000,000

$2,986,000,000

'

'

'

$238,000,000

'

'

'

Accumulated Amortization

'

'

'

'

'

'

-3,537,000,000

-2,485,000,000

'

'

'

-1,691,000,000

-1,116,000,000

'

'

'

-828,000,000

-551,000,000

'

'

'

-44,000,000

-33,000,000

'

'

'

-974,000,000

-699,000,000

'

'

'

-86,000,000

'

'

'

Net

'

'

'

'

'

'

4,303,000,000

5,297,000,000

'

'

'

1,231,000,000

1,662,000,000

'

'

'

932,000,000

1,161,000,000

'

'

'

21,000,000

35,000,000

'

'

'

2,119,000,000

2,287,000,000

'

'

'

152,000,000

'

'

'

Loss Contingency, Cross License Payment Amount Total, 2011-2016

'

'

'

1,500,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Loss Contingency, Cross License Annual Payment Amount, 2011-2013

'

'

'

300,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Loss Contingency, Cross License Annual Payment Amount, 2014-2016

'

'

'

200,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Loss Contingency, Cross License Liability

'

'

'

1,400,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Loss Contingency, Cross License Expense

'

'

'

'

100,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Loss Contingency, Acquired Identified Intangible Asset, Amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,300,000,000

Loss Contingency, Acquired Identified Intangible Asset, Weighted Average Useful Life (in years)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'17 years

'

Loss Contingency, Notes Payable

'

'

'

'

'

587,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Identified Intangible Assets, Acquired During Period [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Identified Intangible Assets Acquired During Period

'

'

'

'

'

'

'

'

'

'

'

114,000,000

168,000,000

'

'

'

60,000,000

238,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

375,000,000

'

'

Acquired Finite-lived Intangible Asset, Weighted Average Useful Life (in years)

'

'

'

'

'

'

'

'

'

'

'

'5 years

'10 years

'

'

'

'7 years

'

'

'

'

'

'

'

'

'

'10 years

'9 years

'

'

'

'

'10 years

'

'

Finite Lived Intangible Assets Purchased

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

36,000,000

815,000,000

'

'

'

'

'

'

'

Identified Intangible Assets, Amortization Expenses [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Amortization of acquisition-related intangibles

'

'

'

'

'

'

'

'

576,000,000

557,000,000

482,000,000

'

'

279,000,000

296,000,000

250,000,000

'

'

12,000,000

12,000,000

10,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Amortization of intangibles

1,242,000,000

1,165,000,000

923,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

272,000,000

214,000,000

181,000,000

'

'

103,000,000

86,000,000

0

'

'

'

'

Identified Intangible Assets, Future Amortization Expenses [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Future Amortization Expense, 2014

1,127,000,000

'

'

'

'

'

'

'

579,000,000

'

'

'

'

268,000,000

'

'

'

'

10,000,000

'

'

'

'

270,000,000

'

'

'

'

'

'

'

'

'

'

'

Future Amortization Expense, 2015

815,000,000

'

'

'

'

'

'

'

303,000,000

'

'

'

'

251,000,000

'

'

'

'

9,000,000

'

'

'

'

252,000,000

'

'

'

'

'

'

'

'

'

'

'

Future Amortization Expense, 2016

685,000,000

'

'

'

'

'

'

'

211,000,000

'

'

'

'

233,000,000

'

'

'

'

3,000,000

'

'

'

'

238,000,000

'

'

'

'

'

'

'

'

'

'

'

Future Amortization Expense, 2017

404,000,000

'

'

'

'

'

'

'

63,000,000

'

'

'

'

142,000,000

'

'

'

'

0

'

'

'

'

199,000,000

'

'

'

'

'

'

'

'

'

'

'

Future Amortization Expense, 2018

$228,000,000

'

'

'

'

'

'

'

$41,000,000

'

'

'

'

$29,000,000

'

'

'

'

$0

'

'

'

'

$158,000,000

'

'

'

'

'

'

'

'

'

'

'

Identified_Intangible_Assets_I

Identified Intangible Assets, Indefinite-Lived Intangible Assets (Detail) (Indefinite-lived Intangible Assets [Member], USD $)	Dec. 28, 2013	Dec. 29, 2012
In Millions, unless otherwise specified
Acquisition-related Trade Names [Member]	'	'
Indefinite-lived Intangible Assets [Line Items]	'	'
Gross assets, Indefinite-Lived Intangible Assets	$818	$809
Other Intangible Assets [Member]	'	'
Indefinite-lived Intangible Assets [Line Items]	'	'
Gross assets, Indefinite-Lived Intangible Assets	$29	$129

Identified_Intangible_Assets_T1

Identified Intangible Assets, Total Intangible Assets (Detail) (USD $)	Dec. 28, 2013	Dec. 29, 2012
In Millions, unless otherwise specified
Identified Intangible Assets [Line Items]	'	'
Gross Assets	$8,687	$8,720
Identified intangible assets, net	5,150	6,235
Indefinite-lived Intangible Assets [Member]	'	'
Identified Intangible Assets [Line Items]	'	'
Gross Assets	$847	$938

Other_LongTerm_Assets_Detail

Other Long-Term Assets (Detail) (USD $)	Dec. 28, 2013	Dec. 29, 2012
In Millions, unless otherwise specified
Other Long-Term Assets Detail [Abstract]	'	'
Equity method investments	$1,038	$992
Non-marketable cost method investments	1,270	1,202
Non-current deferred tax assets	434	358
Loans receivable	952	644
Other	1,795	952
Total other long-term assets	$5,489	$4,148

Restructuring_And_Asset_Impair1

Restructuring And Asset Impairment Charges (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 28, 2013	Dec. 29, 2012	Dec. 31, 2011
	Employee
Restructuring Cost and Reserve [Line Items]	'	'	'
Restructuring and asset impairment charges	$240	$0	$0
Number Of Employees Related To Severance And Benefit Arrangements	3,900	'	'
Restructuring Reserve [Roll Forward]	'	'	'
Restructuring Reserve, Beginning Balance	0	'	'
Restructuring Reserve, Additional accruals	234	'	'
Restructuring Reserve, Adjustments	6	'	'
Restructuring Reserve, Cash payments	-18	'	'
Restructuring Reserve, Non-cash settlements	-39	'	'
Restructuring Reserve, Ending Balance	183	0	'
Employee Severance And Benefits [Member]	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'
Restructuring and asset impairment charges	201	0	0
Restructuring Reserve [Roll Forward]	'	'	'
Restructuring Reserve, Beginning Balance	0	'	'
Restructuring Reserve, Additional accruals	195	'	'
Restructuring Reserve, Adjustments	6	'	'
Restructuring Reserve, Cash payments	-18	'	'
Restructuring Reserve, Non-cash settlements	0	'	'
Restructuring Reserve, Ending Balance	183	0	'
Asset Impairments [Member]	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'
Restructuring and asset impairment charges	39	0	0
Restructuring Reserve [Roll Forward]	'	'	'
Restructuring Reserve, Beginning Balance	0	'	'
Restructuring Reserve, Additional accruals	39	'	'
Restructuring Reserve, Adjustments	0	'	'
Restructuring Reserve, Cash payments	0	'	'
Restructuring Reserve, Non-cash settlements	-39	'	'
Restructuring Reserve, Ending Balance	$0	$0	'

Deferred_Income_Detail

Deferred Income (Detail) (USD $)	Dec. 28, 2013	Dec. 29, 2012
In Millions, unless otherwise specified
Deferred Income Detail [Abstract]	'	'
Deferred income on shipments of components to distributors	$852	$694
Deferred income from software and services operating segments	1,244	1,238
Current deferred income	2,096	1,932
Non-current deferred income from software and services operating segments	506	473
Total deferred income	$2,602	$2,405

Chipset_Design_Issue_Detail

Chipset Design Issue (Detail) (Chipset Design Issue [Member], USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2011
Chipset Design Issue [Member]	'
Loss Contingencies [Line Items]	'
Loss Contingency, Inventory Write-Down Charge to Cost of Sales	$422

Borrowings_Detail

Borrowings (Detail) (USD $)

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 29, 2012

Jul. 27, 2009

Dec. 28, 2013

Dec. 29, 2012

Dec. 16, 2005

Dec. 29, 2012

Sep. 19, 2011

Dec. 28, 2013

Dec. 06, 2007

2012 Senior notes due 2017 at 1.35% [Member]

2012 Senior notes due 2017 at 1.35% [Member]

2012 Senior notes due 2022 at 2.70% [Member]

2012 Senior notes due 2022 at 2.70% [Member]

2012 Senior notes due 2032 at 4.00% [Member]

2012 Senior notes due 2032 at 4.00% [Member]

2012 Senior notes due 2042 at 4.25% [Member]

2012 Senior notes due 2042 at 4.25% [Member]

2011 Senior Notes Due October 1, 2016 At 1.95% [Member]

2011 Senior Notes Due October 1, 2016 At 1.95% [Member]

2011 Senior Notes Due October 1, 2021 At 3.30% [Member]

2011 Senior Notes Due October 1, 2021 At 3.30% [Member]

2011 Senior Notes Due October 1, 2041 At 4.80% [Member]

2011 Senior Notes Due October 1, 2041 At 4.80% [Member]

2009 Junior Subordinated Convertible Debentures Due 2039 At 3.25% [Member]

2009 Junior Subordinated Convertible Debentures Due 2039 At 3.25% [Member]

2009 Junior Subordinated Convertible Debentures Due 2039 At 3.25% [Member]

2005 Junior Subordinated Convertible Debentures Due 2035 At 2.95% [Member]

2005 Junior Subordinated Convertible Debentures Due 2035 At 2.95% [Member]

2005 Junior Subordinated Convertible Debentures Due 2035 At 2.95% [Member]

2012 Senior Notes [Member]

2011 Senior Notes [Member]

2007 Arizona Bonds Due 2037 At 5.3% [Member]

2007 Arizona Bonds Due 2037 At 5.3% [Member]

Debt Instrument [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Face Amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$2,000,000,000

'

'

$1,600,000,000

$6,200,000,000

$5,000,000,000

'

$125,000,000

Outstanding principal

14,775,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,000,000,000

2,000,000,000

'

1,600,000,000

1,600,000,000

'

'

'

'

'

Debt Instrument, Maturity Date

'

'

15-Dec-17

'

15-Dec-22

'

15-Dec-32

'

15-Dec-42

'

1-Oct-16

'

1-Oct-21

'

1-Oct-41

'

1-Aug-39

'

'

15-Dec-35

'

'

'

'

'

'

Net debt carrying amount

'

'

2,997,000,000

2,997,000,000

1,494,000,000

1,494,000,000

744,000,000

743,000,000

924,000,000

924,000,000

1,499,000,000

1,498,000,000

1,996,000,000

1,996,000,000

1,490,000,000

1,489,000,000

1,075,000,000

1,063,000,000

'

946,000,000

932,000,000

'

'

'

'

'

Annual coupon interest rate

'

'

1.35%

'

2.70%

'

4.00%

'

4.25%

'

1.95%

'

3.30%

'

4.80%

'

3.25%

'

'

2.95%

'

'

'

'

5.30%

'

Principal Amount Per Debenture Used In Conversion Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,000

'

'

1,000

'

'

'

'

'

'

Conversion rate (shares of common stock per $1,000 principal amount of debentures)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

45.57

45.05

'

34.6

33.86

'

'

'

'

'

Effective conversion price (per share of common stock)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$21.94

$22.20

'

$28.90

$29.53

'

'

'

'

'

Conversion Rate Adjustments, Quarterly Dividend Distributions Excess Per Share

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.14

'

'

$0.10

'

'

'

'

'

'

Annual effective interest rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

7.20%

'

'

6.45%

'

'

'

'

'

'

Maximum Amount Of Contingent Interest That Will Accrue Per Year (percent)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.50%

'

'

0.40%

'

'

'

'

'

'

Embedded Derivative, Fair Value of Embedded Derivative Liability

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

10,000,000

6,000,000

'

9,000,000

0

'

'

'

'

'

Company Stock As Percentage Of Conversion Price, Surrender For Conversion

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

130.00%

'

'

'

'

'

'

'

'

'

Company Stock As Percentage Of Conversion Price, Redemption Of Principal

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

150.00%

'

'

130.00%

'

'

'

'

'

'

Trading Days During 30 Day Period In Which Company Stock Has Been At Least 130% Of Conversion Price, Surrender for Conversion

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'20 days

'

'

'

'

'

'

'

'

'

Trading Day Period Ending On Last Day Of Preceeding Fiscal Quarter, Surrender for Conversion

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'30 days

'

'

'

'

'

'

'

'

'

Trading Days During 30 Day Period In Which Company Stock Has Been At Least 130% Of Conversion Price, Redemption Of Principal

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'20 days

'

'

'

'

'

'

'

'

'

Trading Days During 30 Day Period In Which Company Stock Has Been At Least 150% Of Conversion Price, Redemption Of Principal

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'20 days

'

'

'

'

'

'

Trading Day Period Prior To Notice of Redemption Date, Redemption Of Principal

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'30 days

'

'

'30 days

'

'

'

'

'

'

Equity component carrying amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

613,000,000

613,000,000

'

466,000,000

466,000,000

'

'

'

'

'

Unamortized discount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

910,000,000

922,000,000

'

643,000,000

656,000,000

'

'

'

'

'

Debt Instrument, Convertible, Remaining Discount Amortization Period (in years)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'26 years

'

'

'22 years

'

'

'

'

'

'

Total long-term debt

13,165,000,000

13,136,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Year Payable, 2014

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Year Payable, 2015

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Year Payable, 2016

1,500,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Year Payable, 2017

3,000,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Year Payable, 2018

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Year Payable, 2019 and thereafter

10,275,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Bank Overdrafts

257,000,000

264,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Short-term Bank Loans and Notes Payable

24,000,000

48,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Board Of Directors Maximum Borrowing Capacity Authorization

3,000,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Maximum Borrowings, Commercial Paper Program

$300,000,000

$500,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Retirement_Benefit_Plans_Detai

Retirement Benefit Plans (Detail) (USD $)

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

3 Months Ended

In Millions, unless otherwise specified

Dec. 28, 2013

Dec. 29, 2012

Dec. 31, 2011

Dec. 28, 2013

Dec. 29, 2012

Dec. 31, 2011

Dec. 27, 2014

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 29, 2012

Dec. 31, 2011

Dec. 27, 2014

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 29, 2012

Dec. 31, 2011

Dec. 27, 2014

Dec. 28, 2013

Mar. 29, 2014

U.S. Pension Benefits [Member]

U.S. Pension Benefits [Member]

U.S. Pension Benefits [Member]

U.S. Pension Benefits [Member]

U.S. Pension Benefits [Member]

U.S. Pension Benefits [Member]

U.S. Pension Benefits [Member]

U.S. Pension Benefits [Member]

U.S. Pension Benefits [Member]

U.S. Pension Benefits [Member]

U.S. Pension Benefits [Member]

U.S. Pension Benefits [Member]

U.S. Pension Benefits [Member]

U.S. Pension Benefits [Member]

U.S. Pension Benefits [Member]

U.S. Pension Benefits [Member]

U.S. Pension Benefits [Member]

U.S. Pension Benefits [Member]

U.S. Pension Benefits [Member]

U.S. Pension Benefits [Member]

U.S. Pension Benefits [Member]

U.S. Pension Benefits [Member]

U.S. Pension Benefits [Member]

U.S. Pension Benefits [Member]

U.S. Pension Benefits [Member]

U.S. Pension Benefits [Member]

Non-U.S. Pension Benefits [Member]

Non-U.S. Pension Benefits [Member]

Non-U.S. Pension Benefits [Member]

Non-U.S. Pension Benefits [Member]

Non-U.S. Pension Benefits [Member]

Non-U.S. Pension Benefits [Member]

Non-U.S. Pension Benefits [Member]

Non-U.S. Pension Benefits [Member]

Non-U.S. Pension Benefits [Member]

Non-U.S. Pension Benefits [Member]

Non-U.S. Pension Benefits [Member]

Non-U.S. Pension Benefits [Member]

Non-U.S. Pension Benefits [Member]

Non-U.S. Pension Benefits [Member]

Non-U.S. Pension Benefits [Member]

Non-U.S. Pension Benefits [Member]

Non-U.S. Pension Benefits [Member]

Non-U.S. Pension Benefits [Member]

Non-U.S. Pension Benefits [Member]

Non-U.S. Pension Benefits [Member]

Non-U.S. Pension Benefits [Member]

Non-U.S. Pension Benefits [Member]

Non-U.S. Pension Benefits [Member]

U.S. Postretirement Medical Benefits [Member]

U.S. Postretirement Medical Benefits [Member]

U.S. Postretirement Medical Benefits [Member]

U.S. Postretirement Medical Benefits [Member]

U.S. Intel Retirement Contribution Plan [Member]

Qualified U.S. Retirement Contribution Plans [Member]

Scenario, Forecast [Member]

Equity Securities [Member]

Equity Securities [Member]

Fixed Income Securities [Member]

Fixed Income Securities [Member]

Other Investments [Member]

Other Investments [Member]

Total assets measured at fair value [Member]

Total assets measured at fair value [Member]

Cash [Member]

Cash [Member]

Level 1 [Member]

Level 1 [Member]

Level 1 [Member]

Level 1 [Member]

Level 2 [Member]

Level 2 [Member]

Level 2 [Member]

Level 2 [Member]

Level 3 [Member]

Level 3 [Member]

Level 3 [Member]

Level 3 [Member]

Scenario, Forecast [Member]

Equity Securities [Member]

Equity Securities [Member]

Fixed Income Securities [Member]

Fixed Income Securities [Member]

Total assets measured at fair value [Member]

Total assets measured at fair value [Member]

Cash [Member]

Cash [Member]

Plan Assets That We Have Control Over - Equity Securities [Member]

Plan Assets That We Have Control Over - Fixed Income Instruments [Member]

Level 1 [Member]

Level 1 [Member]

Level 1 [Member]

Level 2 [Member]

Level 2 [Member]

Level 2 [Member]

Level 3 [Member]

Level 3 [Member]

Level 3 [Member]

Scenario, Forecast [Member]

Subsequent Event [Member]

Equity Securities [Member]

Fixed Income Securities [Member]

Other Investments [Member]

Equity Securities [Member]

Fixed Income Securities [Member]

Other Investments [Member]

Equity Securities [Member]

Fixed Income Securities [Member]

Other Investments [Member]

Equity Securities [Member]

Fixed Income Securities [Member]

Equity Securities [Member]

Fixed Income Securities [Member]

Equity Securities [Member]

Fixed Income Securities [Member]

Retirement Contribution Plans, Textual Detail [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Retirement Contribution Plan, Equity Securities (percent)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

83.00%

'

Retirement Contribution Plan, Fixed-Income Instruments (percent)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

17.00%

'

Defined Contribution Plan, Cost Recognized

$298

$357

$340

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Defined Contribution Plan, Employer Discretionary Contribution Amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

288

Projected Benefit Obligation and Plan Assets [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Projected benefit obligation

'

'

'

1,137

1,742

1,480

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,695

1,412

1,121

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

509

484

369

'

'

'

Service cost

'

'

'

119

98

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

78

64

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

27

30

'

'

'

'

Interest cost

'

'

'

67

69

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

60

52

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

20

17

'

'

'

'

Actuarial (gain) loss

'

'

'

-746

108

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

121

172

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-56

75

'

'

'

'

Defined Benefit Plan, Other Changes In Obligation

'

'

'

-45

-13

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

24

3

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

34

-7

'

'

'

'

Fair value of plan assets

'

'

'

649

684

648

'

220

92

415

582

11

0

646

674

3

10

114

15

88

11

460

205

255

0

72

0

72

0

1,005

838

722

'

361

248

554

574

915

822

90

16

'

'

287

287

0

584

63

521

44

11

33

395

191

116

'

'

'

Actual return on plan assets

'

'

'

10

49

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

81

70

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

49

0

'

'

'

'

Employer Contributions

'

'

'

0

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

65

52

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

162

82

'

'

'

'

Defined Benefit Plan, Other Change In Plan Assets

'

'

'

-45

-13

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

21

-6

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-7

-7

'

'

'

'

Defined Benefit Plan, Target Plan Asset Allocations (percent)

'

'

'

'

'

'

'

40.00%

'

60.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

80.00%

20.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Defined Benefit Plan, Percentage Of Plan Assets Invested In Qualified Insurance Companies

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

38.00%

40.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Defined Benefit Plan, Amounts Recognized in Balance Sheet [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Other long-term assets

'

'

'

0

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

16

1

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

0

'

'

'

'

Other long-term liabilities

'

'

'

-488

-1,058

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-706

-575

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-114

-293

'

'

'

'

Accumulated other comprehensive loss (income), before tax

'

'

'

255

1,050

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

520

477

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

43

138

'

'

'

'

Net amount recognized

'

'

'

-233

-8

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-170

-97

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-71

-155

'

'

'

'

Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net prior service credit (cost)

'

'

'

0

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

25

12

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-54

-60

'

'

'

'

Net actuarial gain (loss)

'

'

'

-255

-1,050

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-545

-489

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

11

-78

'

'

'

'

Accumulated Benefit Obligations [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Defined Benefit Plan, Accumulated Benefit Obligation

'

'

'

497

562

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,300

1,100

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Defined Benefit Plan, Plans with Benefit Obligations in Excess of Plan Assets [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Plans with accumulated benefit obligations in excess of plan assets: Accumulated benefit obligations

'

'

'

0

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

900

813

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Plans with accumulated benefit obligations in excess of plan assets: Plan assets

'

'

'

0

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

563

508

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Plans with projected benefit obligations in excess of plan assets: Projected benefit obligations

'

'

'

1,137

1,742

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,295

1,400

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Plans with projected benefit obligations in excess of plan assets: Plan assets

'

'

'

649

684

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

588

825

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Discount rate

'

'

'

4.80%

3.90%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4.00%

4.20%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4.60%

3.60%

'

'

'

'

Rate of compensation increase

'

'

'

3.80%

4.10%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3.90%

4.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Discount rate

'

'

'

3.90%

4.70%

5.80%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4.20%

5.00%

5.30%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4.20%

4.60%

5.60%

'

'

'

Expected long-term rate of return on plan assets

'

'

'

4.50%

5.00%

5.50%

5.20%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5.20%

5.90%

6.30%

5.70%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

7.70%

3.00%

3.00%

7.40%

'

'

Rate of compensation increase

'

'

'

4.10%

4.50%

4.70%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4.30%

4.10%

4.30%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Defined Benefit Plan, Net Periodic Benefit Cost [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net periodic benefit cost

'

'

'

230

210

88

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

116

88

80

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

77

50

39

'

'

'

Defined Benefit Plan, Estimated Future Employer Contributions [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Defined Benefit Plan, Estimated Future Employer Contributions in Next Fiscal Year

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

62

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Defined Benefit Plan, Expected Future Benefit Payments, Fiscal Year Maturity [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Estimated Benefit Payments, 2014

'

'

'

42

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

33

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

23

'

'

'

'

'

Estimated Benefit Payments, 2015

'

'

'

51

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

32

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

22

'

'

'

'

'

Estimated Benefit Payments, 2016

'

'

'

63

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

32

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

24

'

'

'

'

'

Estimated Benefit Payments, 2017

'

'

'

71

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

36

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

22

'

'

'

'

'

Estimated Benefit Payments, 2018

'

'

'

88

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

38

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

21

'

'

'

'

'

Estimated Benefit Payments, 2019-2023

'

'

'

$691

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$219

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$99

'

'

'

'

'

Defined Benefit Plan, Funded Status Percentage [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Defined Benefit Plan, Funded Status Of Plan (percent)

61.00%

'

'

57.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Defined Benefit Plan, Component Of Worldwide Pension And Postretirement Benefit Obligation (percent)

'

'

'

34.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Commitments_Detail

Commitments (Detail) (USD $)	12 Months Ended
	Dec. 28, 2013	Dec. 29, 2012	Dec. 31, 2011
Operating Leases, Rent Expense, Net [Abstract]	'	'	'
Operating Leases, Rent Expense	$270,000,000	$214,000,000	$178,000,000
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]	'	'	'
Minimum rental commitments payable, 2014	208,000,000	'	'
Minimum rental commitments payable, 2015	172,000,000	'	'
Minimum rental commitments payable, 2016	126,000,000	'	'
Minimum rental commitments payable, 2017	97,000,000	'	'
Minimum rental commitments payable, 2018	69,000,000	'	'
Minimum rental commitments payable, 2019 and thereafter	198,000,000	'	'
Minimum rental commitments with an initial term in excess of one year, Total payable	870,000,000	'	'
Capital Addition Purchase Commitments [Member]	'	'	'
Unrecorded Unconditional Purchase Obligation [Abstract]	'	'	'
Unrecorded Unconditional Purchase Obligation	5,500,000,000	4,600,000,000	'
Other Purchase Obligations And Commitments [Member]	'	'	'
Unrecorded Unconditional Purchase Obligation [Abstract]	'	'	'
Unrecorded Unconditional Purchase Obligation	$1,900,000,000	$2,000,000,000	'

Commitments_Long_Term_Purchase

Commitments, Long Term Purchase Obligation (Detail) (Asml Holding Nv [Member], Research and Development Arrangement [Member])	3 Months Ended
In Millions, unless otherwise specified	Sep. 29, 2012	Dec. 28, 2013	Dec. 28, 2013
	EUR (€)	USD ($)	EUR (€)
Long-term Purchase Commitment [Line Items]	'	'	'
Long-term Purchase Commitment, Amount	€ 829	'	'
Purchase Commitment, Remaining Minimum Amount Committed	'	$1,000	€ 738

Employee_Equity_Incentive_Plan2

Employee Equity Incentive Plans (Detail) (USD $)

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

1 Months Ended

1 Months Ended

12 Months Ended

In Millions, except Per Share data, unless otherwise specified

Dec. 28, 2013

Dec. 29, 2012

Dec. 31, 2011

Dec. 27, 2013

Dec. 25, 2010

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 29, 2012

Dec. 31, 2011

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 29, 2012

Dec. 31, 2011

Dec. 25, 2010

Dec. 28, 2013

Dec. 29, 2012

Dec. 31, 2011

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 29, 2012

Dec. 31, 2011

31-May-13

Dec. 28, 2013

31-May-11

Dec. 28, 2013

Dec. 29, 2012

Dec. 31, 2011

$1.12-$15.00 [Member]

$15.01-$20.00 [Member]

$20.01-$25.00 [Member]

$25.01-$30.00 [Member]

$30.01-$33.03 [Member]

Share-based Compensation [Member]

Share-based Compensation [Member]

Share-based Compensation [Member]

Minimum [Member]

Maximum [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock Units (RSUs) [Member]

Stock Option Awards [Member]

Stock Option Awards [Member]

Stock Option Awards [Member]

Market Based Restricted Stock Units [Member]

Market Based Restricted Stock Units [Member]

Market Based Restricted Stock Units [Member]

Restricted Stock or Stock Units, 2006 Plan [Member]

Restricted Stock or Stock Units, 2006 Plan [Member]

Restricted Stock or Stock Units, 2006 Plan [Member]

Restricted Stock or Stock Units, 2006 Plan [Member]

2006 Equity Incentive Plan [Member]

2006 Equity Incentive Plan [Member]

Stock Purchase Plan [Member]

Stock Purchase Plan [Member]

Stock Purchase Plan [Member]

Stock Purchase Plan [Member]

Minimum [Member]

Maximum [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock Units (RSUs) [Member]

Employee Equity Incentive Plans, (Textual) (Details) [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

123

'

133

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

517

'

'

'

'

719

'

373

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

304

'

216

'

'

Vesting range (percent)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

50.00%

200.00%

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

85.00%

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

20.5

17.4

18.5

Share-based Compensation

$1,118

$1,102

$1,053

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Other Inventory, Capitalized Costs

'

'

'

'

'

'

'

'

'

'

38

41

38

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Employee Service Share-based Compensation, Tax Benefit from Compensation Expense

385

510

327

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value

186

205

226

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,600

'

'

'

75

'

'

'

'

'

'

'

'

'

'

'

'

13

'

'

Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'1 year 1 month

'

'

'

'

'

'

'

'

'

'

'

'

'1 month 15 days

'

'

Exercise price of options exercised (in dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

$1.12

$28.15

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Participation percentage in Stock Purchase Plan

76.00%

72.00%

70.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Employee Purchases, Amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

369

355

318

Restricted Stock Units, Stock Options, And Stock Purchase Plan Estimated Values And Weighted Average Assumptions [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Risk-free interest rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.20%

0.30%

0.70%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Dividend yield

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3.80%

3.30%

3.40%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Volatility (percent)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

25.00%

26.00%

27.00%

'

25.00%

25.00%

27.00%

'

'

'

'

'

'

'

'

'

'

22.00%

24.00%

26.00%

Estimated values (in dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$3.11

$4.22

$3.91

'

'

'

'

'

'

'

'

'

'

$4.52

$5.47

$4.69

Expected life (in years)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'5 years 2 months 12 days

'5 years 3 months 18 days

'5 years 4 months 18 days

'

'

'

'

'

'

'

'

'

'

'6 months

'6 months

'6 months

Risk-free interest rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.80%

1.00%

2.20%

'

'

'

'

'

'

'

'

'

'

0.10%

0.10%

0.20%

Dividend yield

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3.90%

3.30%

3.40%

'

'

'

'

'

'

'

'

'

'

4.00%

3.30%

3.60%

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of RSUs outstanding, beginning balance

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

109.3

107

99.8

'

'

'

'

3

'

'

'

'

'

'

'

'

'

'

'

'

Number of RSUs granted

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

53.4

49.9

43.3

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of RSUs assumed in acquisition

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5.8

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of RSUs vested

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-44.5

-43.2

-37.5

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of RSUs forfeited

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-4.9

-4.4

-4.4

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of RSUs outstanding, ending balance

153

'

'

'

'

'

'

'

'

'

'

'

'

'

'

113.3

109.3

107

'

'

'

'

3

'

'

'

'

'

'

'

'

'

'

'

'

Number Of RSUs expected to vest

107.3

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted-average grant date fair value of RSU balance (in dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$22.47

$22.03

$19.18

$18.56

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted-average grant date fair value of granted RSUs (in dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$21.45

$25.32

$19.86

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted-average grant date fair value of RSUs assumed in acquisition (in dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$20.80

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted-average grant date fair value of vested RSUs (in dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$20.21

$18.88

$18.60

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted-average grant date fair value of forfeited RSUs (in dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$22.06

$20.93

$19.07

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted-average grant date fair value of RSUs expected to vest (in dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$22.49

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Total Fair Value

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,000

1,200

753

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Intrinsic Value Amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

899

816

697

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of options outstanding, beginning balance

202.8

298.3

386.4

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of options granted

20.1

13.5

14.7

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of options assumed in acquisition

'

'

12

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of options exercised

-65

-85.8

-86.3

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of options cancelled and forfeited

-3

-3.9

-8.6

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of options expired

-1.9

-19.3

-19.9

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of options outstanding, ending balance

153

202.8

298.3

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted-average exercise price of stock options (in dollars per share)

$21.10

$20.20

$20.12

'

$20.45

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted-average exercise price for stock option grants during the year (in dollars per share)

$22.99

$27.01

$21.49

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted-average exercise price for stock option assumed in acquisition during the year (in dollars per share)

'

'

$15.80

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted-average exercise price for stock option exercises during the year (in dollars per share)

$18.76

$20.45

$20.06

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted-average exercise price for stock option cancellations and forfeitures during the year (in dollars per share)

$22.58

$21.17

$20.47

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted-average exercise price for stock option expirations during the year (in dollars per share)

$22.56

$22.45

$24.85

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Options exercisable

111.5

139.8

203.6

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted-average exercise price for options exercisable (in dollars per share)

$20.25

$19.76

$20.44

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value

265

517

318

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Options Vested And Expected To Vest [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of options expected to vest

39.6

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Total number of options vested and expected to vest

151.1

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted-average exercise price for expected to vest options (in dollars per share)

$23.40

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted-average exercise price for vested and expected to vest options (in dollars per share)

$21.08

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted-average remaining contractual term for vested options (in years)

'2 years 7 months 12 days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted-average remaining contractual term for expected to vest options (in years)

'5 years 5 months

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted-average remaining contractual term for vested and expected to vest options (in years)

'3 years 4 months

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Aggregate intrinsic value for vested options

617

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Aggregate intrinsic value for expected to vest options

101

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Total Aggregate intrinsic value for vested and expected to vest options

$718

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Closing price of Intel common stock

'

'

'

$25.60

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Range Of Exercise Prices And Options Outstanding [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of outstanding options

'

'

'

'

'

2.2

70.5

57.6

22.4

0.3

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted-average remaining Contractual Life (in years)

'

'

'

'

'

'3 years 8 months

'2 years 8 months

'4 years 2 months

'3 years

'1 month

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted-average remaining Contractual Life (in years), Total

'3 years 4 months

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted-average exercise price for outstanding options (in dollars per share)

'

'

'

'

'

$12.22

$18.22

$22.59

$27.09

$32.31

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of exercisable options

'

'

'

'

'

1.2

70.4

26.2

13.4

0.3

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted-average exercise price for exercisable options (in dollars per share)

'

'

'

'

'

$11.69

$18.20

$22.54

$27.02

$32.31

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit (in dollars per share)

'

'

'

'

'

$1.12

$15.01

$20.01

$25.01

$30.01

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit (in dollars per share)

'

'

'

'

'

$15

$20

$25

$30

$33.03

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common_Stock_Repurchases_Detai

Common Stock Repurchases (Detail) (USD $)	12 Months Ended
	Dec. 28, 2013	Dec. 29, 2012	Dec. 31, 2011
Common Stock Repurchase Program [Member]	'	'	'
Common Stock Repurchases (Textuals) [Abstract]	'	'	'
Total Stock Repurchase Authorization End of Current Period, Value	$45,000,000,000	'	'
Remaining Stock Repurchase Authorization End of Current Period, Value	3,200,000,000	'	'
Stock Repurchased and Retired During Period, Shares	94,100,000	191,000,000	642,300,000
Stock Repurchased and Retired During Period, Value	2,100,000,000	4,800,000,000	14,100,000,000
Accumulated Stock Repurchased During Program, Total Shares	4,400,000,000	'	'
Accumulated Stock Repurchased During Program, Total Value	91,000,000,000	'	'
Restricted Stock Unit Withholdings [Member]	'	'	'
Common Stock Repurchases (Textuals) [Abstract]	'	'	'
Stock Repurchased and Retired During Period, Shares	13,100,000	12,600,000	10,300,000
Stock Repurchased and Retired During Period, Value	$293,000,000	$345,000,000	$207,000,000

Gains_Losses_on_Equity_Investm2

Gains (Losses) on Equity Investments, Net (Detail) (USD $)	12 Months Ended						3 Months Ended
In Millions, unless otherwise specified	Dec. 28, 2013	Dec. 29, 2012	Dec. 31, 2011	Dec. 28, 2013	Dec. 29, 2012	Dec. 31, 2011	Sep. 28, 2013
				Equity Investments [Member]	Equity Investments [Member]	Equity Investments [Member]	Interest In Clearwire, LLC And Shares In Clearwire Corporation [Member]
Schedule Of Investment Type [Line Items]	'	'	'	'	'	'	'
Gain (Loss) On Sale Of Combined Investment	'	'	'	'	'	'	$439
Gains (Losses) on Equity Investments, Net Detail [Abstract]	'	'	'	'	'	'	'
Share of equity method investee losses, net	-69	-81	-204	'	'	'	'
Impairment charges	-123	-154	-132	'	'	'	'
Gains on sales, net	'	'	'	515	183	303	'
Dividends	46	0	0	'	'	'	'
Other, net	102	193	145	'	'	'	'
Total gains (losses) on equity investments, net	$471	$141	$112	'	'	'	'

Interest_and_Other_Net_Detail

Interest and Other, Net (Detail) (USD $)	12 Months Ended			3 Months Ended
In Millions, unless otherwise specified	Dec. 28, 2013	Dec. 29, 2012	Dec. 31, 2011	Apr. 02, 2011
				Intel Ge Care Innovations Llc [Member]
Interest and Other, Net Detail [Abstract]	'	'	'	'
Interest income	$104	$97	$98	'
Interest expense	-244	-90	-41	'
Other, net	-11	87	135	'
Total interest and other, net	-151	94	192	'
Interest Costs, Capitalized During Period	246	240	150	'
Schedule of Equity Method Investments [Line Items]	'	'	'	'
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal	$0	$0	$164	$164

Earnings_Per_Share_Detail

Earnings Per Share (Detail) (USD $)	12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Dec. 28, 2013	Dec. 29, 2012	Dec. 31, 2011
Earnings Per Share [Abstract]	'	'	'
Net income available to common stockholders	$9,620	$11,005	$12,942
Weighted average common shares outstanding-basic	4,970	4,996	5,256
Dilutive effect of employee equity incentive plans (shares)	68	100	101
Dilutive effect of convertible debt (shares)	59	64	54
Weighted average common shares outstanding-diluted	5,097	5,160	5,411
Basic earnings per common share (in dollars per share)	$1.94	$2.20	$2.46
Diluted earnings per common share (in dollars per share)	$1.89	$2.13	$2.39
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (shares)	55	29	90

Income_Taxes_Detail

Income Taxes (Detail) (USD $)	12 Months Ended
	Dec. 28, 2013	Dec. 29, 2012	Dec. 31, 2011
Income Before Taxes and Provision for Taxes [Abstract]	'	'	'
Income before taxes: U.S.	$9,374,000,000	$10,042,000,000	$14,659,000,000
Income before taxes: Non-U.S.	3,237,000,000	4,831,000,000	3,122,000,000
Income before taxes	12,611,000,000	14,873,000,000	17,781,000,000
Provision for taxes, Current: Federal	2,730,000,000	2,539,000,000	3,212,000,000
Provision for taxes, Current: State	68,000,000	52,000,000	104,000,000
Provision for taxes, Current: Non-U.S.	716,000,000	1,135,000,000	374,000,000
Total current provision for taxes	3,514,000,000	3,726,000,000	3,690,000,000
Provision for taxes, Deferred: Federal	-412,000,000	129,000,000	1,175,000,000
Provisions For Taxes, Deferred: Other	-111,000,000	13,000,000	-26,000,000
Total deferred provision for taxes	-523,000,000	142,000,000	1,149,000,000
Total Provision for taxes	2,991,000,000	3,868,000,000	4,839,000,000
Effective tax rate	23.70%	26.00%	27.20%
Effective Income Tax Rate, Continuing Operations, Tax Rate Reconciliation [Abstract]	'	'	'
Statutory federal income tax rate	35.00%	35.00%	35.00%
Increase (reduction) in rate resulting from: Non-U.S. income taxed at different rates	-5.80%	-7.30%	-4.40%
Increase (reduction) in rate resulting from: Research and Development tax credits	-3.50%	0.00%	-1.00%
Increase (reduction) in rate resulting from: Domestic manufacturing deduction benefit	-2.10%	-2.10%	-1.90%
Increase (reduction) in rate resulting from: Other	0.10%	0.40%	-0.50%
Taxes, Other Textual Details [Abstract]	'	'	'
Income tax holiday termination date, end of range	31-Dec-20	'	'
Income Tax Holiday, Aggregate Dollar Amount	213,000,000	252,000,000	554,000,000
Income Tax Holiday, Income Tax Benefits Per Share, Diluted	$0.04	$0.05	$0.10
Income tax benefits (deficiencies) attributable to equity-based compensation transactions allocated to stockholders' equity	3,000,000	137,000,000	-18,000,000
Income Taxes Receivable, Current	65,000,000	866,000,000	'
Accrued Income Taxes, Current	542,000,000	711,000,000	'
Long-term income taxes payable	188,000,000	177,000,000	'
Components of Deferred Tax Assets and Liabilities [Abstract]	'	'	'
Deferred tax assets, Accrued compensation and other benefits	1,047,000,000	1,125,000,000	'
Deferred tax assets, Share-based compensation	564,000,000	638,000,000	'
Deferred tax assets, Deferred income	672,000,000	637,000,000	'
Deferred tax assets, Inventory	733,000,000	506,000,000	'
Deferred tax assets, Unrealized losses on investments and derivatives	0	36,000,000	'
Deferred tax assets, State credits and net operating losses	378,000,000	297,000,000	'
Deferred tax assets, Other, net	654,000,000	654,000,000	'
Gross deferred tax assets	4,048,000,000	3,893,000,000	'
Deferred tax assets, Valuation allowance	-456,000,000	-389,000,000	'
Total deferred tax assets	3,592,000,000	3,504,000,000	'
Deferred tax liabilities, Property, plant and equipment	-2,023,000,000	-2,325,000,000	'
Deferred tax liabilities, Licenses and intangibles	-687,000,000	-778,000,000	'
Deferred tax liabilities, Convertible debt	-911,000,000	-856,000,000	'
Deferred Tax Liabilities, Unrealized Gains On Investments And Derivatives	-815,000,000	0	'
Deferred tax liabilities, Investments in non-U.S. subsidiaries	-244,000,000	-213,000,000	'
Deferred tax liabilities, Other, net	-281,000,000	-269,000,000	'
Total deferred tax liabilities	-4,961,000,000	-4,441,000,000	'
Net deferred tax assets (liabilities)	-1,369,000,000	-937,000,000	'
Current deferred tax assets	2,594,000,000	2,117,000,000	'
Non-current deferred tax assets	434,000,000	358,000,000	'
Non-current deferred tax liabilities	-4,397,000,000	-3,412,000,000	'
Valuation Allowance [Line Items]	'	'	'
Valuation Allowance, Amount	456,000,000	389,000,000	'
Deferred Tax Liability Not Recognized [Line Items]	'	'	'
Undistributed Earnings of Foreign Subsidiaries	20,000,000,000	'	'
Other Basis Differences For Certain Non-U.S. Subsidiaries	2,400,000,000	'	'
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]	'	'	'
Unrecognized tax benefits, Gross, Beginning Balance	189,000,000	212,000,000	216,000,000
Unrecognized tax benefits, Settlements and effective settlements with tax authorities and related remeasurements	-2,000,000	-81,000,000	-63,000,000
Unrecognized tax benefits, Lapse of statute of limitations	0	-5,000,000	-17,000,000
Unrecognized tax benefits, Increases in balances related to tax positions taken during prior periods	21,000,000	56,000,000	91,000,000
Unrecognized tax benefits, Decreases in balances related to tax positions taken during prior periods	-9,000,000	-6,000,000	-21,000,000
Unrecognized tax benefits, Increases in balances related to tax positions taken during current periods	8,000,000	13,000,000	6,000,000
Unrecognized tax benefits, Gross, Ending Balance	207,000,000	189,000,000	212,000,000
Tax Adjustments, Settlements, and Unusual Provisions	'	7,000,000	61,000,000
Unrecognized Tax Benefits that Would Impact Effective Tax Rate	81,000,000	66,000,000	'
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense (Benefit)	'	'	24,000,000
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued	73,000,000	66,000,000	'
Operating Loss Carryforwards [Line Items]	'	'	'
Operating Loss Carryforwards	239,000,000	'	'
Operating Loss Carryforwards, Expiration Dates	31-Dec-33	'	'
U.S. State and Non-U.S. [Member]	'	'	'
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]	'	'	'
Year Which Prior Years' Tax Returns Are Generally No Longer Subject To Tax Examination (date)	31-Dec-01	'	'
U.S. Federal [Member]	'	'	'
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]	'	'	'
Year Which Prior Years' Tax Returns Are No Longer Subject To Tax Examination (date)	31-Dec-09	'	'
Non-U.S. [Member]	'	'	'
Operating Loss Carryforwards [Line Items]	'	'	'
Operating Loss Carryforwards	647,000,000	'	'
Operating loss carryforwards that have a valuation allowance	342,000,000	'	'
State [Member]	'	'	'
Operating Loss Carryforwards [Line Items]	'	'	'
Operating Loss Carryforwards	353,000,000	'	'
State Credit Carry Forwards [Member]	'	'	'
Components of Deferred Tax Assets and Liabilities [Abstract]	'	'	'
Deferred tax assets, Valuation allowance	-364,000,000	'	'
Valuation Allowance [Line Items]	'	'	'
Valuation Allowance, Amount	364,000,000	'	'
Matters Related To Our Non-U.S. Subsidiaries [Member]	'	'	'
Components of Deferred Tax Assets and Liabilities [Abstract]	'	'	'
Deferred tax assets, Valuation allowance	'	-92,000,000	'
Valuation Allowance [Line Items]	'	'	'
Valuation Allowance, Amount	'	$92,000,000	'

Other_Comprehensive_Income_Los2

Other Comprehensive Income (Loss), Accumulated Other Comprehensive Income (Loss) (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 28, 2013	Dec. 29, 2012	Dec. 31, 2011
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'	'
Change in unrealized holding gain (loss) on investments, Before Tax	$1,963	$909	$35
Change in unrealized holding gain (loss) on investments, Tax	-687	-318	-13
Change in unrealized holding gain (loss) on investments, Net of Tax	1,276	591	22
Less: adjustment for (gain) loss on investments included in net income, Before Tax	-146	-187	-299
Less: adjustment for (gain) loss on investments included in net income, Tax	51	66	107
Less: adjustment for (gain) loss on investments included in net income, Net of Tax	-95	-121	-192
Less: adjustment for (gain) loss on deferred tax asset valuation allowance included in net income, Tax	-26	-11	-99
Less: adjustment for (gain) loss on deferred tax asset valuation allowance included in net income, Net of Tax	-26	-11	-99
Change in unrealized holding gain (loss) on derivatives, Before Tax	-166	12	20
Change in unrealized holding gain (loss) on derivatives, Tax	76	8	-16
Change in unrealized holding gain (loss) on derivatives, Net of Tax	-90	20	4
Less: adjustment for amortization of (gain) loss on derivatives, Before Tax	30	78	-161
Less: adjustment for amortization of (gain) loss on derivatives, Tax	-29	-13	38
Less: adjustment for amortization of (gain) loss on derivatives, Net of Tax	1	65	-123
Change in prior service costs, Before Tax	17	-4	0
Change in prior service costs, Tax	-2	1	0
Change in prior service costs, Net of Tax	15	-3	0
Less: adjustment for amortization of prior service costs, Before Tax	4	5	7
Less: adjustment for amortization of prior service costs, Tax	-1	-2	-3
Less: adjustment for amortization of prior service costs, Net of Tax	3	3	4
Change in actuarial valuation, Before Tax	725	-321	-900
Change in actuarial valuation, Tax	-275	91	284
Change in actuarial valuation, Net of Tax	450	-230	-616
Less: adjustment for amortization of actuarial (gain) loss, Before Tax	101	90	43
Less: adjustment for amortization of actuarial (gain) loss, Tax	-31	-32	-15
Less: adjustment for amortization of actuarial (gain) loss, Net of Tax	70	58	28
Change in net foreign currency translation adjustment, Before Tax	45	12	-155
Change in net foreign currency translation adjustment, Tax	-7	-2	13
Change in net foreign currency translation adjustment, Net of Tax	38	10	-142
Total other comprehensive income (loss), Before Tax	2,573	594	-1,410
Total other comprehensive income (loss), Tax	-931	-212	296
Other comprehensive income (loss)	1,642	382	-1,114
Other Comprehensive Income (Loss), before Reclassifications, before Tax	2,584	608	'
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	-11	-14	'
Accumulated Other Comprehensive Income (Loss), Net of Tax	1,243	-399	-781
Defined Benefit Plan, Amortization of Net Prior Service Cost (Credit)	4	'	'
Defined Benefit Plan, Amortization of Net Gains (Losses)	39	'	'
Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months	6	'	'
Unrealized holding gains (losses) on available-for-sale investments [Member]	'	'	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'	'
Total other comprehensive income (loss), Tax	-636	-252	'
Other comprehensive income (loss)	1,181	470	'
Accumulated Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment Including Other Than Temporary Impairments, Net of Tax	1,882	701	231
Other Comprehensive Income (Loss), before Reclassifications, before Tax	1,963	909	'
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	-146	-187	'
Accumulated Deferred Tax Asset Valuation Allowance [Member]	'	'	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'	'
Total other comprehensive income (loss), Tax	-26	-11	'
Other comprehensive income (loss)	-26	-11	'
Accumulated Other Comprehensive Income Loss Net Change In Deferred Tax Asset Valuation Allowance	67	93	104
Other Comprehensive Income (Loss), before Reclassifications, before Tax	0	0	'
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	0	0	'
Unrealized holding gains (losses) on derivatives [Member]	'	'	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'	'
Total other comprehensive income (loss), Tax	47	-5	'
Other comprehensive income (loss)	-89	85	'
Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax	4	93	8
Other Comprehensive Income (Loss), before Reclassifications, before Tax	-166	12	'
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	30	78	'
Prior service credits (costs) [Member]	'	'	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'	'
Total other comprehensive income (loss), Tax	-3	-1	'
Other comprehensive income (loss)	18	0	'
Accumulated Other Comprehensive Income Loss Net Prior Service Cost Net Of Tax	-14	-32	-32
Other Comprehensive Income (Loss), before Reclassifications, before Tax	17	-4	'
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	4	5	'
Actuarial gains (losses) [Member]	'	'	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'	'
Total other comprehensive income (loss), Tax	-306	59	'
Other comprehensive income (loss)	520	-172	'
Accumulated Other Comprehensive Income Loss Net Actuarial Gains Loss Net Of Tax	-602	-1,122	-950
Other Comprehensive Income (Loss), before Reclassifications, before Tax	725	-321	'
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	101	90	'
Foreign Currency translation adjustment [Member]	'	'	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'	'
Total other comprehensive income (loss), Tax	-7	-2	'
Other comprehensive income (loss)	38	10	'
Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax	-94	-132	-142
Other Comprehensive Income (Loss), before Reclassifications, before Tax	45	12	'
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	$0	$0	'

Other_Comprehensive_Income_Los3

Other Comprehensive Income (Loss), Reclassification out of Accumulated Other Comprehensive Income (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 28, 2013	Dec. 29, 2012	Dec. 31, 2011
Reclassification out of Accumulated Other Comprehensive Income [Line Items]	'	'	'
Interest and other, net	($151)	$94	$192
Gains (losses) on equity investments, net	471	141	112
Income before taxes	12,611	14,873	17,781
Cost of sales	-21,187	-20,190	-20,242
Research and development	-10,611	-10,148	-8,350
Marketing, general and administrative	-8,088	-8,057	-7,670
Other Comprehensive (Income) Loss, Amortization Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Prior Service Cost (Credit), before Tax	4	5	7
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Gain (Loss), before Tax	-101	-90	-43
Reclassification out of Accumulated Other Comprehensive Income [Member]	'	'	'
Reclassification out of Accumulated Other Comprehensive Income [Line Items]	'	'	'
Income before taxes	11	14	410
Unrealized holding gains (losses) on available-for-sale investments [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]	'	'	'
Reclassification out of Accumulated Other Comprehensive Income [Line Items]	'	'	'
Interest and other, net	8	-8	-7
Gains (losses) on equity investments, net	138	195	306
Income before taxes	146	187	299
Unrealized holding gains (losses) on derivatives [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]	'	'	'
Reclassification out of Accumulated Other Comprehensive Income [Line Items]	'	'	'
Income before taxes	-30	-78	161
Unrealized holding gains (losses) on derivatives [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member] | Currency Forwards [Member]	'	'	'
Reclassification out of Accumulated Other Comprehensive Income [Line Items]	'	'	'
Cost of sales	-61	11	118
Research and development	30	-63	20
Marketing, general and administrative	0	-25	19
Unrealized holding gains (losses) on derivatives [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member] | Other Instruments [Member]	'	'	'
Reclassification out of Accumulated Other Comprehensive Income [Line Items]	'	'	'
Cost of sales	1	-1	4
Prior service credits (costs) [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]	'	'	'
Reclassification out of Accumulated Other Comprehensive Income [Line Items]	'	'	'
Other Comprehensive (Income) Loss, Amortization Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Prior Service Cost (Credit), before Tax	-4	-5	-7
Actuarial gains (losses) [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]	'	'	'
Reclassification out of Accumulated Other Comprehensive Income [Line Items]	'	'	'
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Gain (Loss), before Tax	-101	-90	-43
Amortization of pension and postretirement benefit components [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]	'	'	'
Reclassification out of Accumulated Other Comprehensive Income [Line Items]	'	'	'
Income before taxes	($105)	($95)	($50)

Contingencies_Detail

Contingencies (Detail)	Aug. 19, 2010	Jun. 30, 2012	31-May-09	31-May-09	Nov. 30, 2008	Jun. 30, 2008	Dec. 31, 2008	Oct. 31, 2010
Share data in Millions, except Per Share data, unless otherwise specified	McAfee, Inc. [Member]	McAfee, Inc. [Member]	EC Fine [Member]	EC Fine [Member]	Korea Fair Trade Commission Antitrust Violation Inquiry [Member]	Korea Fair Trade Commission Antitrust Violation Inquiry [Member]	Lehman Matter [Member]	Lehman Matter [Member]
	McAfee Shareholder Litigation [Member]	McAfee Shareholder Litigation [Member]	USD ($)	EUR (€)	USD ($)	USD ($)	USD ($)	Pending Litigation [Member]
	USD ($)	Pending Litigation [Member]						USD ($)
		USD ($)
Loss Contingencies [Line Items]	'	'	'	'	'	'	'	'
Loss Contingency, Announced Fine Intention	'	'	'	'	'	$25,000,000	'	'
Loss Contingency, Fine	'	'	1,447,000,000	1,060,000,000	20,000,000	'	'	'
Loss Contingency, Pre-Payment Amount For Forward-Purchase Agreement	'	'	'	'	'	'	1,000,000,000	'
Loss Contingency, Cash Collateral Received For Forward-Purchase Agreement	'	'	'	'	'	'	1,000,000,000	'
Loss Contingency, Shares Of Intel Common Stock Required To Be Delivered Under Forward-Purchase Agreement	'	'	'	'	'	'	50	'
Loss Contingency, Cash Collateral Foreclosed On In Forward-Purchase Agreement	'	'	'	'	'	'	1,000,000,000	'
Loss Contingency, Damages Sought, Value	'	'	'	'	'	'	'	$312,000,000
Cash Per Share of Acquiree Common Stock and Common Stock Subject to Restricted Stock Awards, Vested Restricted Stock Unit Awards, and Vested Performance Stock Unit Awards Upon Completion of Acquisition	$48	'	'	'	'	'	'	'
Loss Contingency, Plaintiffs Damages Expert Value Assertion of Share of Acquiree for Purposes of Assessing Damages	'	$62.08	'	'	'	'	'	'

Operating_Segments_and_Geograp2

Operating Segments and Geographic Information (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 28, 2013	Dec. 29, 2012	Dec. 31, 2011
Schedule Of Segment Reporting Information [Abstract]	'	'	'
Net revenue	$52,708	$53,341	$53,999
Operating income (loss)	12,291	14,638	17,477
PC Client Group [Member]	'	'	'
Schedule Of Segment Reporting Information [Abstract]	'	'	'
Net revenue	33,039	34,504	35,624
Operating income (loss)	11,827	13,106	14,840
Data Center Group [Member]	'	'	'
Schedule Of Segment Reporting Information [Abstract]	'	'	'
Net revenue	11,238	10,511	9,911
Operating income (loss)	5,164	5,020	5,053
Other Intel Architecture Operating Segments [Member]	'	'	'
Schedule Of Segment Reporting Information [Abstract]	'	'	'
Net revenue	4,092	4,378	5,005
Operating income (loss)	-2,445	-1,377	-577
Software and Services Operating Segments [Member]	'	'	'
Schedule Of Segment Reporting Information [Abstract]	'	'	'
Net revenue	2,502	2,381	1,870
Operating income (loss)	1	-11	-32
All Other [Member]	'	'	'
Schedule Of Segment Reporting Information [Abstract]	'	'	'
Net revenue	1,837	1,567	1,589
Operating income (loss)	($2,256)	($2,100)	($1,807)

Operating_Segments_and_Geograp3

Operating Segments and Geographic Information, Revenue by Major Customers (Detail)	12 Months Ended
	Dec. 28, 2013	Dec. 29, 2012	Dec. 31, 2011
Hewlett-Packard Company [Member]	'	'	'
Revenue, Major Customer [Line Items]	'	'	'
Entity-Wide Revenue, Major Customer, Percentage	17.00%	18.00%	19.00%
Dell Inc. [Member]	'	'	'
Revenue, Major Customer [Line Items]	'	'	'
Entity-Wide Revenue, Major Customer, Percentage	15.00%	14.00%	15.00%
Lenovo Group Limited [Member]	'	'	'
Revenue, Major Customer [Line Items]	'	'	'
Entity-Wide Revenue, Major Customer, Percentage	12.00%	11.00%	9.00%

Operating_Segments_and_Geograp4

Operating Segments and Geographic Information, Revenues from External Customers by Country (Detail) (USD $)	12 Months Ended
	Dec. 28, 2013	Dec. 29, 2012	Dec. 31, 2011
Schedule of Revenues from External Customers, By Country [Line Items]	'	'	'
Net revenue	$52,708,000,000	$53,341,000,000	$53,999,000,000
Revenue From External Customers Attributed To Foreign Countries	43,600,000,000	45,000,000,000	45,000,000,000
Singapore [Member]	'	'	'
Schedule of Revenues from External Customers, By Country [Line Items]	'	'	'
Net revenue	10,997,000,000	12,622,000,000	13,626,000,000
China (Including Hong Kong) [Member]	'	'	'
Schedule of Revenues from External Customers, By Country [Line Items]	'	'	'
Net revenue	9,890,000,000	8,299,000,000	7,133,000,000
United States [Member]	'	'	'
Schedule of Revenues from External Customers, By Country [Line Items]	'	'	'
Net revenue	9,091,000,000	8,348,000,000	9,005,000,000
Taiwan [Member]	'	'	'
Schedule of Revenues from External Customers, By Country [Line Items]	'	'	'
Net revenue	8,888,000,000	9,327,000,000	8,534,000,000
Japan [Member]	'	'	'
Schedule of Revenues from External Customers, By Country [Line Items]	'	'	'
Net revenue	3,725,000,000	4,303,000,000	4,538,000,000
Other Countries [Member]	'	'	'
Schedule of Revenues from External Customers, By Country [Line Items]	'	'	'
Net revenue	$10,117,000,000	$10,442,000,000	$11,163,000,000

Operating_Segments_and_Geograp5

Operating Segments and Geographic Information, Long-Lived Assets (Detail) (USD $)	Dec. 28, 2013	Dec. 29, 2012	Dec. 31, 2011
Schedule Of Long-Lived Assets [Line Items]	'	'	'
Property, plant and equipment, net	$31,428,000,000	$27,983,000,000	$23,627,000,000
Long-Lived Assets	7,800,000,000	7,400,000,000	7,200,000,000
United States [Member]	'	'	'
Schedule Of Long-Lived Assets [Line Items]	'	'	'
Property, plant and equipment, net	23,624,000,000	20,542,000,000	16,448,000,000
Ireland [Member]	'	'	'
Schedule Of Long-Lived Assets [Line Items]	'	'	'
Property, plant and equipment, net	2,986,000,000	1,523,000,000	1,198,000,000
Israel [Member]	'	'	'
Schedule Of Long-Lived Assets [Line Items]	'	'	'
Property, plant and equipment, net	2,667,000,000	3,389,000,000	3,356,000,000
Other Countries [Member]	'	'	'
Schedule Of Long-Lived Assets [Line Items]	'	'	'
Property, plant and equipment, net	$2,151,000,000	$2,529,000,000	$2,625,000,000

Valuation_and_Qualifying_Accou1

Valuation and Qualifying Accounts (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 28, 2013	Dec. 29, 2012	Dec. 31, 2011
Allowance for doubtful receivables [Member]	'	'	'
Valuation Allowances And Reserves, Disclosure [Roll Forward]	'	'	'
Valuation Allowances And Reserves, Beginning Balance	$38	$36	$28
Valuation Allowances And Reserves, Additions Charged to Expenses/Other Accounts	5	3	8
Valuation Allowances And Reserves, Net (Deductions) Recoveries	-5	-1	0
Valuation Allowances And Reserves, Ending Balance	38	38	36
Valuation allowance for deferred tax assets [Member]	'	'	'
Valuation Allowances And Reserves, Disclosure [Roll Forward]	'	'	'
Valuation Allowances And Reserves, Beginning Balance	389	373	252
Valuation Allowances And Reserves, Additions Charged to Expenses/Other Accounts	88	77	121
Valuation Allowances And Reserves, Net (Deductions) Recoveries	-21	-61	0
Valuation Allowances And Reserves, Ending Balance	$456	$389	$373